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Abstract
Mouse skin tumourigenesis occurs through a series of discrete steps associated with 
specific genetic alterations, from an initiated cell, to a benign papilloma, and subsequently 
to a malignant squamous carcinoma. A proportion of these malignant tumours undergo a 
dramatic change in cell phenotype, which is accompanied by substantial alterations in the 
expression of several markers of epithelial differentiation. These spindle cell carcinomas 
have been well characterised biologically, but the genetic events which are responsible for 
the transition to these invasive tumours are not well understood. The work presented in 
this thesis was designed to address the genetic basis of the spindle transition by 
cytogenetic, molecular genetic and functional approaches.
Amplification of the mutant H-ms allele and / or loss of the normal H-ras allele are 
consistently found in spindle cell carcinomas, which also frequently show imbalances of 
chromosome 7. The mechanistic basis for these ras / chromosome 7 changes was 
investigated by Fluorescence in situ Hybridisation using chromosome paints. In the 
squamous carcinoma cell line, B9, increases in mutant H-ras were caused by whole 
chromosome duplication, while in the clonally-related spindle cell lines, A5 and D3, a 
further increase in expression was achieved by localised amplification of the mutant H-ras 
gene on double minute chromosomes.
To establish the nature of the gene(s) lost at the squamous-spindle transition, somatic cell 
fusions were carried out between the clonally-related B9 and A5 cells. The hybrids were 
epithelial in morphology and expressed characteristic epithelial proteins, such as E- 
cadherin and the keratins. In addition, they were found to be suppressed in their ability to 
form tumours following injection into nude mice. These experiments demonstrate that 
spindle cells arise by a mechanism involving loss of a tumour suppressor gene.
To identify putative tumour suppressor loci, we developed an approach using hybrid cells 
generated between a keratinocyte cell line, C5N, and the spindle carcinoma cell line, 
carB. Tumourigenicity was initially suppressed in these hybrids, but the tumours which 
did arise, after a long latency, were poorly differentiated squamous carcinomas or 
undifferentiated
spindle carcinomas. Allelotype analysis of the tumours enabled us to identify regions on 
mouse chromosomes 4 and 7, which harbour putative tumour suppressor genes involved 
in mouse skin tumourigenesis.
In order to determine the function and relevance of each of these loci in the acquisition of 
the spindle phenotype, the syntenic regions from the human genome were introduced by 
microcell-mediated monochromosome transfer into spindle carcinoma cell lines. This 
strategy, involving a single human chromosome on ai mouse background, facilitates finer 
mapping of the loci in revertant clones.
Using this approach, we have identified a locus on chromosome 15 corresponding to the 
locus identified on mouse chromosome 7, which may cause growth inhibition of A5 cells. 
Introduction of human chromosome 9 into A5 and carB cells caused a partial reversion to 
the squamous phenotype and tumour suppression. The loss of the p i6 tumour suppressor 
gene located on human chromosome 9p21, is known to be associated with the loss of 
differentiation which occurs in the transition to the spindle phenotype. Therefore the 
effect of human chromosome 9 on spindle cells; may be partly explained by the 
consequences of introducing pl6 . However, several lines of evidence point to the 
existence of a second locus on human chromosome 9 which may be important in the 
conversion to spindle carcinomas. Future work will focus on the identification of this 
gene(s) and the role it plays in this last stage of mouse skin tumourigenesis.
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Introduction
Chapter 1 : Introduction.
1. Mouse skin - a model system.
The mouse skin carcinogenesis model has provided remarkable insights into the 
biology, biochemistry, pharmacology, and genetics of carcinogenesis. Many of the 
landmarks of cancer research have evolved from studies of mouse skin : the mechanism 
of action of tumour promoters, the common origin of benign and malignant tumours, 
the hereditary susceptibility to tumour formation, and the requirement for multiple 
changes to accumulate during malignant progression. The fact that so many of the 
general principles defined from such studies find parallels in human squamous cancers, 
suggests that the conceptual framework established in mouse skin keratinocytes serves 
as a prototype for understanding the pathogenesis of most epithelial neoplasms. This, in 
time, should contribute to better diagnosis, and preventive and therapeutic approaches 
for the treatment of human cancers.
1.1. The regulation o f normal epidermal growth and differentiation in the skin.
A fine balance exists in a normal cell between the regulation of cell proliferation and 
differentiation. It has long been recognised that the successive loss of certain 
differentiated features of epithelial cells is an important hallmark of malignancy. 
Epithelial cells which usually grow within highly ordered tissue structures, often 
become much less organised in a carcinoma, changing interactions with their 
neighbouring cells, and with the basement membrane, and altering their apical-basal 
polarity.
In a stratified epithelium such as the epidermis, keratinocytes in the basal layer contact 
adjacent cells, and adhere to an epithelial-specific basement membrane. The basal layer 
is the proliferating layer, and migration of cells into the more superficial spinous layer 
is associated with the loss of proliferative capability. The terminal phase of 
differentiation is initiated once cells have migrated to the granular cell compartment, 
where the cells become larger and flatter. Finally, at the comified layer, the plasma 
membrane of the cells is replaced by a rigid, comified envelope, the nucleus 
disintegrates, and the cells become nonviable squames, which form a skin barrier 
(Fuchs, 1990). If cancer represents a disease of aberrant differentiation, then the study of 
the mechanisms regulating expression of the differentiated state in normal cells should 
provide insight into the possible defects in malignant cells.
The stratified epidermis displays a highly coordinated program of sequential changes in 
gene expression which are coincident with the evolution from a proliferating basal cell
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to a mature, nonviable squame (Fuchs, 1990). These are depicted in Figure 1. The 
interaction between basal cells and the basement membrane is mediated largely, if not 
entirely, by members of the integrin family of receptors (Tennenbaum et al.,1992; 
Hynes, 1992). In particular, basal cells express the a6|34 integrin complex, which is 
polarized on the basal surface, although other integrins mediate cell-cell and cell-matrix 
interactions to maintain the stratified phenotype (Hertle et al.,1991). Integrins bind to 
extracellular matrix proteins such as fibronectin, collagens, and laminin, and translate 
these external cues into signals that affect cytoskeletal organization, cell shape and 
motility, by way of their direct interaction with cytoskeletal proteins like actin, and 
intermediate filaments within the cell (Hynes, 1992).
A principle regulator for keratinocyte growth and differentiation is a gradient of 
extracellular and intracellular calcium across the epidermis which is low in the basal 
cell compartment and high in the granular cell layer (Menon et al.,1985). This, and an 
opposing vitamin A gradient may contribute to the regulation of keratinocyte gene 
expression (Darmon,1991).
Basal cells express the characteristic epidermal keratins, K5 and K14, which are 
replaced by K1 and K10 in the cells of the spinous layer, markers of the early stage of 
keratinocyte differentiation. Upon further migration into the granular layer, the 
expression of K1 and K10 is suppressed, and the expression of loricrin, filaggrin and 
transglutaminase is up-regulated, processes which require the activation of protein 
kinase C (PKC) (Dlugosz and Yuspa,1993). The activation of transglutaminase in 
granular cells cross-links loricrin and other substrates to form the rigid, permeable 
comified envelope that replaces the plasma membrane in the cells of the comified layer. 
Transduction of the Ca2+ signal is associated with increased activity of phospholipase C 
(PLC) (Lee and Yuspa,1991; Punnonen et al.,1993), and the associated rise in PLC- 
generated diacylglycerol may contribute to the activation of PKC that is essential to the 
terminal phase of maturation (Ziboh et al.,1984).
Restraint on cell proliferation in the basal layer is mediated, in part, by TGF|31, while 
positive growth control is contributed by local expression of TGFa and several other 
EGF receptor ligands. Proliferation is strictly confined to the basal layer through 
production of the growth inhibitor, TGF(32 and down-regulation of the EGF receptor, in 
suprabasal cells (Glick et al.,1993; King et al.,1990; Vassar and Fuchs,1991).
Compartmentalization and differential expression of epidermal-specific genes are the 
key to the organization and regulation of epidermal differentiation. Disruption of this 
tightly regulated process is at the heart of many cutaneous disorders and neoplasms.
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1.2. Mouse skin carcinogenesis.
The mouse skin model offers a model system for the study of the multistep nature of 
tumour formation. The development of squamous cell carcinomas from normal skin 
epithelia involves three distinct steps ; initiation, promotion and progression (Yuspa 
and Poirier, 1988). Each of these defined stages in chemically-induced skin 
carcinogenesis is characterised by specific genetic and biological alterations.
The development of skin tumours in mice can be easily followed. After a single 
application of an initiator and multiple applications of a promoter, numerous benign 
papillomas arise on the back of the treated mouse. About 5-10% of these progress 
towards malignancy. The resulting carcinomas can be of two types ; they may be well- 
differentiated squamous carcinomas, which retain many of the differentiation features 
of the original tissue, including expression of E-cadherin and the keratins, or they may 
be a more advanced spindle carcinoma, which has lost these epithelial markers, and is 
composed of fusiform cells (Klein-Szanto et al.,1989; Navarro et al.,1991; Diaz-Guerra 
et al.,1992).
1.2.1 Initiation.
Treatment of mouse skin with a chemical carcinogen causes a subtle change in the 
phenotype of the keratinocyte, which is unrecognisable in the context of the intact 
epidermis. However, the fact that these intiated cells can lie dormant in the skin for 
long periods, while still retaining the capacity to form benign papillomas following 
treatment with a promoter (Van Duuren et al.,1975), indicates that the effect of the 
initiating agent is permanent and irreversible.
The observation that different initiating chemicals were associated with specific 
mutations in the H-ras gene, led to the proposal that the carcinogen interacts directly 
with DNA to cause a genetic mutation (Zarbl et al.,1985a; Zarbl et al.,1985b). In this 
regard, over 90% of tumours initiated with DMBA (dimethylbenzanthracene), have the 
same A-T transversion mutation at codon 61 of the H-ras gene (Quintanilla et al.,1986). 
The causal nature of H-ras mutations in the initiation stage of carcinogenesis was 
formally demonstrated when it was observed that direct application of retroviruses 
carrying activated H-ras to mouse skin could replace chemical initiation by DMBA 
(Brown et al.,1986).
Many human benign and malignant skin tumours contain ras gene mutations, and 
members of the ras gene family are found to be activated in a large proportion of 
different human cancers (reviewed in Bos, 1989), including mutations in codon 12 of
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the K-ras gene in premalignant adenomas in the colon (Forrester et al.,1987). In most 
cases, activation of ras is regarded as an early event.
1.2.2. Promotion.
Application of tumour promoters to initiated epidermis causes the selective outgrowth 
of initiated cells to produce benign papillomas (Deamant and Iannaccone,1987; 
Iannaccone et al.,1987). This idea of a papilloma being an expanded clone of initiated 
cells has gained credibility from both in vivo and in vitro systems. The most potent 
exogenous skin tumour promoters, and the agents about which most are known, are the 
phorbol esters, which includes 12-O-tetradecanoylphorbol-13-acetate (TPA). Their 
effects in vitro, in epidermal cell cultures, and in vivo, in mouse skin, range from rapid 
changes in cell membrane properties, leading to an inhibition in intercellular 
communication (Fitzgerald and Murray, 1980), to more prolonged effects on DNA 
synthesis (Yuspa et al.,1976; Fusenig and Samsel,1978), and changes in the expression 
of epidermal proteins (Balmain,1976; Cabral et al.,1981; Laskin et al.,1981; Schwezer 
and Winter, 1982).
It is difficult to predict the relationship of rapid membrane effects to the mechanism of 
action of tumour promoters. However, cell-cell communication is thought to play a 
crucial role in the control of cell proliferation and differentiation (Lowenstein,1981).
The effects o f TP A on proliferation and differentiation.
A separate, more direct role of TPA on epithelial proliferation was demonstrated by 
Yuspa's group, who provided evidence for both stimulatory and inhibitory effects 
(Steinert and Yuspa,1978; Yuspa et al.,1982). After a brief exposure to TPA, a transient 
decrease in DNA synthesis was followed by a five to tenfold increase in synthesis and 
mitotic rate (Yuspa et al,1976). In line with this, and other data, they proposed that 
initiated epidermis is composed of a heterogeneous population of cells which differ in 
their response to TPA. The appearance of a visible tumour is thereby caused by the 
preferential proliferation of initiated cells over surrounding normal cells, facilitated by 
tumour promoters. Indeed, treatment of mouse dorsal skin with DMBA increased the 
population of epidermal cells that continued to proliferate under conditions in which 
normal cells are obliged to differentiate (Kilkenny et al.,1980; Yuspa and 
Morgan, 1981). If tumour promoters accomplish their effects by preventing initiated 
cells from entering into terminal differentiation, and thereby maintaining their 
proliferation, then an essential role of the initiators must be to disrupt genes involved in 
cellular commitment to differentiation.
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Phorbol esters exert effects on gene expression through the modulation of the protein 
kinase C (PKC) subspecies. The functions of the various PKC proteins are diverse. As 
well as inducing the expression of various proto-oncogenes, they also play a negative 
role in the control of cellular proliferation (Nishizuka,1986).
PKC is generally thought to play a crucial role in the promotion stage of mouse skin 
carcinogenesis. TPA activates PKC by masquerading as a diacylglycerol-like molecule, 
which is the normal activator of PKC (Castagna et al.,1982). TPA-induced down- 
regulation has been reported in several of the PKC isoforms, including PKC a , |3 and 6 
(Olivier et al.,1992). Conflicting observations have been reported regarding the r\ 
isoform, which shows tissue specificity for the skin and lung (Osada et al.,1990). 
Gschwent et al., (1992) originally reported that treatment of mouse skin with TPA 
caused complete down-regulation of the r| isoform. However, recently, several groups 
have shown that the activity of the q isoform was not altered following treatment with 
TPA or bryostatin, both activators of PKC (Denning et al.,1995; Reynolds et al.,1994; 
Murakami et al.,1996). In agreement with these more recent reports, cholesterol sulfate, 
an activator of the q isoform was found to be a potent inhibitor of the promotion phase 
of mouse skin carcinogenesis (Chida et al.,1995).
Staurosporine, an inhibitor of tyrosine and serine kinases, prevented the tyrosine 
phosphorylation of PKC6, and induced terminal differentiation in v-rasH and 
carcinogen-initiated keratinocytes (Denning et al.,1993; Dlugosz et al.,1991). In vivo, 
staurosporine caused irreversible papilloma regression (Strickland et al.,1993).
Thus, differential modification of isoforms of PKC, particularly activation of PKCq 
and inhibition of PKC6, produces keratinocytes with enhanced proliferative capacity 
and reduced sensitivity to signals for terminal differentiation. In normal keratinocytes, 
the effect of TPA-mediated activation of PKC is to accelerate terminal differentiation. 
Initiated keratinocytes, in contrast, are resistant to terminal differentiation induced by 
activators of PKC. This differential response of normal and initiated cells favours the 
growth of the neoplastic subpopulation, enhancing clonal outgrowth and producing 
papillomas.
TPA and growth factors.
Exposure to exogenous chemicals is required for the earliest stages of skin 
carcinogenesis, as is the case in most internal tissues as well. However, in internal 
tissues, the early stages of tumourigenesis may be mediated by promoting agents which 
are endogenous to the organism, such as hormones and growth factors.
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Numerous in vitro studies have documented alterations in TGFa and its receptor, 
EGFR, associated with v-rasH-mediated transformation of epithelial cells. Expression 
of v-rasH in cultured mouse keratinocytes induced a large increase in TGFa mRNA and 
protein expression (Glick et al.,1991; Cheng et al.,1993), and treatment of normal 
keratinocytes in vitro with exogenous TGFa elicits many of the same phenotypic 
alterations as v-rasH (Cheng et al.,1993).
Autocrine activation of the epidermal growth factor receptor by TGFa has also been 
implicated in epithelial neoplasia in vivo. Transgenic mice, in which overexpression of 
TGFa was targeted to the epidermis, using K1 or K14 promoters, developed 
hyperplasia and papillomas following tumour promotion by wounding or TPA 
treatment (Vassar et al.,1992; Wang et al.,1994). This indicated that overexpression of 
TGFa could substitute for H-ras gene activation as an initiator in two-stage cutaneous 
carcinogenesis. TGFa might also act as a tumour-promoting stimulus, since treatment 
of TGFa transgenic mice with DMBA led to the production of both papillomas and 
carcinomas (Jhappan et al.,1994). High levels of TGFa have been detected in 
papillomas generated using the two-stage chemical carcinogenesis protocol (Rho et 
al.,1994), again suggesting that oncogenic ras may alter keratinocyte behaviour, at least 
in part, via activation of the TGFa / EGFR signalling pathway.
An anomalous situation is found in mice with genetic defects in TGFa expression. 
TGFa homozygous null mice produced the same number of papillomas and carcinomas 
as wild-type controls (Ashley Dunn and Ken Brown, unpublished observations), 
indicating that TGFa expression is not obligatory in ras-mediated epidermal 
tumourigenesis. Furthermore, \-rasu keratinocytes derived from control as well TGFa- 
deficient mice both produced squamous tumours when grafted onto nude mice, and 
these lesions expressed high levels of structurally-related ‘alternate’ EGFR ligands 
(Dlugosz et al.,1995). These findings suggest that another EGFR ligand(s) may be 
capable of substituting for TGFa to stimulate the growth of v-rasH-transformed 
keratinocytes in vitro. The role of these ligands in the physiology of normal or 
neoplastic keratinocytes in vitro or in vivo has not yet been defined.
The role of AP-1 and AP-1-dependent transcription in mouse skin tumour progression. 
Continuous treatment of DMBA-initiated mouse skin, or benign mouse keratinocytes in 
culture, with TPA leads to deregulated expression of a number of genes (Holliday et 
al.,1992; Rorth et al.,1990). The expression of these genes is regulated, in part, by TPA- 
responsive elements (TREs) in the promoter region (Angel et al.,1987a). The factors 
which bind these TREs, and participate in the regulation of gene expression, have been
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identified as the AP-1 transcription factor complexes, composed of jun'.jun or jumfos 
dimers, as well as other heterodimers (Lee et al.,1987; Chiu et al.,1988).
The fact that AP-1 plays an important role in the conversion to, and maintenance of the 
malignant phenotype of squamous carcinoma cells was inferred from experiments in 
which a deletion mutant jun protein, which acts as a dominant negative transcription 
factor, was introduced into malignant keratinocytes (Bowden et al.,1994). 
Transcriptional transactivation of AP-1 responsive reporter constructs was inhibited by 
the mutant jun. Furthermore, these cells were inhibited in their ability to form tumours 
when injected subcutaneously into nude mice. Thus, inhibition of AP-1-mediated 
transcriptional transactivation is sufficient to suppress the tumourigenic phenotype of 
some malignant mouse epidermal cell lines.
TPA has also been shown to induce c-jun expression directly (Lamph et al.,1988), and 
enhance its transcriptional transactivation potential by phosphorylation of certain 
residues (Franklin et al.,1992). The fact that the transcription of many genes is 
dependent on c-jun and AP-1 activity, means that this aspect of phorbol esters has more 
general consequences, which are important at stages other than promotion. For 
example, there are several lines of evidence supporting the view that acquisition of 
constitutive AP-1 activity is of importance, particularly at late stages of mouse skin 
cancer (Greenhalgh and Yuspa,1988; Domann et al.,1994b; Bowden et al.,1994) . One 
of the possible reasons for this is that basement-membrane degrading enzymes, such as 
stromelysin and collagenase, are among some of the targets of AP-1 mediated 
transcription (Angel et al.,1987b; Sirum and Brinckerhoff,1989; Domann et al.,1994a).
Despite the fact that many of these effects are induced directly by TPA, the same 
changes in gene expression, cell growth and differentiation occur in most cancer cells.
1.2.3. Progression.
The progression stage can be further subdivided into premalignant progression and 
benign-malignant progression. The former definition deals with the selection and clonal 
outgrowth of cells which have acquired a growth advantage, usually as a result of 
chromosomal changes, or alterations in the expression patterns of certain proteins. 
Some benign lesions go no further than this stage, and some may regress. Benign- 
malignant progression can be defined as the transition from papillomas to malignant 
carcinomas, and is a result of further genetic changes, although epigenetic mechanisms 
may also play a role.
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Premalignant progression - high and low risk papillomas.
A subset of papillomas has been identified, which have a high probability of 
progressing to carcinomas. This subpopulation is also more sensitive to mutagen- 
induced progression (Hennings et al., 1990a). Thus, the factors which determine overall 
risk for progression, must increase susceptibility to genetic changes. High risk 
papillomas appear early, grow large and do not regress when promotion is stopped 
(Hennings et al., 1985; Hennings et al., 1990b), suggesting that tumour cell growth must 
be especially enhanced in this group. If these tumours are particularly 
hyperproliferative, this, in turn, could enhance the accumulation of genetic or 
chromosomal changes.
Although specific genetic events distinguishing the two types of papillomas have not 
yet been formally demonstrated, they do differ with respect to their profile of growth 
factors. The TGF(3s are potent growth inhibitors of normal keratinocytes in vitro and in 
vivo, and TGF|31 is found to be induced in response to TPA treatment of mouse skin. 
Despite the presence of TGF|31 and TGF|32 mRNA in normal skin and both types of 
benign lesions, the proteins are absent in high risk papillomas (Fowlis et al.,1992; Glick 
et al.,1993), which explains their increased rate of proliferation. High risk papillomas 
are also characterised by several phenotypic markers. In contrast to low risk papillomas, 
they do not express keratin 1 (Kl), but instead synthesise K13, and a6|34 integrin is 
detectable in suprabasal and basal cells in high risk papillomas, while in normal cells 
and low risk papillomas, its expression is restricted to the basal surface of basal cells 
(Tennenbaum et al.,1993).
These distinct phenotypic and behavioural characteristics, which are detectable at the 
earliest sign of benign tumour formation, suggest that high and low risk papillomas are 
derived from distinct populations of initiated cells within the skin. Evidence to support 
this notion was gleaned from ras transgenic mice, in which an activated H-ras 
transgene was expressed in two different cell types within the epidermis.
When the ras oncogene was placed under the control of the keratin 10 promoter, the 
mice developed hyperkeratosis of the skin and forestomach, where the expression of 
keratin 10 is high. In addition, at sites of wounding, the mice formed papillomas. 
However these did not progress to carcinomas within the time-scale of the experiment 
(Bailleul et al.,1990). A K5-ras transgene whose expression was restricted to the hair 
follicles, gave very different results. Mo»st animals displayed a ‘mild’ phenotype, in 
which papillomas frequently progressed to both squamous and spindle carcinomas, but 
some animals developed carcinoma in situ within the first few weeks after birth. 
(Brown et al., submitted for publication). Thus, expression of oncogenic ras in different
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cell types within the same lineage led to benign lesions in one case, and frequent 
progression to malignancy in the other.
Benign-malignant progression.
Malignant conversion of benign tumours is a relatively rare occurrence since only 5- 
10% of papillomas spontaneously convert to carcinomas (Hennings et al.,1983). 
Furthermore, since the progression frequency of papillomas to carcinomas does not 
change if TPA is continued or discontinued after papilloma formation (Hennings et 
al.,1983), the transition from a benign to a malignant lesion is regarded as being 
promoter-independent. However, the number of carcinomas can be enhanced and 
accelerated by exposing animals bearing papillomas to a mutagen (Hennings et 
al., 1990b). This, and other evidence from in vitro experiments, in which papilloma cell 
lines were converted to squamous carcinoma cells following introduction of specific 
oncogenes (Harper et al.,1986; Dotto et al.,1988; Greenhalgh and Yuspa,1988; 
Greenhalgh et al.,1989), supports a genetic basis for progression.
Despite the fact that the involvement of tumour suppressor genes is well documented in 
human cancers, until fairly recently, studies using animal models of cancer have lagged 
behind, partly because of the widespread use of inbred rodent strains. These do not lend 
themselves to the detection of putative suppressor loci through loss of heterozygosity 
studies (LOH). Nevertheless, tumours arising in FI hybrid mice between distantly- 
related inbred strains do carry distinct restriction fragment length polymorphisms 
(RFLP) (Bremner and Balmain, 1990), and this approach is now widely used in LOH 
analyses of numerous tumour types. In one such study, LOH was detected on 
chromosome 11 in 30% of chemically-induced carcinomas, but was absent in 
papillomas (Kemp et al., 1993b). Mutational analysis of the p53 gene, located on this 
chromosome, and known to be altered in many human malignancies, revealed that it 
behaves as a classical tumour suppressor gene in mouse skin carcinomas. In those cases 
where one allele of p53 was lost, the other invariably carried a mutation (Bums et 
al.,1991). Since no alterations were found in any of the papillomas examined, the loss 
of p53 function must be associated with the benign-malignant transition. Despite the 
fact that loss of p53 appears to precede the development of spindle carcinomas, there 
are two lines of evidence which support the idea that loss of p53 is also selected for, in 
tumours progressing to a less differentiated, more invasive phenotype.
An analysis of the status of p53 in several tumours by immunoprecipitation with an 
antibody which specifically recognises mutant p53, indicated that out of the seven 
tumours which exhibited alterations of p53, six of them were classified as Stage II 
squamous cell carcinomas or greater in their histological grade (Ruggeri et al.,1991).
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Secondly, a comparison of the incidence of chemically-induced skin tumours in 
homozygous, heterozygous and wild-type p53 littermates indicated that the small 
number of papillomas which arose in the null mice showed a 10-fold increase in the 
frequency of progression. The resulting carcinomas were also found to be less well 
differentiated and showed earlier metastasis than control mice (Kemp et al.,1993a).
The loss of wild-type p53 function by deletion or mutation may contribute to tumour 
progression by way of its ability to render cells resistant to the growth inhibitory effects 
of TGFp. In vitro, introduction of mutant p53 into neoplastic epithelial cells, which 
retained wild-type p53 function, imparted resistance to TGFp-induced growth 
inhibition, suggesting a possible link between mutations in p53, TGFp and tumour 
progression (Reiss and Sartorelli,1987; Gerwin et al.,1992).
In a separate set of experiments, keratinocytes isolated from p53 +/+, +/-, or -/- mice 
were analysed for their ability to form tumours, following introduction of oncogenic 
ras. Mice receiving wild-type p53 keratinocytes, transduced with v-rasH developed 
papillomas, while both p53 null and heterozygous keratinocytes gave rise to 
carcinomas, although in the latter case with a longer latency (Weinberg et al., 1994). 
Part of the reason for the difference in the behaviour of the three cell lines may be a 
result of the difference in their response to TGFp observed in vitro : keratinocytes from 
p53 knockout mice were less sensitive to growth inhibition by TGFpi or TGFp2, 
compared with wild-type keratinocytes, while p53 heterozygous keratinocytes were 
intermediate in their response. Additionally, it was noted that the responsiveness of p53 
null keratinocytes was decreased further when v-rasH was present (Yuspa,1994), 
indicating a further co-operation between p53 mutations and oncogenic ras. Cells 
harbouring a mutation in p53 may be among the 10% of carcinomas, and 20% of high 
risk papillomas which retain TGFp expression.
Corroborating evidence, linking the loss of TGFpi with accelerated tumour 
progression, comes from studies using keratinocytes cultured from knockout mice, 
which have a targeted disruption of the TGFpi gene. Introduction of v-rasH into wild- 
type, TGFpi null or heterozygous keratinocytes led to papillomas when the cells were 
grafted to nude mice. However, in the case of the TGFpi null cells, carcinomas 
developed within four weeks after grafting (Yuspa,1994). This independent study 
appears to demonstrate that the TGFp family of growth inhibitors serve as suppressors 
of malignant progression, and the loss of TGFp perse, or, perhaps the loss of response 
to TGFp, is an important event in the progression to malignancy.
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Apparent contrasting evidence was obtained from experiments in which the expression 
of TGFpi, in its active form, was targeted to the epidermis of transgenic mice. This 
experiment also helped to settle several anomalies regarding the function of TGFpi. 
The mice were more resistant to the development of benign skin tumours, however, the 
number of papillomas which converted to malignant carcinomas was greatly increased 
compared with control animals (Cui et al.,1996). The carcinomas which did arise were 
frequently less differentiated, spindle carcinomas, indicating that TGFpi might actually 
enhance malignant conversion. Thus the action of TGFpi in mouse skin carcinogenesis 
is biphasic. At early stages, TGFp acts as a tumour suppressor, inhibiting the formation 
of benign lesions, but later, it enhances the conversion to a more undifferentiated 
tumour. The latter role of TGFpi in the squamous-spindle transition shall be discussed 
in the section on epithelial-mesenchymal transitions.
1.3. Relevance of chemical carcinogenesis to spontaneous tumours.
In the past, it has been argued that the study of the various stages during chemically- 
induced tumourigenesis in mice is of little relevance to naturally-occurring tumours 
either in mice or humans. It was believed by some, that by forcing the process of 
tumour formation along a particular pathway, starting with activation of H-ras, that the 
subsequent genetic events would not reflect those involved in spontaneously-occurring 
tumours.
This has fortunately proved not to be the case. The genes involved in mouse skin 
carcinogenesis have been found to be altered in a wide range of mouse and human 
cancers. In addition, in vitro work has shown that cell lines derived from untreated and 
carcinogen-treated epidermal cultures do not differ considerably in their morphological 
and functional characteristics with respect to clonability, growth in agar, and in vivo 
tumourigenicity (Fusenig et al.,1985). Furthermore, carcinogen or promoter treatment 
did not significantly increase the probability of obtaining permanent cell lines from 
primary epidermal cells. Rather, carcinogens appeared to enhance or accelerate altered 
cell growth and cytogenetic changes, which, in their absence took much longer, but 
nevertheless still occurred (Petrusevska et al.,1988).
Although the process of skin carcinogenesis has been well defined in mice, distinct 
steps in the development of human skin tumours largely remain to be elucidated. 
Extrapolation from mouse studies has been of some use in this respect. Three genetic 
alterations, identified in the mouse skin model, which are relevant for skin cancer in 
man, are mutational inactivation of p53, oncogenic activation of c-rasH and inactivation 
of p i  6 by mutation or deletion. Individuals with mutations in p i  6 are susceptible to the 
development of melanomas (Hussussian et al.,1994), and homozygous deletions of p i  6
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are found in many melanoma cell lines, and some primary tumours (Kamb et al.,1994; 
Nobori et al.,1994). Mutations in p53 are found in a high number of basal and 
squamous cell carcinomas, and the types of mutations are indicative of U.V. irradiation 
(Brash et al.,1991; Ziegler et al.,1993). Such mutations have also been found in sun- 
exposed but histologically normal skin (Nakazawa et al.,1994), thus, inactivation ofp53 
is a very early event in human non-melanoma skin cancer, ras was shown to be 
activated not only in malignant squamous and basal cell carcinomas, but also in 
keratoacanthomas, benign and often spontaneously regressing skin tumours (Corominas 
et al.,1989; Pierceall et al.,1991), indicating that, as in the mouse system, ras activation 
is also an early event.
1.3.1. Parallels with colorectal carcinogenesis.
Colorectal cancer is the paradigm for human multistep tumourigenesis. Abundant 
clinical and histopathological data suggest that most, if not all, malignant colorectal 
tumours arise from preexisting benign lesions called adenomas (Muto et al.,1975). As 
further proof of this, cells isolated from a human colonic adenoma can be converted in 
vitro to carcinomas (Paraskeva et al.,1992). The salient points regarding the genetic 
basis of colorectal tumourigenesis are (i) that alterations in oncogenes and tumour 
suppressor genes are involved, (ii) at least seven genetic events are required to reach 
malignancy, and (iii) both hereditary and environmental factors contribute to the 
development of colorectal tumours (Fearon and Vogelstein,1990; Kinzler and 
Vogelstein,1996).
As in the mouse skin model of multistep carcinogenesis, mutation of ras is also an early 
event in colorectal cancer. Mutations in K-ras were detected in 58% of large but still 
premalignant adenomas. However, examination of smaller, earlier adenomas revealed 
that only 9% carried this activated oncogene (Vogelstein et al.,1988). This indicated 
that alteration of another gene might initiate colon carcinogenesis, and activation of ras 
might enhance the expansion of the small population of cells in early adenomas, into 
larger adenomas. The gene responsible for initiation in the colon is thought to be APC.
Germline mutations in APC cause FAP (Familial Adenomatous Polyposis), a syndrome 
which predisposes individuals to the development of hundreds or thousands of 
adenomatous polyps in the colon (Groden et al.,1991; Nishisho et al.,1991). Kinzler and 
Vogelstein (1996) have recently proposed that APC acts as the 'gatekeeper' of colonic 
epithelial cell proliferation, and its inactivation is an essential step in the initiation of 
these tumours. In normal colonic epithelium its function is to maintain a constant cell 
number by ensuring that the response to stimuli for cell growth is appropriate, for 
example, following tissue damage. Thus, even if other mutations are present in
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otherwise normal colonic epithelium, these are incapable, in the presence of an intact 
gatekeeper, of causing neoplasia.
In mouse skin carcinogenesis, mutations in the H-ras proto-oncogene initiate a 
sequence of events by imparting selective pressure on downstream effectors, such as 
cyclin D1 and pl6 . In this system, H-ras may act as the gatekeeper of epidermal cell 
proliferation. Following inactivation of the gatekeeper in either mouse skin or colonic 
epithelium, subsequent events occur in both tissues in a fairly defined order.
This concept of a gatekeeper relies on the fact that mutations in other genes in the 
presence of a normal gatekeeper do not lead to a sustainable growth perturbation. This 
is borne out by studies on the phenotype of colonic epithelial cells harbouring an 
oncogenic ras. In fact, cells containing mutations in ras are fairly common and form 
foci of hyperproliferative cells (Pretlow et al.,1993). These hyperplastic cells retain a 
normal cellular organization, unlike their dysplastic counterparts which carry an APC 
mutation (Jen et al., 1994b). In addition, these hyperplastic lesions have little or no 
potential to form malignant tumours and may regress by apoptosis (Shpitz et al.,1996).
Mutations in p53 are found in approximately 75% of colorectal cancers (Baker et 
al.,1989; Baker et al.,1990), yet in the absence of a second mutation in APC, 
individuals carrying a germline mutation in p53 are not at high risk for developing 
colorectal cancer, nor do they develop polyposis (Garber et al.,1991).
In the scheme of tumour progression in vivo, p53 is associated with the transition from 
late, benign adenomas to malignant carcinomas, and mutations in p53 also occur at this 
stage in an in vitro model system of colorectal cancer (Baker et al.,1990; Williams et 
al.,1993). The involvement of p53 at the benign-malignant transition is therefore 
conserved in human colorectal cancer and mouse skin carcinogenesis.
Alterations in ras and p53 are found in both systems, and this is particularly reassuring 
as they are amongst the most common genetic abnormalities found in a wide range of 
human malignancies. The stages at which they are important also seem to be conserved, 
inferring that the loss of their functions are of universal importance in the development 
of many tumours. The genetic alterations in the two systems are illustrated in Figure 2.
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Figure 2 : Genetic changes associated with human colorectal cancer 
and mouse skin carcinogenesis.
APC mutations initiate the neoplastic process in colorectal 
epithelial cells, while H-ras provides this function in skin 
carcinogenesis. Tumour progression results from mutations 
in the other genes indicated, some of which, likep53, are 
commonly altered in both systems. (ACF = aberrant crypt foci)
Alterations in cell adhesion molecules are found in mouse skin tumours and human 
colorectal tumours. However, the stages of tumour development in which these 
molecules are implicated are apparently different. Mutations in the APC gene are very 
early events in familial and sporadic colon cancers (Kinzler and Vogelstein, 1996), 
while loss of E-cadherin is generally associated with invasive properties (reviewed in 
Birchmeier et al.,1993), and in the mouse skin model system, usually occurs at the 
squamous-spindle transition (Stoler et al.,1993).
The APC protein physically associates with the a - and |3- catenins (Rubinfeld et 
al.,1993; Su et al.,1993), which form part of the adhesive junction, and it appears that 
APC and E-cadherin may directly compete for binding to |3-catenin (Hulsken et 
al.,1994; Rubinfeld et al.,1995). The latest evidence indicates that early mutations in the 
APC gene could be the cause of changes in intracellular signalling pathways which 
result in increased cell growth (Gumbiner,1995). In contrast, E-cadherin loss directly 
leads to a reduction in cell adhesion (Frixen et al.,1991), thereby releasing the tumour 
cells from the confines of the growth-restraining signals associated with such adhesion, 
and thereby permits invasion and metastatic spread.
Finally, interesting parallels can be seen between the two systems with respect to the 
loss of response to the growth-inhibitory effects of TGFp. The timing of the events 
involved in TGFp resistance can be localised at the papilloma to carcinoma transition in 
mouse skin (Haddow et al.,1991). In human colorectal tumourigenesis, adenoma cell 
lines are more sensitive to the inhibitory effects of TGFp than cell lines derived from
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carcinomas, and the conversion of an adenoma cell line in vitro to a tumourigenic 
phenotype was accompanied by a reduction in the response to TGF|3 (Manning et 
al.,1991). Thus, in both cases, the acquisition of resistance to TGFp is associated with 
the conversion to a tumourigenic phenotype.
In this respect, it is of interest to note that introduction of human chromosome 18 into a 
colorectal cancer cell line partially restored its responsiveness to TGFp, and in addition, 
caused a reduction in tumourigenicity in the nude mouse assay (Goyette et al.,1992). 
This effect was likely to be mediated by the DPC4 gene, located at 18q21, which is 
commonly deleted in many pancreatic cancers (Schutte et al.,1996), and also in the 
transition from intermediate to late adenomas in colorectal cancer (Hahn et al.,1996). 
DPC4 and its Drosophila homologue, MAD, act as downstream effectors in the TGFp / 
DPP signalling pathway (Eppert et al.,1996).
2. Tumour suppression.
Although the tumour suppressor field has lagged behind the study of oncogenes, several 
unique techniques have been developed as tools for the identification and functional 
characterisation of these genes.
2.1. Somatic cell fusions.
It is now well established that the fusion of a malignant cell with a normal cell produces 
hybrids which are suppressed in their ability to form tumours in nude mice, that is, so 
long as they retain specific chromosomes from the normal parent (Harris et al.,1969). In 
other words, malignancy behaves as a recessive trait, and tumour suppression has a 
genetic basis.
Support for this observation came from Stanbridge's group who fused normal human 
fibroblasts with the cervical cancer cell line, HeLa (Stanbridge,1976). The initial 
hybrids were non-tumourigenic, but still behaved as transformed cells in culture 
(Stanbridge and Wilkinson, 1978). This proved unequivocally that tumourigenicity and 
transformation were under separate genetic control, and was in consonance with the 
multistep model of tumour development which states that multiple genetic lesions are 
required to produce a malignant cell. After prolonged passage in culture, rare 
tumourigenic segregants arose, and the re-appearance of malignancy was associated 
with the loss of chromosome 11 derived from the normal parent (Stanbridge et 
al.,1981).
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2.2. Loss of heterozygosity studies.
The basic strategy for discovering the location of putative tumour suppressor loci was 
based on this type of analysis of chromosome segregation during the growth of hybrid 
cells in culture. Genes are now more frequently identified as a consequence of genetic 
analysis of loss of heterozygosity (LOH). In fact, the only successful attempts to 
identify and clone tumour suppressor genes have resulted from the application of 
molecular genetic approaches based on the use of polymorphic markers to find regions 
of the genome showing LOH in tumours, followed by positional cloning strategies, and 
mutation analyses to identify the gene involved.
Rare familial cancers have allowed the identification of many tumour suppressor genes. 
Although activated oncogenes are rarely transmitted as constitutional mutations, many 
rare Mendelian cancers arise following inactivation of tumour suppressor genes. 
Mapping the genes in these rare families opens the way to identification and cloning of 
the tumour suppressor gene. Although few of these cases are as simple genetically as 
retinoblastoma, this tumour exemplifies Knudson's two-hit hypothesis.
Retinoblastoma is a rare, aggressive childhood tumour of the retina. Sixty percent of 
cases are sporadic and unilateral; the other 40% are inherited as an autosomal dominant 
trait. In familial retinoblastoma, bilateral tumours are common. This led Knudson to 
hypothesize that two successive mutations were required to convert a normal cell into a 
tumour cell (Knudson, 1971). Investigations in retinoblastoma families localised the 
gene to chromosome 13ql4. Subsequent studies by Cavenee et al (1983) proved 
Knudson's hypothesis and established the paradigm for all subsequent investigations of 
tumour suppressor genes.
Commonly the first (inherited) mutation is a point mutation or some other other small 
change confined to the tumour suppressor gene. Often, the second mutation, whether in 
a familial or a sporadic case, involves loss of all or part of a chromosome. The 
mechanism may be nondisjunction (leading to loss of a whole chromosome), mitotic 
recombination (resulting in loss of those parts of the chromosome distal to the 
crossover) or a de novo interstitial deletion. In each case, one allele of any marker close 
to the tumour suppressor gene is lost, that is, the tumours become homozygous at this 
locus. In this way, LOH is a key pointer to the existence of tumour suppressor genes. 
The complementary approaches of linkage analysis in familial cancers, and LOH 
analysis of paired tumour and normal samples, have suggested the existence of a 
surprisingly large number of tumour suppressor genes, most of which have not yet been 
identified.
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2.3. Microcell-mediated monochromosome transfer.
While molecular genetic approaches may lead to the identification of the location of 
tumour suppressor genes, formal proof that a gene has a tumour suppressive function 
must come from re-introduction of the gene itself. In the interim, between identification 
of a putative region on a particular chromosome, and cloning of the gene, some idea of 
the functions of these genes can be provided by approaches such as microcell-mediated 
monochromosome transfer.
The possibility that single chromosomes contain sufficient genetic information to 
reverse neoplastic growth was inferred from the indirect evidence correlating the loss of 
certain chromosomes from hybrids which were initially suppressed, with re-expression 
of the malignant phenotype (Harris et al.,1969). The chromosome transfer technique 
provides a more direct test of this mode l.
Microcell-mediated monochromosome transfer allows the introduction and selective 
retention of single specific chromosomes into recipient cells. The conventional strategy 
involves transfection of a normal humam fibroblast cell line with plasmid vectors which 
contain selectable markers, such as neomycin (Koi et al., 1989b) These integrate 
randomly into different chromosomes. Prolonged treatment of these donor cells with 
the mitotic inhibitor, colcemid, initially blocks the the cells in metaphase, when the 
chromosomes are scattered throughout! the cell. On leaving mitosis, micronuclei are 
formed, which contain one or more chromosomes. A combination of cytochalasin B 
and centrifugal force causes these micronuclei to be extruded from the cell and pelleted, 
and the microcell suspension is then f iltered to remove any large micronuclei which 
contain more than one chromosome. T!he filtered microcells are fused with mouse A9 
cells, and growth in appropriate medium ensures selective retention of a single marked 
human chromosome on a mouse background. The identity of the marked chromosome 
is established by cytogenetic, biochemical, and molecular procedures, including Giemsa 
banding, chromosome painting, and isoenzyme assays. By this approach, a library of 
microcell hybrids representing the whole human genome, can be generated, and used 
for transfer experiments into carcinomia cell lines (Fournier and Ruddle, 1977). This 
same procedure, involving prolonged colcemid treatment, centrifugation and filtration 
is then used to introduce individual huiman chromosomes into recipient tumour cells, 
and is illustrated schematically in Figune 3.
The key advantages of the technique ane that the introduced chromosome is retained as 
a complete structural unit through subsequent generations, and in most cases, the 
transfer of a single copy of a chromosome is sufficient to induce tumour suppression. In
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addition, since the genes residing on introduced chromosomes are under the control of 
their own promoters, they are expressed at physiological levels.
Chromosome transfer was the method employed to provide formal proof that 
chromosome 11 was involved in the tumourigenic expression of HeLa cells. A single 
copy, introduced into the tumourigenic segregants, or into HeLa cells by chromosome 
transfer, resulted in tumour suppression (Saxon et al.,1986). Other examples include the 
the introduction of chromosome 13 into retinoblastoma cells (Banerjee et al.,1992), and 
introducing chromosome 11 into a Wilms' tumour cell line (Weissman et al.,1987), 
both of which resulted in suppression of tumourigenicity. In some instances, such as 
colorectal cancer, multiple chromosomes carry a tumour suppressing effect, however, 
the introduction of any one of these causes tumour suppression (Tanaka et al.,1991).
The ability to revert malignant cells to a non-tumourigenic state by introduction of a 
chromosome indicates the presence of putative tumour suppressor loci on that 
chromosome. The task of identifying and cloning these tumour suppressor genes is 
considerably more arduous, as the ability to further reduce the region containing the 
putative tumour suppressor can be hindered by the limited availability of selectable 
markers. In addition, there is no suitable in vitro assay system to efficiently identify 
tumour suppressor genes. Dominantly-acting oncogenes can be recognised by their 
ability to form foci of transformed cells on a background of normal, contact-inhibited 
cells. In searching for genes that suppress tumourigenicity, one is looking for the rare 
cell that is non-tumourigenic, but which still behaves as a transformed cell in culture.
In the past, the choice of which chromosome to introduce was largely determined by 
the presence of naturally-occurring selectable markers, such as the HPRT gene on the X 
chromosome. The range of chromosomes available for transfer has improved to such an 
extent that several libraries of marked chromosomes exist, which are tagged with 
different selectable markers. This, in theory, should allow introduction of more than 
one introduced chromosome into a particular cell, to examine gene dosage effects, and 
to study interactions between two or more tumour suppressor genes. Techniques have 
also been developed, and successfully employed, for the transfer of sub-chromosomal 
fragments (Koi et al.,1993; Dowdy et al.,1990) to enable more accurate localisation of 
functional tumour suppressor genes.
2.4. The functions of tumour suppressor genes.
The biochemical function of tumour suppressor gene products has proved to be harder 
to unravel than the function of oncogene products. The family of tumour suppressor 
genes is proving to be a biologically heterogeneous class, involved in negative
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regulation of the cell cycle, differentiation, maintenance of genomic stability, and 
replicative cell senescence. We describe here a few of the most important classes of 
tumour suppressor genes.
Tumour suppressor genes, by definition, should be mutated and / or inactivated by 
deletion in tumours. In consequence, re-introduction of these genes back into tumour 
cells in which they have been inactivated, should restore normal growth control. The 
behaviour of some of the classical tumour suppressor genes, such as p53 and Rb fits 
such criteria. However, new classes of genes are emerging which only exhibit some of 
these features. Nevertheless, they are included in this section since they play important 
roles in the development of tumours, although they cannot strictly be classified as bona 
fide tumour suppressor genes.
2.4.1. pRb
The product of the Rb gene is a nuclear phosphoprotein, which is believed to play a key 
role in controlling cell proliferation. At least part of this role is to bind and inactivate 
the group of cellular transcription factors, called E2F, which are required for cell cycle 
progression (Chellappan et al.,1991; Hiebert et al.,1992). In normal cells, pRb is 
inactivated by phosphorylation, and activated by dephosphorylation. Shortly before a 
cell enters S phase of the cell cycle, pRb is phosphorylated, releasing E2F and allowing 
the cells to proceed to S phase (Weinberg, 1995). Phosphorylation is governed by a 
whole series of cyclins, cy cl in-dependent kinases (cdks) and cdk inhibitors. This seems 
to constitute the most crucial single checkpoint in the cell cycle.
The extensive array of positive and negative controls in place to ensure tight regulation 
of the cell cycle, through the modulation of Rb phosphorylation, provide a complexity 
of mechanisms by which tumour cells can facilitate increased cell proliferation. Tumour 
cells can adopt positive regulatory mechanisms to stimulate tumour growth. For 
instance, members of the cyclin D family, mainly cyclin D l, and its cdk partner, cdk4, 
are amplified in certain tumour types (reviewed in Hunter and Pines, 1994), in line with 
their positive role in stimulating Rb phosphorylation and progression through the cell 
cycle. Conversely, tumour cells can eliminate negative regulatory pathways. Two of the 
cdk inhibitors, p l6 INK4a and p l5 INK4b, are homozygously deleted in a large number of 
tumour cell lines and in many primary tumours (reviewed in Sheaff and Roberts, 1995).
2.4.2. p53
p53 was first described in 1979 as a protein found in SV40-transformed cells, where it 
was associated with the large T antigen (Lane and Crawford, 1979; Linzer and 
Levine,1979). Later, the p53 gene, which encodes p53, was found to cooperate with
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activated ras genes in transfection studies to transform rodent cells (Parada et al.,1984), 
and so was classed as an oncogene. It subsequently transpired that p53 from tumour 
cells was oncogenic because it harboured mutations, and that wild-type p53 in fact 
acted as a tumour suppressor (Oren,1992).
Loss or mutation of p53 is probably the most common single genetic defect in cancer, 
and individuals with Li-Fraumeni syndrome, who have constitutional mutations in p53 
(Malkin, 1990) develop multiple primary tumours, typically including soft tissue 
sarcomas, osteosarcomas, tumours of the breast, brain and adrenal cortex, and 
leukaemia.
The only clearly identified biochemical function of p53 is as a transcription factor. 
Tetramers of p53 bind DNA and can activate transcription of reporter genes placed 
downstream of a p53 consensus binding site (Kern et al.,1991; Bargonetti et al.,1991). 
However, Lane (1992) has proposed a much broader role for p53 in the cell, which he 
has termed its role as 'Guardian of the Genome'. One of its guardian functions is to stop 
cells replicating damaged DNA. Cells which lack functional p53 do not arrest at the 
Gl/S checkpoint and do not repair their damage (Yin et al.,1992; Livingstone et 
al.,1992), and this presumably leads to the accumulation of random genetic changes, 
some of which are oncogenic.
Probably related to this, is a crucial role for p53 in cell death (reviewed in Oren,1994). 
In response to particular stimuli, such as radiation-induced DNA damage, cells undergo 
apoptosis (programmed cell death). Organisms use this as a mechanism to protect 
themselves from the consequences of harbouring damaged DNA. A common pathway 
in carcinogenesis is loss of this control, and cells lacking p53 do not undergo apoptosis.
2.4.3. Mutator genes.
The conversion of a normal cell into a malignant cell requires on average seven or more 
alterations. The chance of a single cell undergoing so many independent events is 
negligible. However, two general mechanisms exist which can make progression more 
likely. Alterations in some genes enhance cell proliferation, creating an expanded target 
population of cells for the next event. Alterations at other loci affect the stability of the 
entire genome, increasing the overall mutation rate.
Mutations of oncogenes and tumour suppressor genes create expanded populations of 
cells which are targets for future mutations. These genes can be directly involved in the 
cell cycle controls which are aberrant in cancer. There exists a third class of genes 
which are commonly mutated in cancer cells, which are not part of these pathways.
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These mutator genes have a general role in ensuring the integrity of the genetic 
information, and mutations in these genes lead to inefficient replication or repair of 
DNA. Some of their members, such as p53, are classical tumour suppressor genes, and 
like the tumour suppressor genes, they are inactivated by the two-hit mechanism.
Most of the genes responsible for chromosomal instability have not yet been identified, 
but two diseases, colon cancer and ataxia telangiectasia, have provided pointers to 
genes responsible for instability at the DNA level.
Hereditary non polyposis colon cancer (HNPCC) is an autosomal dominant condition, 
which predisposes to colon cancer. LOH studies on these tumours showed an entirely 
unexpected phenomena. Rather than lacking alleles, some tumour specimens appeared 
to contain extra, novel microsatellite alleles (Aalttonen et al.,1993). These new alleles 
were evident in every dinucleotide and trinucleotide repeat examined, suggesting a 
genome-wide instability of the replication or repair of simple repeated sequences. This 
form of instability was similar to that first described in a subset of sporadic 
(nonfamilial) colorectal cancers (Peinado et al.,1992; Ionov et al.,1993; Thibodeau et 
al.,1993) which suggested that related mechanisms might be involved.
Strand et al. (1993) related this phenotype to so-called mutator genes in E.coli and 
yeast. These genes encode an error correction system which checks the DNA for 
mismatched base pairs (Modrich et al.,1995), and corrects them. Mutations in the genes 
that encode the mutHLS mismatch repair system lead to a 100- to 1000-fold increase in 
mutation rates. The human homologue of mutS was cloned, and maps to chromosome 
2p, which shows tight linkage to the disease (Fishel et al.,1993). Thus, HNPCC 
individuals are constitutionally heterozygous for a loss-of-function mutation in one or 
more of these mutator genes (Leach et al.,1993). Their normal cells still have a 
functional mismatch repair system, and do not show the mutator phenotype. In a 
tumour, the second copy is lost by non-disjunction, mitotic recombination, deletion or 
by a second point mutation.
It is currently believed that mutations in three human mismatch repair genes (hMSH2, 
hMLHl, and hPMS2) account for the great majority of HNPCC kindreds. Strong 
supportive evidence that mutator genes were important in HNPCC was provided by 
biochemical experiments. Transfer of a human chromosome containing a normal copy 
of hMLHl into a human cancer cell line with a mutant hMLHl gene completely 
restored mismatch repair activity, and reversed the microsatellite instability (Koi et 
al.,1994)
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Ataxia telangiectasia (AT) is a recessive disorder characterised by a number of features, 
the most relevant being that AT patients have a strong predisposition to cancer 
(Sedgwick and Boder,1991). Homozygotes usually die of malignant disease before the 
age of 25, and there have been suggestions that AT heterozygotes also have an 
increased risk of cancer. In vitro, cells of AT patients show chromosomal instability, 
with breaks and translocations. Patients have mutations in the same gene, ATM, which 
is located on human chromosome llq22-23 (Savitsky et al.,1995). The ATM gene 
product is thought to be involved in the maintenance of genome stability, by controlling 
cell cycle progression following DNA damage.
2.4.4. Differentiation-controlling genes
There are many examples of malignant cell types which have lost their neoplastic 
potential following the induction of differentiation (Pierce and Wallace,1971; 
Sachs, 1978), and for this reason it has been suggested that neoplastic growth, 
characterised by uncontrolled proliferation, represents some defect in normal 
differentiation (Mintz,1978).
This association between the acquisition of a differentiated phenotype and loss of 
tumourigenic capacity was demonstrated quite elegantly by a set of somatic cell fusion 
experiments. Fusion of HeLa cells with normal human fibroblasts gave rise to non- 
tumourigenic hybrids which became more fibroblastic in morphology, expressed a 
collagenous extracellular matrix, and ceased to multiply. Tumourigenic segregants of 
these hybrids failed to express the characteristic differentiation products of fibroblasts, 
and gave undifferentiated epithelial tumours in vivo (Harris, 1985). Hybrids formed 
between HeLa cells and keratinocytes were also non-tumourigenic, and expressed 
involucrin, a protein involved in the onset of terminal differentiation in human 
keratinocytes (Harris and Bramwell,1987). In vivo, they formed nodules composed of 
highly-differentiated cells containing keratohyalin granules and keratin-filled cysts 
which neither progressed nor regressed (Peehl and Stanbridge, 1981).
By imposing the terminal differentiation programme of the normal parent cell on the 
malignant cell, the hybrids in both cases assumed a differentiated state, and became 
non-tumourigenic. In other situations, information contributed by the normal cell may 
complement a particular genetic defect which impairs differentiation in the malignant 
cell. Hence, in this way genes involved in differentiation may act as bona fide tumour 
suppressors.
Recent experiments involving the introduction of molecules associated with 
differentiation, into tumour cells have demonstrated that overexpression of keratin 1
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can inhibit growth in vitro and suppress the formation of tumours in vivo (Harris et 
al.,1996). However, the significance of this data is not clear, since the proteins were 
expressed at very high levels in the cells. In addition, with respect to tumour biology, 
keratins are unlikely targets for mutation or deletion, as they can be easily regulated at 
the translational level.
3. Malignant conversion -  the squamous-spindle transition.
Many human tumours of epithelial origin undergo a transition to a fibroblastic 
morphology, which is associated in vivo with increased invasiveness and metastatic 
properties (Matsui and Kitagawa, 1991; Kaufman et al.,1983; Steeper et al.,1983; Evans 
and Smith, 1980). These spindle cell carcinomas, which tend to be recurrent or 
metastatic tumours, are the major causes of therapeutic failure.
A similar transition has been identified in mouse skin tumours (Klein-Szanto et 
al.,1989). In keeping with the profound changes in cellular morphology which are seen 
in spindle cell tumours, substantial alterations can be seen in the expression of a series 
of epidermal differentiation markers, including integrins, cell adhesion molecules, and 
intermediate filament proteins. The spindle conversion is associated invariably with the 
loss of epithelial markers, and the acquisition of a fibroblastic pattern of expression. 
While these spindle cells do become more invasive, it is unclear whether the change in 
phenotype has any relevance to metastasis, since squamous tumours can also give rise 
to metastatic deposits which are squamous. This process may be facilitated by the 
involvement of spindle intermediates which appear transiently, and act as a migratory 
form of the squamous carcinoma cells. A more stable epithelial organisation may be 
recovered once these cells have reached another site, where the particular 
microenvironment of the cells might favour this type of growth. Permanent conversion 
to a spindle phenotype is therefore not seen in all mouse skin carcinomas, and in fact, it 
is even less common in human tumourigenesis. Nevertheless, reversible conversion 
may be more common, and therefore is still of great interest.
The state of differentiation and degree of invasiveness of a tumour are known to 
determine cancer prognosis. The squamous-spindle transition in mouse skin 
tumourigenesis is an excellent system for analysing the molecular mechanisms by 
which tumour cells lose almost all of the differentiation markers of the original cell, and 
in addition, may reveal information regarding the control of epithelial differentiation 
processes, and provide insights into the processes of invasion and perhaps metastasis.
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3.1. Metastasis, invasion and angiogenesis.
The processes of metastasis, invasion and angiogenesis are inextricably linked. 
Metastasis is a multi-step process involving numerous cell-host and cell-matrix 
interactions. In order to form a metastatic deposit, a cell, or group of cells, must be able 
to leave the primary tumour, invade the local host tissue, enter the circulation, avoid 
host immune surveillance mechanisms, arrest at the distant vascular bed, extravasate 
into the target organ, and proliferate as a secondary colony.
There have been numerous proposals put forward to explain how tumour cells 
accomplish this series of events, including their ability to produce proteases, to escape 
from the immune system and to modify the expression of particular cell adhesion 
molecules. Any, or all of these, may play a role in the ability of cells to metastasise, but 
as stated by Frost and Levin (1992), "tumour cells do not accomplish any novel feats", 
in that "there is nothing that a metastatic cell can do, that is not a routine task for 
normal cells such as lymphocytes, monocytes or leukocytes."
Angiogenesis.
Angiogenesis, or the formation of new capillary blood vessels, is needed if a tumour is 
to expand in three dimensions beyond about 2mm or so in size (Nowell, 1976). In its 
absence, tumour size is restricted by the limits of oxygen and nutrient diffusion. In 
addition, blood vessels which penetrate the primary tumour are frequent sites of entry 
into the circulation to permit secondary spread.
Abundant evidence supports the view that tumours can themselves induce angiogenesis 
through a variety of soluble factors. Following a stimulus, endothelial cells resting in 
the parent vessels are stimulated to degrade the endothelial basement membrane, 
migrate into the stroma, and initiate a capillary sprout, which migrates towards the 
stimulus (Ausprunk and Folkman,1977). The sprout expands, assumes a tubular 
structure, and endothelial proliferation then permits extension of the capillaries which 
develop into a functioning circulatory network.
The exit of the endothelial cells from the parent vessel, and degradation of the 
extracellular matrix, shares features with the process of invasion of cancer cells into the 
basement membrane (Cliff,1963; Kalebic et al.,1983). The two processes are illustrated 
in Figure 4. Stimulated endothelial cells, like metastatic tumour cells, can produce 
degradative proteinases such as type IV collagenase, and other members of the matrix 
metalloproteinases. Thus specific inhibitors of type IV collagenases can block 
endothelial cell invasion of the extracellular matrix, as well as preventing tumour cell
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invasion in the same assay (Thorgiersson et al.,1982; Thorgiersson et al.,1984; Mignatti 
et al.,1986; Mignatti et al.,1989; Moses et al.,1990).
A net positive proteolytic balance is required for the elongation of the capillary sprout 
and formation of the lumen during angiogenesis. The positive effects of a variety of 
angiogenic peptides, such as fibroblast growth factors or transforming growth factors, 
which can be provided by normal or tumour cells, are counteracted by negative 
regulatory proteins such as thrombospondin, an inhibitor of angiogenesis reviewed in 
Liotta and Stetler-Stevenson,1991). Cytokines which tip the balance toward 
antiproteolysis do this by increasing inhibitors, such as TIMP-1 (tissue inhibitors of 
metalloproteinases) and by decreasing proteinases, and thereby inhibit angiogenesis 
(Moses et al.,1990). This indicates that proteolysis is an essential part of the angiogenic 
process.
A common feature of many of the agents which induce angiogenesis is their ability to 
promote not only proteolysis, but also endothelial cell motility and growth. Motility is 
necessary for the chemotactic response of the cells to the angiogenic stimulus, and 
alignment of the cells to form a sprout. Proteolysis mediates the penetration of the 
capillary sprout into, and lateral expansion within, the extracellular matrix. Finally, 
proliferation of the endothelial cells is required so that they can populate the expanding 
vascular network (reviewed in Liotta et al.,1991). These same three functions also 
define an invasive tumor cell, however in contrast to malignant cells, endothelial cells 
can revert to being non-angiogenic once the stimulus is removed. In the autonomous 
malignant cell, these processes are unregulated or autoregulated.
If the balance is tipped too far in one direction, such that proteolytic activity is 
excessive, haemangioma-like cystic structures are formed. Haemangiomas arise when 
the surrounding matrix is destroyed in an uncontrolled manner, and the endothelial cells 
line a large blood-filled cavity. This phenomenon has been studied in vitro using 
endothelioma cell lines, which produced uPA (plasminogen activator), but no PAI (PA 
inhibitor) (Montesano et al.,1990).
Invasion.
A group of coordinated cellular processes, not just one gene product, is responsible for 
invasion and metastasis, however, none of the interactions which characterise the 
process of invasion, are unique to tumour cell behaviour. Attachment, proteolysis and 
migration are steps of trophoblast implantation, mammary gland involution, embryonic 
morphogenesis and tissue remodelling. The difference between normal physiological 
processes and the process of tumour cell invasion is therefore one of regulation.
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Cellular invasion depends on the spatial and temporal coordination of adhesive and 
proteolytic events. At the level of the individual cell, this is translated into a series of 
cyclic on-off processes.
Protrusion of a pseudopod is the first step. These structures are devoid of nuclei, but 
possess a supporting structure of actin filaments, which allow them to protrude into free 
space, in response to stimulation by the appropriate ligands (Condeelis,1993; 
Stossel,1993). The advancing pseudopod focuses the action of cell surface proteinases, 
enzymes, receptors and activators. Proteinases at the tip may locally disrupt the matrix, 
and permit forward extension (Guirguis et al.,1987). However, the balance must then 
switch to adhesion in order for the cell to grip the matrix and pull the cell forward. At 
the rear of the cell, dissociation from adjacent cells, and detachment from previous 
attachment sites are necessary to release the cell. To achieve forward motion then, the 
invading cell must coordinate local proteolysis with limited attachment and detachment 
(Liotta et al.,1991; Damsky and Werb,1992; Blasi,1993). The basement membrane and 
stroma play an important part in the regulation of these processes. As well as providing 
physical barriers that restrict movement, they may also be a source of latent proteases 
and cytokines, including angiogenesis-promoting factors, which can be activated or 
released by the pseudopodia.
Many of the steps in the metastatic process involve cell / cell and cell / matrix 
interactions mediated by specific cell surface molecules. These cell adhesion molecules 
are likely to play a major role in modulating metastatic spread, and they are illustrated 
in Figure 5.
E-cadherin - the invasion suppressor.
E-cadherin is a Ca2+-dependent cell adhesion molecule, which is thought to promote the 
assembly of the cytoskeleton, mediated by its interaction with the a-, |3-, and y-catenins 
(Ozawa and Kemler,1992). E-cadherin is found exclusively in epithelial cells, and is 
lost in the transition to the mesenchymal phenotype, for example, when the mesoderm 
separates from the ectoderm during early development (Takeichi,1988). A large body of 
evidence has been accumulated relating the loss of E-cadherin expression, or E- 
cadherin-mediated cell-cell adhesion, to the loss of epithelial differentiation and 
acquisition of invasive properties in carcinomas (Frixen et al.,1991, and reviewed in 
Birchmeier et al.,1993, and Takeichi,1993). In addition, a correlation between cadherin 
expression and incidence of metastasis has been reported in human gastric (Matsuura et 
al.,1992), prostate (Umbas et al.,1992), breast (Oka et al.,1993), and head and neck 
cancers (Schipper et al.,1991).
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B =  i n t e g r i n  e x p r e s s i o n ,  m e d i a t i n g  i n t e r a c t i o n  w i t h  e x t r a c e l l u l a r  m a t r i x  
C  =  l a c k  o f  M H C  c l a s s  1 a n t i g e n  e x p r e s s i o n  b y  t u m o u r  c e l l s ,  p e r m i t t i n g  
e s c a p e  f r o m  c y t o l y t i c  T - c e l l s  
D =  s h e d d i n g  o f  I - C A M -1 i n t o  c i r c u l a t i o n  m a y  b l o c k  T - c e l l  r e c e p t o r s  
f o r  t h i s  m o l e c u l e  a n d  p r e v e n t  t u m o u r  c e l l  I c y t o l y t i c  c e l l  i n t e r a c t i o n s  
E =  a t t a c h m e n t  a t  s e c o n d a r y  s i t e  m e d i a t e d  b y  d i f f e r e n t  i n t e g r i n s  
F  =  e x t r a v a s a t i o n  t o  e s t a b l i s h  a t  s e c o n d a r y  s i t e .  D u r i n g  m o t i l i t y ,
i n t e g r i n  r e c e p t o r s  p o l a r i s e  a t  t h e  m i g r a t i n g  f r o n t  o f  t h e  t u m o u r  c e l l  
t o  p r o v i d e  t r a c t i o n ,  a s  w e l l  a s  d e - a d h e r e n c e  a t  t h e  t r a i l i n g  e d g e  t o  
p e r m i t  f o r w a r d  m o v e m e n t  
G  =  m e t a s t a s e s  m a y  b e  i n v a s i v e  t u m o u r s  j u s t  l i k e  t h e  p r i m a r y  t u m o u r s ,  
a n d  t h e r e b y  r e l e a s e  c e l l s  i n t o  a n e w  r o u n d  o f  m u l t i s t e p  i n v a s i o n  
( F i g u r e  a d a p t e d  f r o m  M a r e e l  e t  a l . ,  1 9 9 7  a n d  H a r t  a n d  S a i n i ,  1 9 9 2 )
This association between loss of E-cadherin and invasion was demonstrated in non­
transformed MDCK cells in vitro. Addition of antibodies directed against E-cadherin to 
these and other epithelial cells, led to inhibition of intercellular adhesion and 
acquisition of invasive properties. The cells assumed a fibroblastic-like, 
undifferentiated morphology, which was similar to the phenotype induced by 
introducing viral oncogenic ras into these same cells (Behrens et al.,1985; Behrens et 
al.,1989). Conversely, introduction of E-cadherin back into tumour cells which no 
longer expressed the protein prevented invasion of the cells in the in vitro collagen 
assay (Frixen et al.,1991).
The human gene has been mapped to chromosome 16q22 (Natt et al.,1989), a region 
which is subject to allelic deletion in carcinomas of the prostate (Carter et al.,1990), 
ovary (Sato et al.,1991), breast (Sato et al.,1990), and in Wilms' tumour (Maw et 
al.,1992). Examination of mutations in the coding region of E-cadherin in 
gynecological cancers however, revealed only four tumours with mutations, out of a 
total of 135 samples, and the two mutations most likely associated with functional 
inactivation of the gene product, were not accompanied by allelic loss (Risinger et 
al.,1994). In contrast, mutations have been detected in a substantial number of gastric 
tumours. These mutations frequently led to loss of important functional domains of the 
protein by exon-skipping, and were accompanied by loss of the remaining normal allele 
(Becker et al.,1994; Oda et al.,1994).
Despite the fact that E-cadherin acts as a tumour suppressor gene in some cell types, the 
mechanism of inactivation does not always fit the classical two-hit model proposed by 
Knudson (1971). E-cadherin function may be abolished by epigenetic mechanisms. 
Yoshiura and colleagues (1995) found that in carcinoma cells which were negative for 
E-cadherin expression, the E-cadherin promoter was methylated. Furthermore, 
treatment of E-cadherin negative tumour cell lines with 5-azacytidine resulted in re- 
expression of the gene, and the scattered spindle-shaped cells reverted to a more 
epithelial morphology.
It has recently become clear that loss of differentiation of epithelial cells in vitro or in 
vivo, can occur while cadherin expression is maintained. Transformation of chick 
embryo fibroblasts or MDCK cells with Rous sarcoma virus suppressed N-cadherin- 
mediated cell-cell adhesion by tyrosine phosphorylation of the catenins (Hamaguchi et 
al.,1993; Behrens et al.,1993).
27
Thus the overriding conclusion is that disruption of cadherin-mediated cell-cell contact 
by deletion, mutation, phosphorylation, or methylation of any of the components of the 
adhesive complex, will render cells more invasive.
If homophilic cell-cell interactions have to be disrupted for invasion to occur, then so 
must cell-substrate interactions, which anchor the cells to the basement membrane. 
Many of the interactions between cells and adhesive proteins of the extracellular matrix 
are mediated through the integrins. Ligand specificity of these receptors is a 
consequence of particular a  and (3 subunit associations, although binding to 
extracellular matrix proteins often occurs via recognition of a specific tripeptide 
sequence, Arg-Gly-Asp - the RGD motif (Hynes, 1992). An important role of the 
integrins in the metastatic process was confirmed by the demonstration that RGD- 
containing peptides inhibit invasive capacity in vitro, and reduce the lung-colonising 
potential of tumour cells in vivo (Humphries et al.,1986). Interesting observations have 
also been made in the case of malignant melanomas. Albelda et al. (1990) noticed that 
increased levels of a3(31, the fibronectin receptor, a4(31, and av(33, the receptor for 
vitronectin, all correlated with increasing tumour progression. It is unlikely however, 
that the array of integrins expressed by a group of tumour cells remains static : these 
receptors are likely to be differentially utilised during tumour invasion and spread.
Matrix metalloproteinases are a family of matrix-degrading enzymes, which include the 
collagenases, gelatinases, and the stromelysins, all of which have been implicated in 
invasive cell behaviour. A causal role for metalloproteinases in tumour invasion and 
metastasis was demonstrated by the observation that introducing the tissue inhibitor of 
metalloproteinases (TIMP) into a number of different tumour types decreased tumour 
metastases in vivo (Schultz et al.,1988; Alvarez et al.,1990).
All classes of matrix metalloproteinases are secreted as inactive zymogens, therefore 
enzyme activation is likely to be an important controlling step in proteolysis. The in 
vivo mechanism is unknown but may involve the action of other proteinases, either in 
solution or via a cell surface-dependent mechanism. The latter mode of activation 
would allow precise cellular control at the point of matrix interaction (Herron et 
al.,1986; He et al.,1989).
Tumour cells must escape host immune surveillance.
Immune surveillance is mediated largely by cytotoxic T lymphocytes. These cells 
recognise antigenic peptides only when they are presented in association with major 
histocompatibility (MHC) class I molecules. Tumour cells which lack MHC class I 
antigens would thus be able to evade immune surveillance. A further mechanism
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employed by circulating tumour cells to avoid immune detection and elimination, is to 
prevent the binding of the lymphocytes to them. This interaction is ordinarily stabilised 
by interactions between an integrin on the lymphocytes and the ICAM-1 ligand 
expressed by the target cell (Hart, 1989). Lack of expression of ICAM-1 might therefore 
permit escape from cytotoxic T-cell mediated killing. Rather paradoxically, analysis of 
some cutaneous melanomas has revealed that they up-regulate expression of ICAM-1. 
However, the detection of soluble ICAM-1 in the serum of some patients indicates that 
the over-production of this molecule by tumour cells, and release into the bloodstream, 
may serve to protect them by blocking the receptor on circulating lymphocytes (Hart 
and Saini,1992).
Genetic control of the metastatic process.
Tumour development is characterised by a loss of growth control leading to 
uncontrolled proliferation, however this property alone is not sufficient to cause 
invasion and metastasis. Additional genetic alterations must be required. There is some 
evidence that a metastatic subpopulation exists in the primary tumour mass (Fidler and 
Hart, 1982), and an estimation of the size of this subpopulation, by measuring the levels 
of specific markers or amplified oncogenes, can be predictive for determining the 
probability of metastasis and recurrence (McGuire et al.,1990; Slamon et al.,1989).
Although the search for specific metastasis-inducing genes continues, we can obtain 
some idea of the effector processes required for the cell to undergo invasion and 
metastasis from oncogene transformation studies. Activated ras, transfected into 
NIH3T3 cells, causes the cells to produce numerous metastases (Thorgiersson et 
al.,1985), and the metastatic potential of certain fibroblast and epithelial cell lines, 
derived from both human and rodent species, can be induced specifically by members 
of the H-ras oncogene family (reviewed in Liotta and Stetler-Stevenson,1991). 
Subsequent introduction of the adenovirus El a protein into the transfected NIH3T3 
cells suppressed their ability to metastasise, but had no effect on their ability to form 
colonies on soft agar (Pozzatti et al.,1986). Hence, metastasis and tumourigenicity are 
under separate genetic control. And in the case of ras, the pathway leading to 
transformation uses a different set of effector genes to those involved in the induction 
of metastasis, and these two sets of effector genes can be regulated independently. In 
consequence, it may be necessary to disrupt both the proliferation and differentiation 
functions of ras in order to achieve the metastatic phenotype. The serine-threonine 
kinases, \-mos, v-raf, A-raf, and the tyrosine kinase, v-src are also capable of inducing 
the metastatic phenotype if introduced into the appropriate recipient cell, albeit less 
efficiently than ras (Egan et al.,1987).
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One of the common threads connecting all these oncogenes and metastasis-inducing 
genes, is their ability to rapidly induce c-fos. Several invasion-associated proteins are 
among the genes which are responsive to AP-1-mediated transcriptional activation, 
including the two proteases, stromelysin and collagenase (Angel et al., 1987b; Sirum et 
al.,1989; Domann et al.,1994a). This may provide some clue as to the mechanism by 
which these oncogenes can induce transformation but can also contribute to the 
metastatic process.
As well as the various oncogenes implicated in angiogenesis, invasion and metastasis, it 
has now become clear that the loss or inactivation of negative regulatory molecules 
may be just as important as acquisition of positive effectors. The existence of specific 
metastasis suppressor genes has been suggested by cell fusion experiments in which 
fusion of normal cells with metastatic cells resulted in tumourigenic, but non-metastatic 
cells (Turpeenniemi-Hujanen et al.,1985).
The role of E-cadherin as an invasion suppressor has already been discussed. Formal 
demonstration of the role of TIMPs has also been demonstrated. What remains now is 
for some of the controlling genes, which initiate the cascade, to be identified. The 
closest the scientific community has come to this, is by the use of chromosome transfer, 
however few, if any, of these types of master-controllers have subsequently been 
identified. Two recent reports have shown that human chromosome 6 can suppress 
metastasis of melanoma cell lines, while having no effect on their tumourigenic 
potential (Welch et al.,1994; Miele et al.,1996). Human chromosome 8 contains 
metastasis suppressor genes for rat prostate cancer, and the region has recently been 
mapped to 8p21-pl2 (Ichikawa et al.,1992). The same region is also capable of 
suppressing both the tumourigenicity and invasiveness of colon carcinoma cells 
(Ichikawa et al.,1994; Tanaka et al.,1996). The corresponding genes responsible for the 
suppression have not yet been identified, however, this is likely to be an active area for 
future research.
3.2. Epithelial-mesenchymal transitions.
Epithelia are composed of closely associated, essentially immobile cells, while 
mesenchyme contains more mobile fibroblast-like cells which are only loosely 
associated with one another. The two types of tissue are present in most organs where 
they communicate via paracrine signalling to facilitate ordered growth, morphogenesis 
and differentiation. During normal development, transitions between epithelia and 
mesenchyme occur, for example in gastrulation, and mesenchyme can differentiate into 
new epithelia, such as in kidney development (Vestweber et al.,1985; Ekblom,1989). 
However, such processes are not limited to development. The loss of epithelial
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characteristics, resulting in the appearance of invasive, motile cells, is also of major 
importance in organ remodelling, wound-healing, and, of course, tumour development.
The ability of seemingly well-differentiated, non-invasive tumour cells to produce 
secondary metastases which are also well-differentiated can be explained by the 
likelihood that certain tumour cells have the ability to undergo a transient, reversible 
transition to a more motile cell. Numerous experimental approaches have been used to 
induce or reverse the transition, with a view to elucidating some of the mechanisms 
involved in the process. Indeed, many normal epithelial and tumour cell lines in vitro 
can be shown to undergo an epithelial-mesenchymal transition in response to local 
production of some growth factors or expression of some oncogenes.
In vitro studies support this type of role for TGF|3. In vitro, members of the TGF(3 
family can exert mitogenic effects on various mesenchymal cells, while inhibiting the 
proliferation of epithelial and endothelial cells, as well as stimulating the production of 
extracellular matrix. Treatment of mammary epithelial cells resulted in a reversible 
reduction in the expression of E-cadherin, ZO-1 and desmoplakin (Welch et al.,1990), 
molecules involved in cell adhesion and maintenance of apical-basal polarity. In 
addition, the mesenchymal cells began to express several fibroblast markers, including 
fibronectin, and re-organised their actin fibres to resemble those found in fibroblasts. 
This response was accompanied by growth inhibition, which was mediated through a 
distinct set of type I receptors to those involved in the transdifferentiation response 
(Miettinen et al.,1994).
NBT-II cells treated at subconfluence with acidic fibroblast growth factor (aFGF) 
dissociate from one another, and produce individual elongated, motile cells (Valles et 
al.,1990a; Valles et al.,1990b). EGF applied to subconfluent cultures of rat intestinal 
epithelial cells at physiological concentrations, induced a similar response (Blay and 
Brown, 1985). In vivo, tumour cells which have invaded the basement membrane, are in 
close proximity to endothelial cells producing such components, so these neighbouring 
endothelial cells are likely to play a crucial part in tumour cell motility. Tumour cells in 
this position will also be in contact with connective tissue which is rich in extracellular 
components. In vitro work suggests that these are also likely to contribute to the 
enhanced motility of the cells.
In support of this, several genes, such as DCC, and fat, which were defined as tumour 
suppressors by virtue of the fact that they are lost during tumour progression, code for 
proteins that are constituents of the ECM (Hedrick et al.,1993; Mahoney et al.,1991). 
And epithelial cells, such as Madin-Darby canine kidney (MDCK) cells, give rise to
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fibroblast-like cells when they are suspended within type I collagen gels. These 
fusiform cells extend pseudopodia, show mesenchymal polarity, and produce both 
keratin and vimentin (Zuk et al.,1989).
The c-met tyrosine kinase receptor was initially identified because of its transforming 
activity when mutated. The met oncogene which encodes a cytoplasmically located 
tyrosine kinase was originally discovered in an osteosarcoma cell line, but is also 
frequently observed in human gastric carcinomas. Understanding about the role of the 
c-met receptor in tumourigenesis came from the identification of its ligand. Scatter 
factor (SF) / hepatocyte growth factor (HGF) was characterised independently in 
different laboratories as a factor that induces growth of primary hepatocytes (Nakamura 
et al.,1987), and as a factor that generates dissociation and motility of epithelial and 
endothelial cells (Stoker and Perryman, 1985). Under the appropriate culture conditions, 
SF / HGF can induce a wide range of responses in epithelial cells, including 
dissociation of a continuous epithelial sheet, changes in cell morphology from epithelial 
to mesenchymal characteristics, increased cell motility and the ability to invade 
collagen (Weidner et al.,1990). Conversely, NIH3T3 fibroblasts coexpressing c-met and 
SF / HGF, formed tumours which expressed E-cadherin, desmoplakin, desmoglein, and 
cytokeratin, all of which are characteristic products of epithelial cells, and not normally 
associated with NIH3T3 cells in vitro or in tumours, in vivo. This difference in response 
between the two cell types may be explained by the finding that c-met is ordinarily 
expressed by epithelial cells (Chan et al.,1988), whereas SF / HGF is secreted by 
mesenchymal cells (Stoker and Perryman, 1985). This is an example of the type of 
paracrine signalling which mediates the interaction between adjacent cell types.
Members of the AP-1 family of transcription factors are nuclear targets of most of the 
signal transduction pathways initiated by ligands such as TGFp, SF, and EGF, and thus 
represent a common end-point to effect the epithelial-mesenchymal transition in a range 
of normal and malignant cell types, c-fos directly induced severe changes in the 
epithelial polarity of mammary epithelial cells (Reichmann et al.,1992), and activation 
of an estrogen-dependent c-junER fusion protein, also in mouse mammary epithelial 
cells, caused a reversible loss of epithelial polarity, and disruption of the E-cadherin / p- 
catenin complex.
3.3. Biological changes associated with the spindle phenotype in mouse skin tumour 
cell lines.
In this laboratory, a series of cell lines have been isolated from tumours after chemical 
treatment of mouse skin. These cell lines have been analysed extensively, with respect 
to both their genetic and biological alterations. Two clonal cell lines isolated from a
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mixed squamous and spindle tumour, have proved to be especially useful in the 
analysis of those properties distinguishing undifferentiated and invasive spindle cells 
from their more differentiated precursors. The squamous-spindle transition provides an 
excellent system for defining the genetic basis of invasion, metastasis, and epithelial- 
mesenchymal transitions, since the spindle cells display many of the biological markers 
which have already been shown to play important roles in the ability of tumour cells to 
invade locally, and spread to distant sites to form secondary metastases.
3.4. Genetic changes associated with the spindle phenotype.
The genetic events leading to the development of squamous cell carcinomas in mouse 
skin have been well characterised. In contrast, few of the genetic alterations related to 
the further progression of these well-differentiated tumours to anaplastic, spindle 
tumours have been identified. It has been particularly difficult to identify the causative 
changes occurring at this stage, since neoplastic cells accumulate increasing numbers of 
genetic alterations generated by random somatic mutational events, only a portion of 
which are related to the spindle phenotype.
Amplification of the mutant H-ms allele is found consistently in spindle tumours, and 
is sometimes accompanied by a loss of the wild-type allele, implying that a further 
increase in ras activity is involved in the transition to the spindle phenotype 
(Buchmann et al.,1991). Alterations at this locus correlate well with the degree of 
tumourigenicity but do not affect the morphology of the cells (Robert Crombie, PhD 
thesis, 1993). Thus, ras alone is not sufficient for the spindle transition, and is likely to 
act in concert with one or more other proteins in this final stage.
The p l6 INK4a gene, known to undergo homozygous deletion in a high proportion of 
human tumours (Kamb et al.,1994; Jen et al.,1994a; Nishikawa et al.,1995), is one 
candidate, since p i 6 and its close neighbours, p i5, and the alternatively-spliced 
transcript of p i 6, called p i were all found to be present in a series of twenty 
squamous cell lines, but one or all were homozygously deleted in 8/10 cell lines derived 
from spindle carcinomas (Linardopoulos et al.,1995).
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The main aims of the work presented in this thesis were
(i) to identify the mechanistic basis for the ras / chromosome 7 changes associated with 
the spindle phenotype by Fluorescence in situ Hybridisation,
(ii) to establish the nature of the gene(s) which are lost at the transition from squamous 
to spindle cell carcinomas by somatic cell fusion,
(iii) to identify putative tumour suppressor loci in somatic cell hybrid xenografts by 
deletion mapping, and
(iv) to elucidate the role of each of these loci in determining the biological, 
morphological and tumourigenic properties of spindle carcinoma cells, through 
introduction of the syntenic regions from the human genome by chromosome transfer.
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Materials and Methods
2.1 Materials
2.1.1 Chemicals
All chemicals were of AnalaR grade and were obtained from BDH Chemicals Ltd., Poole, 
Dorset or Sigma Chemical Co. Ltd., Poole, Dorset except those obtained from the suppliers 
listed below.
Advanced Biotechnologies Ltd.. Surrey 
Taq polymerase 
Buffer I
Advanced Protein Products 
Foetal calf serum
Alpha Labs. Eastleigh. Hants.
Streck Tissue Fixative
Amersham International PLC. Amersham. Buckinghamshire 
a 32P dCTP
rainbow protein markers
ECL Western blotting detection kit
Beatson Institute Central Services 
sterile PBS 
PE
BDH
Repelcote
Biogenesis 
RNazol B
Boehringer Mannheim UK Ltd.. Lewes. East Sussex 
proteinase K
DOTAP transfection reagant
Polyethylene glycol 1500
Hygromycin B
block
DAPI
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BRL (UK), Gibco Ltd.. Paisley 
all restriction enzymes 
Taq polymerase
J.Burrough (FAD) Ltd., Witham, Essex 
ethanol
Calbiochem. San Diego, CA 
Hygromycin B
FMC. Rockland. ME 
Nusieve agarose
Gateway pic.. Glasgow 
Marvel dried non-fat milk powder
Gibco Europe, Life Technologies Ltd.. Paisley 
Special Liquid Medium (SLM)
10 x DMEM 
200mM glutamine 
2.5% trypsin 
penicillin 
streptomycin 
geneticin (G418)
RNA ladder
DNA ladders
50 x HAT supplement
BioNick Labelling System
Colcemid
Pharmacia Ltd.. Milton Keynes. Buckinghamshire 
Ultrapure dNTP Set 2' Deoxynucleoside 5' Triphosphate
Promega. Madison. WI 
Taq DNA polymerase 
dNTPs
Rathburn Chemicals Ltd.. Walkerbum. Peebleshire 
phenol (water saturated)
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Research Genetics, Huntsville. AL 
mouse and human MapPairs™
Severn Biotech. Kidderminster 
acrylamide (30% and 40%)
Sigma Chemical Co. Ltd.. Poole. Dorset
agarose
Tween 20
ethidium bromide
TEMED
|3-mercaptoethanol 
orange G 
bromophenol blue 
xylene cyanol 
proteinase K
Lectin from Phaseolus vulgaris PHA-P (Red Kidney Bean) Phytohemagglutinin
demecolcine
cytochalasin B
2-amino-6-mercaptopurine (6-thioguanine)
RNase
Pepsin
Propidium iodide
Stratagene, La Jolla. CA
Prime-It RmT Random Primer Labelling Kit
Vector Laboratories Inc., Burlington, USA 
Vectashield antifade mounting medium 
horse serum
2.1.2. Equipment and plasticware
Amersham International PLC. Amersham. Bucks 
Hybond-N membrane
Applied Biosvstems Ltd.
PCR reaction tubes (thin-walled)
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Becton Dickinson Labware. Plymouth, Devon 
tissue culture dishes (90mm)
BioRad
Zetaprobe membrane
Costar Corp., Cambridge. MA
Nucleopore Swinlock Holders (25mm diameter)
Polycarbonate Nucleopore capillary pore membranes (8pm and 5pm)
Eastman Kodak Co., Rochester, New York 
x-ray film (XAR-5) 
duplicating film 
Ektachrome colour slide film
Fuji Photo Co. Ltd., Japan 
x-ray film
Gibco Europe. Life Technologies Ltd.. Paisley
Nunc 1ml cryotubes
Nunc 8-well chamber slides (permanox)
Nunc 25cm2, 75cm2 and 175cm2 tissue culture flasks
Griener Labortechnik Ltd., Durslev 
eppendorf tubes
Hvbaid Ltd.. Teddington. Middlesex 
Omnislide in situ system
Labsvstems. Basingstoke 
pipette tips
Molecular Bioproducts, San Diego. CA 
aerosol-resistant tips
Pharmacia Ltd., Milton Keynes 
Nick columns
Whatman International Ltd., Maidstone 
3MM paper
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2.1.3. Antibodies
Amersham International pic. Buckinghamshire
Anti-rat Ig, peroxidase-linked species-specific whole antibody (from sheep) 
Anti-mouse Ig, peroxidase-linked whole antibody (from sheep), affinity purified
Boehringer Mannheim UK Ltd.. Lewes. East Sussex
anti-digoxigenin (Affinity purified sheep IgG)
anti-biotin (monoclonal antibody from mouse-mouse hybrid cells)
Stratech. Luton. Bedfordshire
Fluorescein (FITC)-conjugated AffinitiPure Goat Anti-Mouse IgG 
Fluorescein (FITC)-conjugated AffinitiPure Donkey Anti-Sheep IgG
Sigma Chemical Co. Ltd.. Poole. Dorset 
pan keratin (mouse monoclonal) 
vimentin (mouse monoclonal)
Takara Biomedicals. Shiga, Japan.
Monoclonal antibody to mouse E-cadherin (ECCD-2)
2.1.4. Probes for FISH
Appligene Oncor. Durham
DIG-labelled Coatasome total human chromosome 15 paint 
Cambio. Cambridge
FITC-labelled STAR FISH whole mouse chromosome paints
2.1.5. Probes used for Southern blot hybridisation
H-ras : 300bp EcoRI insert of BS9 (Ellis et al.,1980) 
p l6  : first exon probe of murinep l6  (Quelle et al.,1995)
2.1.6. Plasmids
Plasmids are shown in Figure 1.
pBABE hygro (Morgenstern and Land, 1990)
pHomer6 (Spandidos and Wilkie, 1984)
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B a m  H I
E c o R E c o R
S V 4 0M O L T R
di l l
A P H
p H O M E R 6
( 8 . 7 k b )
T K
E c o R
Cl o n i n g  si te
CO CO  c / 5  U J  o o
U3 R USR US
h y g r ogag p U C O r i ampS V 4 0
p B A B E  h y g r o  ( 5 . 2 kh
F i g u r e  1 : S c h e m a t i c  r e p r e s e n t a t i o n s  of  p l a s mi d  m a p s  for  
p H O M E R 6  a nd  p B A B E h y g r o .
2.2. Cell culture
Cell lines derived from mouse skin or from epithelial tumours were routinely maintained at 
37°C in sealed plastic flasks containing Special Liquid Medium (SLM) supplemented with 
10% foetal calf serum (FCS) and 2mM glutamine in an incubator adjusted to 5% C 02. 
Cells were routinely passaged when subconfluent by aspirating the medium, washing once 
with PBS then adding a small volume of trypsin (10% v/v trypsin, 0.01% EDTA in PBS). 
They were incubated at 37°C until the cells detached. The cells were then resuspended in 
fresh serum-containing medium to inactivate the trypsin, and reseeded at the appropriate 
dilution.
Monochromosomal hybrid cell lines containing a single Hytk-tagged human chromosome 
were cultured in DMEM supplemented with 10% FCS and 400 units/ml hygromycin B 
(Calbiochem) for A9 donors, or RPM I1640 supplemented with 10% FCS and 500 units/ml 
hygromycin for the Klhytk9 donor cell line.
Cell cultures were routinely monitored for mycoplasma infection by DAPI staining, and 
were found to be negative.
2.2.1. Cell lines
C5N........................... non-tumourigenic, immortalized cell line isolated by single cell
cloning of MCA3D cells derived from a Balb/c mouse 
(Kulesz-Martin et al.,1983)
MSCP1, MSCP6....... cell lines derived from papillomas induced by treatment of mus
spretus / mus musculus FI hybrid mice with DMBA / TP A 
(Haddow et al., 1991)
B9...............................squamous explant from the MSC11 carcinoma produced by
multiple DMBA treatment of a mus spretus / mus musculus FI 
hybrid mouse (single cell clone) (Bums et al., 1991)
A5, D3........................ spindle explants from the MSC11 carcinoma produced by
multiple DMBA treatment of a mus spretus / mus musculus FI 
hybrid mouse (single cell clones) (Bums et al., 1991)
carB,carC...................highly aggressive spindle cell lines isolated from carcinomas
produced in NIH mice following DMBA / TPA treatment 
(Diaz-Guerra et al., 1992)
A9Hytk9, A9hytkll and A9hytkl5 monochromosome hybrids generated by direct
microcell-mediated chromosome transfer from 
Hytk-transfected normal adult human skin
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fibroblasts into mouse A9 cells (Cuthbert et 
al., 1995, and obtained in collaboration with 
R.Newbold, Brunei University, UK).
Klhytk9................................................ monochromosome hybrid generated by
retagging the normal human chromosome 9 
from the PK-87-9 monochromosome hybrid, 
followed by microcell transfer into Chinese 
Hamster Ovary (CHO) cells (England et 
al.,1996, and obtained in collaboration with 
R.Newbold, Brunei University, UK).
PK-87-9 monochromosome hybrid which carries a
cytogenetically normal human chromosome 9, in 
a Chinese hamster UV-135 (CHO) background 
(Warburton et al., 1990)
2.2.2. Long-term storage of cells
Subconfluent FI 75 flasks (surface area 175cm2) were trypsinised and the cells resuspended 
in serum-containing medium. The cells were then pelleted by centrifugation and 
resuspended in 2.5ml fresh medium. An equal volume of freezing medium (50% SLM, 
30% FCS, 20% DMSO) was added dropwise and 1ml aliquots were transferred to -70°C in 
a cell-freezing container overnight. This permitted slow cooling of the cells to -70°C before 
the vials were transferred to liquid nitrogen for long-term storage.
2.2.3. Ring-cloning
Suitable colonies were identified microscopically with respect to their morphology 
following growth in selective medium. Cloning rings, held in place by sterile vaseline, 
were placed over the colony, and lOOpl trypsin was added so that only cells within the ring 
were transferred to 24 well plates. These clones were then expanded for analysis.
2.2.4. Transfection of cell lines
Cells were transfected when they reached approximately 60% confluency in 90mm plates 
by the DOTAP method, according to the manufacturer’s instructions (Boehringer 
Mannheim UK Ltd.). 50-100ng DNA DOTAP was mixed with approximately lOpg 
plasmid DNA made up to a total volume of 400pl with sterile HBS. The suspension was 
incubated at room temperature for 15 minutes to allow stable complexes to form between 
the DNA and the liposomes. Following the addition of 1ml normal growth medium, this 
mixture was applied to cells and incubated at 37°C for 2 hours in a humid incubator. The
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plates were gently agitated every 15 minutes during this time, and then 4ml medium was 
added to the cells for overnight incubation.
The following day, the cells were washed twice with PBS and refed with fresh growth 
medium. After a second overnight incubation, the cells were reseeded into ten 90mm plates 
and appropriate antibiotic selection was added at this time. After 2-4 weeks, colonies were 
ring-cloned for future analysis.
2.2.5. Assessment of tumourigenlcity in nude mice
Adherent cells were trypsinised, resuspended and counted using a haemocytometer. The 
cells were pelleted, washed once in PBS, and resuspended in PBS to give a concentration 
of 1 x 106 cells per lOOpl PBS. 1 x 106 cells were injected subcutaneously into nude mice 
at 2 different sites. The mice were monitored regularly, and any tumours were measured. In 
accordance with Home Office Guidelines, the mice were sacrificed when their tumours 
reached a diameter of 1cm.
A small piece of the tumours was fixed in 10% formalin, embedded in paraffin wax, and 
7pm sections were stained with haematoxylin and eosin according to standard procedures. 
This was carried out by Glasgow University Veterinary School histology service. 
Histological grading was assessed for all tumours collected and the remainder of the 
sample was frozen at -70°C to allow molecular analysis.
2.3. Somatic Cell Genetics
2.3.1. Somatic cell fusion
The two parental cell lines were harvested, counted, and cocultured in 90mm dishes for 24 
hours at 37°C in normal growth medium. The monolayer of cells was then fused by a 75 
second exposure to Polyethylene Glycol (PEG) 1500 (50% w/v in Hepes, 75mmol/l 
pH8.0). The PEG was immediately removed, and the cells were washed gently several 
times with serum-free medium, and then incubated in fresh serum-free medium for 1 hour 
at 37°C. This was replaced by serum-containing medium and the cells were left to recover 
overnight at 37°C. After 24 hours, the cells were harvested and assayed for hybrid 
formation by plating out at between 104 and 105 cells per 90mm dish in selective medium 
for 2-4 weeks. After this time, colonies were large enough to allow ring-cloning. For the 
A5 x B9 hybrids, the selection medium contained 300pg/ml G418 and 175pg/ml 
hygromycin (Boehringer Mannheim). carB x C5N hybrids were selected in 400pg/ml 
G418 and HAT (lx, Gibco).
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2.3.2. Microcell-mediated Monochromosome Transfer
The donor monochromosomal hybrid cells, carrying a single Hytk-tagged human 
chromosome, were plated out in multiples of six flasks (Nunc, 25cm2), and after 24 hours 
growth in DMEM + 20% FCS (in the absence of hygromycin), they were treated with 
colcemid at a final concentration of 0.06pg/ml for 48 hours.
For enucleation, the medium was aspirated, and replaced by 30ml fresh serum-free DMEM 
containing cytochalasin B at a concentration of 10pg/ml. The flasks were carefully 
balanced, then placed in a 30° fixed angle rotor for centrifugation at 9500g for 1 hour at 
37°C. The pots of the rotor contained 75ml of water which acted as a cushion. 
Approximately linear rates of acceleration and deceleration were maintained to minimise 
breakage of flasks.
Microcell pellets were removed from the flasks, pooled and filtered through polycarbonate 
membrane filters in series, using 1 x 8pm and 2 x 5pm filters. The microcell pellet was 
resuspended in 3ml serum-free DMEM + lOOpg/ml phytohaemagglutinin (PHA-P) and the 
suspension was added to semi-confluent recipient cells, which had been pre-washed with 
serum-free medium. Recipient cells were plated out 2 days before use in order to obtain 
even monolayers. (For carB cells, the plates were pre-coated with a sterile 0.1% gelatine 
solution, dissolved in PBS.) Microcells were allowed to attach to the monolayer for 20 - 30 
minutes at 37°C, and then fused by a 60 second exposure to 3ml PEG1500. The cells were 
quickly rinsed 3 times with serum-free medium to remove excess polyethylene glycol 
(PEG) and then incubated for 24 hours in normal growth medium containing 10% serum. 
Fused cells were trypsinised, resuspended in fresh medium and seeded into ten 90mm 
dishes. Microcell hybrids formed colonies in the selection medium which was composed of 
SLM + 10% FCS + hygromycin (350 units per ml) and HAT (to prevent growth of any 
whole A9 cells which may have passed through the filters). Colonies were ring-cloned after 
10-14 days, expanded and analysed by microsatellites and by Fluorescence In Situ 
Hybridisation (FISH) to confirm the presence and integrity of the introduced chromosome.
2.4. Nucleic Acid Analysis
2.4.1. Extraction of DNA from adherent cells for PCR
Cells were trypsinised from a sub-confluent 75cm2 flask, resuspended in PBS and pelleted. 
The pellet was then resuspended in 1.5ml lysis buffer (lOOmM Tris pH8.5, 5mM EDTA, 
200mM NaCl, 0.2% SDS) containing proteinase K (lOOpg/ml), and left to rotate at 37°C 
until the solution was completely clear. An equal volume of isopropanol was added to
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precipitate the DNA, which was then spooled onto a disposable sterile tip and dissolved in 
approximately 300pil of ddH20  or TE (lOmM Tris pH 8.0, O.lmM EDTA).
2.4.2. Extraction of RNA from adherent cells
Total RNA was isolated from actively-growing cells by a commercial version of the 
guanidinium-phenol method (Chomczynski and Sacchi,1987). Cells were grown in a 
75cm2 flask until sub-confluent. The medium was aspirated and the cells washed twice in 
PBS. 3ml RNazol was then added directly to the flask and the lysate was transferred to a 
polypropylene tube. 350pil chloroform was added and after vortexing, the lysates were left 
on ice for 15 minutes, then centrifuged at 10,000rpm for 20 minutes at 4°C. The upper 
aqueous phase was then transferred into a new tube, and an equal volume of isopropanol 
was added to precipitate the RNA. The mixture was left at 4°C for 3-4 hours.
To obtain the RNA, the lysates were centrifuged at 10,000 rpm for 30 mintues at 4°C, then 
the pellet was washed in 75% ethanol, and centrifuged again at 7,000 rpm for 20 minutes at 
4°C. The pellet was left to air-dry and then dissolved in lOOpl RNA dilution buffer (2% 
sarcosyl, 15mM EDTA, lOpg/ml proteinase K). RNA samples were stored at -20°C.
2.4.3. Extraction of DNA from frozen tumours or tissue samples, or adherent cells by 
the phenol chloroform extraction method
Frozen samples were ground to a powder using a mortar and pestel, which were pre-cooled 
on dry ice to prevent thawing of the samples. The powder was transferred to a Falcon tube 
containing 3ml lysis buffer (as described in 2.4.1.) and left to rotate at 37°C overnight.
For adherent cells, after rinsing in PBS, lysis buffer was added directly to the flask, which 
was left shaking overnight at 37oC. This viscous suspension was transferred to a Falcon 
tube containing 3ml lysis buffer (as described in 2.4.1.) for phenol: chloroform extractions.
Two phenol : chloroform extractions were performed by addition of one volume of phenol 
: chloroform (pH 8.0) and rotation for 15 minutes at 37°C. Centrifugation at 2500rpm for 
15 minutes separated the aqueous and organic phases, and allowed the transfer of the top 
aqueous layer containing the DNA (and some RNA) into a fresh tube. 30pl of RNase 
(25mg/ml) was added to remove any RNA, and after 2 hours of rotating at 37°C, 30pl 
proteinase K (lOmg/ml) was added and the tubes left overnight on the rotater at 37°C.
After one more phenol : chloroform extraction, the DNA was precipitated with 2 volumes 
of ice-cold 100% ethanol, and spooled onto a disposable pipette tip. DNA was dissolved in 
ddH20, and stored at 4°C.
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2.4.4. Southern blot transfer of DNA
20pg of restriction enzyme digested DNA was separated by agarose gel electrophoresis and 
transferred to Zetaprobe nylon membrane by the method of Rigaud et al. (1987). Following 
ethidium bromide staining and photography, the size-fractionated DNA was denatured by 
soaking the gel in 1M NaCl, 0.5M NaOH then neutralised for 30 minutes in 0.5M Tris-HCl 
pH 7.4, 3M NaCl. The transfer of DNA from the gel to the membrane was carried out on a 
raised platform covered with a wick of 3MM paper soaked in 20 x SSC transfer buffer. The 
gel was placed on the wick with Saranwrap surrounding it to minimise evaporation and 
ensure that all capillary action was through the gel and membrane. Zetaprobe membrane 
was placed on top of the gel and then covered in 3 sheets of 3MM paper soaked in transfer 
buffer, a stack of paper towels and a weight. Transfer took place overnight, then the 
membrane was washed in 2 x SSC and crosslinked using a Stratagene UV Stratalinker 
1800.
2.4.5. Northern blot transfer of RNA
Total RNA was isolated by the RNazol method outlined in Sections 2.4.2 and 2.4.4. 20pg 
of RNA was fractionated on 1.1% agarose gels (6% formaldehyde, 0.2M MOPS, 0.5M 
sodium acetate, 0.01M EDTA) in 1 x MOPS buffer. The gels were soaked in 50mM NaOH 
and 20 x SSC for 30 minutes each before the RNA was transferred to nylon membranes 
(Hybond N+) using 20 x SSC as described by Sambrook et al., 1989.
2.4.6. Bulk preparation of plasmid DNA
Individual colonies were transferred into 10ml L-broth containing lOOug/ml ampicillin, 
and incubated for 6 hours at 37°C. This suspension was added to 500ml L-broth + 
lOOpg/ml ampicillin and incubated overnight at 37°C. The culture was centrifuged in 
500ml Sorvall bottles at 5,000rpm for 5 minutes at 4°C, and the pellet was resuspended in 
25ml ice-cold lysis solution (50mM glucose, 2mg/ml lysozyme, 25mM TrisHCl, lOmM 
EDTA). After 15 minutes on ice, 50ml of alkaline solution (0.2M NaOH, 1% SDS) was 
added and the solution mixed vigorously by vortexing. 37.5ml of potassium acetate 
solution (3M KAc, 5M acetic acid) was added and the bottles incubated on ice for 15 
minutes.The bottles were centrifuged at 6,000rpm for 15 minutes at 4°C, and the 
supernatant was then filtered through gauze, and precipitated with 0.6 volumes of 
isopropanol. The pellet was resuspended in TE.
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The plasmid DNA was further purified by equilibrium centrifugation in a continuous CsCl 
gradient. 1.55g/ml CsCl was dissolved in the DNA solution. Ethidium bromide was added 
to a final concentration of 1 mg/ml. The refractive index of the solution was checked to 
ensure the density of the solution was correct (1.55g/ml ; refractive index 1.3860). The 
DNA sample was then loaded into polycarbonate tubes and centrifuged at 40,000rpm for 
40-60 hours at 15°C. The ethidium bromide was removed from the DNA by extraction with 
butanol. This was repeated until the red colour of the ethidium bromide had disappeared.
2.4.7. Restriction enzyme digestion of plasmid DNA
Plasmid DNA was digested by incubation at 37°C for 2 hours in the appropriate reaction 
buffer, 5 units of enzyme per pg of DNA, ImM spermidine and lOOpg/ml BSA.
2.4.8. Agarose gel electrophoresis
Horizontal apparatus was used in all cases. 1-2% gels (w/v) were cast in 1 x TAE buffer 
(40mM Tris base, 16mM acetic acid, ImM EDTA, pH8) containing lpg/ml ethidium 
bromide. Low melting point agarose was used for gels from which plasmid inserts were to 
be isolated for use as probes.
Gels were submerged in 1 x TAE buffer and samples were loaded with 0.25% 
bromophenol blue, 0.25% xylene cyanole, 50% glycerol, 1 x TAE. Gels for Southern blots 
were run at 25-50V for 20-24 hours and low melting point agarose gels were run at 50V 
until the bands were sufficiently resolved. The appropriate molecular weight markers were 
included on each gel. After electrophoresis, the size-fractionated DNA was visualised by 
ultraviolet light illumination and photographed.
2.4.9. Isolation of plasmid insert DNA for use as a probe
Plasmid DNA was digested as described in 2.4.5., and separated from the insert by 
electrophoresis in 1% low melting point agarose. The insert band was then cut from the gel 
when visualised by UV illumination, and heated at 65°C for 5 minutes. The DNA was then 
isolated from the agarose using the Wizard Prep Kit from Promega.
lml resin was added to the DNA / agarose suspension and the mixture vortexed for 60 
seconds. This was passed through a filter which captures the DNA. 2ml of 80% 
isopropanol was added to a syringe and passed through the filter. To get rid of the 
remaining isopropanol, the tubes are spun at 13,000rpm for 20 seconds, and the filter, 
which still contains the DNA, was then left to air-dry for 20-30 minutes. 33pl TE was
46
added to the filter for 1 minute to allow the DNA to dissolve. A second spin at 13,000rpm 
for 20 seconds, ensured the DNA was eluted from the filter.
2.4.10. Radioactive labelling of probes by the random priming method
Labelled probes were made by the random priming method. Approximately 50-100ng of 
purified insert DNA was added to a reaction mixture (from Stratagene's Prime-It RMT 
dCTP kit) containing oligonucleotide labelling buffer and dNTPs. The mixture was then 
boiled for 5-10 minutes to ensure denaturation, cooled and 1.85MBq of a 32P dCTP + 5 
units of Klenow enzyme were added. The reaction was incubated at 37°C for at least lh  
15minutes.
The unincorporated nucleotides were removed by running the probe through a Nick 
column (Pharmacia), and its specific activity measured using a scintillation counter. The 
probe was denatured by boiling for 5-10 minutes, and then placed on ice for 5 minutes 
before it was added to the pre-hybridisation buffer.
2.4.11. Southern blot hybridisation
Southern blots were pre-hybridised for 30 minutes at 65°C in Church buffer (0.2M NaP04 
pH7.2, ImM EDTA, 7% SDS, 15% formamide, 1% BSA) containing lmg/ml yeast tRNA 
(Church and Gilbert, 1984). The labelled probe was then added directly to the solution in 
the bag, and left to incubate overnight at 65°C.
The hybridisation solution was removed, and the membrane was washed twice at room 
temperature in 3% SDS, 20mM NaH2P 04 pH 7.2 ( 1 x 5  minutes, 1 x 15 minutes) then 
twice in 1% SDS, 20mM NaH2P 0 4 pH 7.2 for 20 minutes each at 65°C.
2.4.12. Northern blot hybridisation
Northern blots were prehybridised in 40% formamide buffer containing lmg/ml yeast 
tRNA for 5 hours at 42°C. Following the addition of the labelled probe, the membrane was 
incubated overnight at 42°C.
The membrane was washed in a series of solutions of decreasing salt concentration, 
beginning with two washes at room temperature in 2 x SSC, 0.1% SDS ( 1x5  minutes, 1 x 
15 minutes), then twice in 1 x SSC, 0.1% SDS at 65°C for 20 minutes each. The 
background counts were monitored and further washes with 0.1 x SSC, 0.1% SDS at 65°C 
were carried out if deemed necessary.
47
2.5. PCR
2.5.1. PCR amplification using mouse microsatellites
25pl reactions were performed with 150ng of genomic DNA in a reaction mixture with 
250pM of each dNTP, 2 oligonucleotide primers at 0.1 pM each and 0.1 unit of Taq 
polymerase (from a variety of suppliers) with the appropriate buffer containing MgCl2 at 
1.5mM.
All reactions were conducted using a Perkin Elmer GeneAmp PCR thermal cycler under 
the following standard conditions in thin-walled reaction tubes (Applied Biosystems) : an 
initial denaturation step at 95°C for 3 minutes followed by 30 cycles of denaturation (95°C, 
30s), annealing (50°C or 55°C, 30s) and extension (72°C, 30s). The annealing temperature 
was varied to give the best amplification at highest stringency. Amplimers were obtained 
from Research Genetics, Huntsville, Alabama.
2.5.2. PCR amplification on monochromosomal hybrids using human microsatellite 
primers
25ul reactions were performed with 40ng genomic DNA in a reaction mixture containing 
200pM each dNTP, oligonucleotide primers at luM each (obtained from Research 
Genetics) and 0.2 units Taq polymerase (from Advanced Biotechnologies, supplied with 
Buffer I (500mM KC1, lOOmM Tris-HCl pH8.3, 15mM MgCl2). All reactions were 
conducted in a Perkin Elmer GeneAmp PCR thermal cycler under the following conditions 
: 95°C 3minutes, 80°C for 10 minutes, 94°C for 30s and 60°C for 30s (repeated for 6 
cycles), 94°C for 30s, 58°C for 30s, and 72°C for 30s (repeated for 28 cycles), and finally 
72°C for 7 minutes.
2.5.3. PCR amplification of hph sequences in monochromosomal hybrids
Microcell hybrids were analysed for the presence of the integrated HyTK fusion gene. 
Oligonucleotide primers were designed to amplify a 187bp fragment of the hygromycin 
phosphotransferase gene, as described in Trott et al.,1995. The sequences of the primers 
used were 5 ’ GCCTGACCT ATTGC ATCTCCCG 3’ (forward) and
5’GCCATGTAGTGTATTGACCGATTCC 3’ (reverse).
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All PCR reactions were performed in lOmM Tris-HCl, pH 9.0; 50mM KC1; 0.1% Triton 
X-100; 1.5mM MgCL ; 200mM each dNTP; lpM  each primer; and 0.02U/pl Taq 
polymerase (Promega Corporation Ltd., Madison, WI). The thermal cycles were 94°C for 5 
minutes; 94°C, 62°C and 72°C (each for 15seconds, for 30 cycles); and 72°C for 3 minutes.
2.5.4. Separation of PCR-amplified products
PCR products were resolved on either 4% agarose or 6% acrylamide gels. The 4% gels 
were composed of 3% Nusieve (FMC), 1% agarose (Sigma), 0.5pg/ml ethidium bromide 
and TBE buffer. Amplified DNA was loaded with 0.25% orange G in 50% glycerol, 50% 1 
x TBE and the gels were run at 100V for 1 hour, then photographed.
6% non-denaturing acrylamide gels formed using 20 x 38cm glass plates (EV400 gel tank, 
Cambridge Electrophoresis) coated with Repelcote were used for analysing PCR 
microsatellite products which were could not be resolved on agarose gels. PCR reaction 
products were loaded with 50% glycerol, 1 x TBE, 0.25% bromophenol blue, 0.25% 
xylene cyanole and electrophoresis was conducted at room temperature for 2 hours at 20W. 
The gel was then silver stained.
For microcell hybrid clones, PCR products were run on 1% agarose gels in lxTAE, as 
described in 2.4.6.
2.5.5. Silver staining of acrylamide gels
Acrylamide gels were fixed in 10% ethanol, 0.5% acetic acid for 10 minutes by gently 
shaking at room temperature and the solution was then replaced by silver nitrate (6mM) 
for 15 minutes. After two rinses in water, developer (0.15% formaldehyde (v/v) in 375mM 
NaOH) was added until bands were clearly visible, and the gels were then placed in stop 
solution (70mM Na2C 03) for 10 minutes, then sealed in a bag, and stored in the dark.
2.6. Fluorescence in situ Hybridisation (FISH)
2.6.1. Preparation of metaphase spreads
For normal mouse macrophages, mouse femurs were flushed out and the resident bone 
marrow cells were cultured for 6 days in the presence of macrophage colony stimulating 
factor (M-CSF). The cells were then treated with colcemid (0.lug/ml) at 37°C for 1 hour, 
and harvested. The cells were centrifuged at 1500rpm for 5 minutes. Most of the 
supernatant was removed and the cells were resuspended in the remaining medium. Pre­
warmed hypotonic buffer (0.075M KC1, 37°C) was added dropwise. The cells were
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incubated at 37°C for 5-10 minutes, then centrifuged at 1500 rpm for 5 minutes. Most of 
the supernatant was removed and the cells were resuspended in the remaining buffer. The 
swollen cells were then fixed in 3:1 methanol / acetic acid, and left at room temperature for 
15 minutes, then centrifuged at 1500rpm for 5 minutes, to remove the supernatant. Fixation 
was repeated twice. The cells were dropped from a height onto clean, moist slides and 
immediately washed in 3:1 methanol / acetic acid.
Established cell lines were cultured until subconfluent, at which time they were treated 
with colcemid (O.Olug/ml) for 2-3 hours at 37°C, and then harvested. Chromosomes were 
prepared as described for mouse macrophages.
2.6.2. Preparation of probes
FITC-labelled whole mouse chromosome paints were purchased from Cambio. For each 
slide, lOul of probe was denatured at 75°C for 5 minutes, and incubated at 37°C for 30 
minutes to allow for pre-annealing of Cotl repetitive DNA prior to application to 
metaphase chromosomes.
Human whole chromosome paints were obtained from Oncor, labelled with digoxigenin 
(DIG). Again, lOul of probe per slide was denatured at 75°C for 5 minutes, and the probe 
was incubated for 2 hours at 37°C to allow pre-annealing of repetitive sequences .
2.6.3. In situ hybridisation
Metaphase spreads were fixed in 3:1 methanol / acetic acid for 1 hour, rinsed in 2xSSC, 
and then treated with RNase (lOOg/ml) in 2xSSC at 37°C for 1 hour. Slides were rinsed in 
2xSSC, then treated with 0.01% pepsin in 0.01M HC1 at 37°C for 10 minutes. After rinsing 
in phosphate buffered saline (PBS) and fixing in Streck Tissue Fixative for 10 minutes at 
room temperature, the chromosomes were then dehydrated in 70% and 100% ethanol. 
Chromosomes were denatured prior to the hybridisation in 70% formamide in 2xSSC at 
80°C for 3 minutes. Slides were quenched in ice-cold 70% ethanol, then dehydrated. The 
probe was applied to the denatured chromosomes, and hybridisation was carried out under 
a sealed coverslip at 37°C overnight in a humidified chamber.
2.6.4. Probe detection
After hybridisation, coverslips were removed in 2xSSC and slides were washed in 50% 
formamide / lxSSC and then 2xSSC, both at 42°C for 20 minutes each. For DIG-labelled 
human whole chromosome paints, prior to the first detection step, slides were incubated 
with block (0.5% blocking reagant, Boehringer Mannheim, in 4xSSC-tween) at 37°C for
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10 minutes. All antibodies were diluted in this blocking solution. Chromosomes were 
incubated with a sheep anti-DIG antibody (diluted 1:200) for 1 hour at room temperature, 
then washed for 10 minutes in 4xSSC-T. Chromosomes were then incubated in the 2nd 
layer of detection - an FITC-conjugated donkey anti-sheep secondary antibody (diluted 
1:500) for 1 hour at room temperature. Metaphase spreads were then washed for 10 
minutes in 4xSSC-T and then dehydrated in 70% and 100% ethanol, and mounted in anti­
fade medium (Vectashield, Vector Labs) containing O.lpg/ml DAPI and 0.3pg/ml PI.
The mouse whole chromosome paints were directly labelled with FITC, and so following 
the wash steps in 50% formamide and 2xSSC, these could be dehydrated in 70% and 100% 
ethanol, and mounted in anti-fade medium containing DAPI and PI as before. Fluorescence 
was analysed in both cases using a BioRad MRC-600 laser scanning confocal microscope 
equipped with a krypton argon ion laser, using 488/568nm line excitation, and dual channel 
522nm and 585nm filters.
2.7. Protein Analysis
2.7.1. Preparation of total protein extracts
Whole cell extracts containing known numbers of cells per ml were prepared in the 
following manner. Equal numbers of cells were plated into four 100mm dishes. When 
subconfluent, the total number of cells in one dish was counted. The remaining three dishes 
were washed with ice-cold PBS and the cells were lysed in 1ml of lysis buffer (10% 
glycerol, 5% SDS, 0.08M Tris pH 6.8) plus |3-mercaptoethanol (40pl/ml) added just before 
use. The viscous lysate was removed from the dish using a cell scraper. After boiling, 
sonication (2 x 10s) and centrifugation at 14,000rpm for 15 minutes, the lysates were 
adjusted using lysis buffer to give 1 x 106 cells/ml. Lysates were stored at -20°C.
2.7.2. Immunoblotting
Whole cell lysates were prepared as described.
Proteins were separated according to the method of Laemmli (1970) by electrophoresis on 
8% SDS polyacrylamide gels (size 14 x 14cm). Gels were loaded with 5 x 104 lysed cells 
per lane. lOpl of rainbow coloured molecular weight markers in 30pl western lysis buffer 
were included on each gel. All samples were denatured by boiling for 5 minutes followed 
by rapid cooling on ice prior to loading. Separated proteins were transferred onto 
nitrocellulose membranes as described by Towbin et al., (1979) for 1 hour 20 minutes 
using a semidry electroblotter.
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After transfer was complete, the membrane was blocked with blotto (5% powdered milk in 
TBS, 0.05% Tween-20) for at least 2 hours. It was then incubated with a minimum volume 
of primary antibody diluted in fresh blotto overnight at 4°C. The following day, filters were 
washed 3 x 1 0  minutes in blocking solution and incubated with the appropriate horseradish 
peroxidase conjugated secondary antibody for 1 hour at room temperature. Blots were then 
washed thoroughly; 3 x 10 minutes in blotto and 3 x 10 minutes in TBS / Tween, then 
immunodetection of antigens on the nitrocellulose was performed using enhanced 
chemiluminescence (ECL).
The following primary antibodies were used :
Protein______Antibody___________Source______ Dilution_____ Clone No.
E-cadherin rat monoclonal Takara 1/50,000 M108/003FD
keratin mouse monoclonal Boehringer 1/300,000 C-1801/PCK-26
vimentin mouse monoclonal Sigma 1/20,000 V-5255/VIM13.2
These were detected using HRP-Iinked anti-mouse - 1/4000 (for vimentin and keratin) or 
anti-rat - 1/1000 (for E-cadherin) secondary antibodies.
2.7.3. Immunofluorescence
For immunodetection of E-cadherin, 5 x 104 cells were seeded in 8-well Permanox 
chamber slides, and left overnight to become sub-confluent. Cells were washed in ice-cold 
PBS then fixed and permeabilised with methanol at -20°C for 10 minutes. They were then 
washed thoroughly in PBS, and after blocking with horse serum for 20 minutes (diluted 
1:10), cells were incubated with a rat monoclonal anti-E-cadherin antibody, ECCD-2 
(Takara), at a 1:500 dilution for 1 hour at room temperature. The slides were washed in 
PBS/0.15M NaCl/0.05% Tween-20 and an anti-rat FITC-linked secondary antibody was 
applied (40 fold dilution) for 20 minutes. After further washing in PBS/NaCl/Tween and 
rinsing in water, the slides were mounted with Vectashield antifade using nail varnish to 
seal the coverslips and viewed at 40x magnification using a Leitz fluorescence microscope.
The same procedure was followed for staining with pan keratin and vimentin antibodies. 
These were used at 1:300 and 1:200 dilutions respectively, and the secondary antibody was 
an anti-mouse IgG-fluorescein isothiocyanate conjugate used at a 200 fold dilution.
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Results
Chapter 3. Mouse chromosome 7 is altered in the squamous-spindle 
transition.
The H-ras proto-oncogene plays an important role at several stages in mouse skin 
carcinogenesis, since it is mutated to an activated form by the initiating carcinogen, 
DMBA, and the mutant allele is further duplicated or amplified in benign and malignant 
tumours (Balmain and Pragnell,1983; Quintanilla et al.,1986; Bremner and 
Balmain, 1990). Alterations in H-ras are also relevant to the squamous-spindle 
transition. Analysis of microdissected primary mouse skin tumours comprising both 
morphologies showed that the spindle areas frequently had additional copies of the 
mutant allele, and in many cases had also lost the normal ras gene (Buchmann et 
al.,1991).
A unique pair of squamous and spindle cell lines derived from the same primary 
tumour provided definitive evidence that spindle cells are derived from squamous cells, 
since the two cell types had exactly the same mutations in ras and p53 (Burns et 
al.,1991). Further analysis of these cell lines revealed that the squamous carcinoma cell 
line, B9, had a 2:1 ratio of mutant : normal alleles, while in the spindle cells, A5 and 
D3, the level of expression of the mutant H-ras was substantially elevated, and they 
expressed lower amounts of the normal allele (Robbie Crombie, PhD thesis, 1993).
Analysis of LOH in tumours generated in FI hybrid mice showed that imbalance of 
alleles on mouse chromosome 7, on which YL-ras is located, occurs frequently in 
tumours which have activated ras (Bremner and Balmain, 1990; Kemp et al., 1993b). 
However, the nature of ras / chromosome 7 involvement at this stage was unclear. In 
particular, it was not known whether the main consequence of the genetic events 
involving mouse chromosome 7 was overexpression of the mutant allele, loss of the 
normal allele, or indeed altered function of other genes on this chromosome.
To try to address some of these questions, and to determine the mechanism of 
alterations leading to homozygosity at the ras locus, in this study we have undertaken 
to characterise the clonally-related squamous and spindle cell lines, B9, A5 and D3, 
using whole chromosome paints. A chromosome paint is a complex mixture of DNA 
probes which hybridise to the entire length of a specific chromosome. Paints are 
generated by flow sorting of chromosomes, followed by PCR using fluorescently- 
labelled, locus-specific primers, (Rabbitts et al., 1995) and they allow the direct 
visualisation of specific chromosomes both in metaphase spreads and interphase cells.
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Hybridisation of a chromosome 7-specific paint to B9, A5 or D3 cells, revealed 
dramatic differences in the copy number of chromosome 7. The three cell lines were all 
aneuploid with a hyperdiploid mode of around 70 chromosomes. The two spindle cell 
lines, A5 and D3, were trisomic for chromosome 7 compared with their squamous 
counterpart, B9, which had on average five or six copies of chromosome 7 (Figure 1). 
In addition, both spindle cell lines contained double minute chromosomes (Figure 2c 
and d), some of which appeared to hybridise to the chromosome 7 paint. A proportion 
of these labelled double minutes had integrated into other chromosomes.
FISH analysis using a genomic H-ras clone to metaphase chromosomes from either of 
the spindle clones, combined with data from molecular approaches, revealed that these 
double minute chromosomes carried multiple copies of mutant H-ras (Robbie 
Crombie, PhD thesis, 1993; Nicol Keith, unpublished observations).
Interestingly cyclin D l, which is located on the distal part of mouse chromosome 7, in 
the same region as the H-ras gene is also frequently overexpressed in mouse skin 
carcinoma cell lines (Sheena Haddow, unpublished observations). However, in situ 
hybridisation of a genomic cyclin Dl probe to metaphase spreads prepared from A5 or 
D3 cells, showed that this gene was not part of the H-ras amplicon in the spindle cells 
(Nicol Keith, unpublished observations)
We have detected a structural chromosomal aberration involving chromosome 7 in the 
B9 cells. A significant proportion of the cells in the population carried a non-reciprocal 
translocation (Figure 2a), and several cells harboured an insertion of a part of 
chromosome 7 into an unknown chromosome (Figure 2b). These rearrangements were 
not present in either of the spindle cell lines, implying that B9 cells must have diverged 
from the A5 and D3 cells prior to this event. At present, the significance of this 
translocation / insertion event is not understood, as it is unclear whether it involves the 
H-ras gene. This could be addressed by carrying out a double hybridisation with the 
FITC-labelled chromosome paint and a Cy5-labelled genomic H-ras clone.
Analysis of chromosomes 4 and 6 in squamous and spindle cells.
An allelotype analysis of chemically-induced mouse skin tumours revealed that markers 
on chromosomes 6 and 7 were imbalanced, consistent with trisomy in both benign and 
malignant skin tumours. In addition, LOH on chromosomes 4 and 6 were observed 
specifically in spindle carcinomas (Kemp et al., 1993b) implying that alterations in these 
chromosomes might be important at this stage. We have attempted to address the
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Figure 1 : Analysis of chromosome 7 copy number in clonally-related squamous and 
spindle cell lines by FISH.
The mouse chromosome 7 paint was hybridised to metaphase spreads 
prepared from normal mouse macrophages (a) and the B9, A5 and D3 cell 
lines (b and c). In each case, the number of hybridisation signals was counted 
in 50 metaphase spreads, and the data plotted as the proportion of cells 
containing a particular number of copies of chromosome 7.
Figure 2 Analysis ol structural aberrations oi chromosome 7 in clonalh-related 
squamous and spindle cells using chromosome paints.
T h e  t o p  t w o  i m a g e s  ( a  a n d  b )  s h o w  a n o n - r e c i p r o c a l  
t r a n s l o c a t i o n  p r e s e n t  in th e  s q u a m o u s  c a r c i n o m a  c e l l  l ine .  B 9 .
O n h  a  p o r t i o n  o l  t h e  c h r o m o s o m e s  i n d i c a t e d  b \  a r r o w s  h y b r id i s e  
t o  t h e  c h r o m o s o m e  7 p a in t .  T h e  b o t t o m  t w o  i m a g e s  t c  a n d  d )  
i l l u s t r a t e  t h e  p r e s e n c e  o l ' d o u b l e  m i n u t e  c h r o m o s o m e s  in  th e  
s p i n d l e  c a r c i n o m a  ce ll  l ine . D 3 .  A t le a s t  s o m e  o l  t h e s e  c o n t a i n  
g e n e s  o n  c h r o m o s o m e  7 . a n d  a  s m a l l  p r o p o r t i o n  o l  t h e s e  l a b e l l e d  
d o u b l e  m i n u t e s  a p p e a r  to  be i n t e g r a t e d  in t o  o t h e r  c h r o m o s o m e s .
possible involvement of these chromosomes in the squamous-spindle transition by 
examining these chromosomes in B9, A5, and D3 cell lines using FISH.
Figure 3 shows representative metaphase spreads from the chromosome painting 
analysis. In situ hybridisation of a fluorescein-labelled paint for mouse chromosome 6 
to metaphase spreads prepared from normal mouse macrophages, demonstrate the high 
specificity and absence of background of the hybridisation signals (Figure 3a). The 
paints hybridised to the expected number of chromosomes in these diploid control 
cells, and the signals appeared to be evenly distributed over the stained region.
The squamous and spindle cell lines did not differ with respect to chromosome 6. All 
of them carried three or four copies of chromosome 6 (Figure 3 and Figure 4b and d). 
In addition, no structural aberrations involving this chromosome were identified which 
could distinguish between the cell lines. The fact that the cell lines did not differ 
significantly in the number of copies of chromosome 6 underlines the importance of the 
findings on chromosome 7.
The allelotype analysis indicated that trisomy of chromosomes 6 and 7 occurred in 
papillomas as well as in carcinomas. The presence of four copies of chromosome 6 in 
the carcinoma cell lines examined in this study, implies that there may be selection for a 
further increase in copy number of this chromosome in carcinomas. This may not have 
been detected in the allelotype analysis, since ratios of 2:1 and 3:1 would be hard to 
distinguish. Alternatively, further changes in chromosome 6 may have occurred in 
these cell lines in culture.
p i 6 expression and chromosome 4 copy number.
p i 6 is located on mouse chromosome 4, and the status of p i 6 in these cell lines has 
already been determined (Linardopoulos et al.,1995). Alterations in p l6  occur 
concomitantly with the loss of differentiation associated with the transition to the 
spindle phenotype. It was therefore of interest to establish any relationship between the 
expression of this gene, with the chromosome on which it is located, with reference to 
the spindle phenotype. Table 1 shows a summary of the p i 6 status and chromosome 4 
copy number of the cell lines used in this study.
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Figure 4 : Analysis of chromosome 4 and 6 copy number in squamous 
and spindle carcinoma cell lines.
B9, A5 and D3 cells show trisomy for chromosome 4, and all 
three cell lines carry three or four copies of chromosome 6.
Cell line p i6 expression No.of copies of ch.4
C5N + 5
B9 + 3
A 5/D 3 +++ 3 /3
carB / carC - 2 H A
Table 1 : Expression of p i  6 protein and number of copies 
of chromosome 4 in cell lines derived from C5N 
cells, or cell lines derived from squamous and 
spindle carcinomas.
Despite the fact that A5 and B9 both contained three copies of chromosome 4 (Figure 
4a and c), p i 6 was found to be overexpressed in A5 compared with B9. This finding 
means that overexpression of p i 6 in A5 cells was not due to an increase in gene 
dosage, and was likely to be at the level of mRNA, either by an increase in 
transcription, or by stabilisation of the message. This result confirms data previously 
obtained by Southern blotting analysis (Linardopoulos et. al., 1995).
Interestingly, the keratinocyte cell line, C5N, which contained five copies of 
chromosome 4, expressed p i  6 at very low levels, and carB / carC, both spindle 
carcinoma cell lines, had a homozygous deletion at this locus on chromosome 4. In the 
case of carB, this may have occurred by two separate deletion events in the two 
chromosomes, however, in the sub-population of carC cells which have four copies of 
chromosome 4, this is more readily explained by one or two deletion events, followed 
by duplication.
Characterisation of mouse skin cell lines by FISH
The panel of cell lines frequently used for the analysis of the genetic and biological 
events in mouse skin carcinogenesis has been well characterised, and they are believed 
to be representative of the various tumour types. In this part of the study, we wished 
to characterise these cell lines, derived from different stages of mouse skin 
carcinogenesis, using the chromosome paints. Table 2 summarises the results obtained 
with mouse chromosomes 4, 6 and 7 in these cells.
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Cell line No. of copies* of TNC
#
Chr.4 Chr.6 Chr.7
Macrophages 2 (100) 2 (100) 2 (92) 40
C5N 5 (66) 5 (50) 4  (73) 67
PI 2 (52) 3 (52) 3 (66) ND
P6 2/3 (41/38) 3 (49) 3 (50) ND
B9 3 (74) 4 (6 8 ) 5 (50) 67
A5 3 (74) 4  (84) 3 (86) 68
D3 3 (80) 3 (52) 3 (62) 69
carB 2 (76) 2 (78) 2 /4  (39/42) 40
carC 2 /4  (46/42) 4  (58) 2 /4  (40/42) 64
Table 2 : Summary of chromosome painting analysis.
* To obtain chromosome copy numbers, a minimum of 25 metaphase 
spreads were analysed per cell line per chromosome, and in
most cases, 50 spreads were examined.
# total number of chromosomes (TNC). The mean of 10 individual 
metaphase spreads is given.
The figure given in parentheses after the copy number refers to 
the % of all metaphase spreads examined which contained 
that number of copies of a particular chromosome.
ND not determined
The cell lines used in the study described in 2.2.1., however briefly, C5N is an 
immortalised keratinocyte cell line, PI and P6 are cell lines derived from papillomas, 
B9 (squamous) and A5 & D3 (spindle) are cell lines derived from the same carcinoma, 
and carB and carC were derived from spindle carcinomas. All tumours were generated 
by the DMBA/TPA or multiple DMBA protocols, and as a result, all cell lines (except 
C5N) carry the same A-T mutation at codon 61 of the H-ras gene. Mouse 
macrophages were included as normal diploid controls.
Immortal keratinocyte line, C5N - a word o f caution.
C5N, a normal keratinocyte cell line, spontaneously immortalised following DMBA 
treatment, is nontumourigenic in the nude mouse assay. It is often used as a ‘normal’ 
control to compare results found in cell lines derived from tumours. The results 
otained in this study indicate that some caution is required in the classification of C5N 
as a ‘normal control’. The capacity for genetic variation is particularly evident in this 
cell line, which shows a median of 67 chromosomes, representing a near-tetraploid 
chromosome complement. In addition, chromosome painting revealed that multiple
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copies of all three chromosomes were present, with on average, five copies of 
chromosome 4, five copies of chromosome 6 and four copies of chromosome 7. Also 
observable in the C5N cell line was the presence of an isochromosome structure 
involving chromosome 6, found in at least 42% of metaphase spreads (Figure 5). 
These are formed by abnormal centromere division during mitosis. Structural 
aberrations such as these are indicative of genomic instability.
Papilloma cell lines, PI and P6 show trisomies o f chromosomes 6 and 7 
Papillomas induced in vivo consistently show trisomies of chromosomes 6 and 7 as 
their only alterations (Aldaz et al., 1989; Kemp et al.,1993). Both papilloma cell lines 
displayed trisomies of chromosomes 6 and 7 (Figure 6b and c), which is in agreement 
with the in vivo molecular data (Kemp et al., 1993b). In phenotype, they appear only to 
differ with respect to their response to TGF|3. PI is resistant to TGF(3, while P6 is 
sensitive (Haddow et al.,1991). There were several, subtle differences between the two 
cell lines with regards to chromosome copy number. PI had two copies of 
chromosome 4, whereas a large proportion of cells (38%) in the P6 cell line were 
trisomic for chromosome 4 (Figure 6a). Additionally, we found that in P6, about one 
quarter of its population contained four copies of chromosome 6, and the same 
proportion had four copies of chromosome 7.
Further increases in the copy number of chromosomes 6 and 7 could have been 
selected for in vitro, particularly if they enhance the growth of the cells in this 
environment. TGFa, located on mouse chromosome 6 may play some part in this 
selection. In addition, further increases in H-ras (on mouse chromosome 7) and raf-1 
(on mouse chromosome 6) may also be advantageous.
Spindle carcinoma cell lines, carB and carC are composed o f two subpopulations 
which differ in their karyotype.
Despite being the most malignant cell lines, carB and carC appeared to have no 
detectable rearrangements or amplifications, and in fact, carB appeared to have a 
diploid karyotype, with a mean total chromosome number of 40. The notable feature 
was that car B appeared to have a dual population with respect to chromosome 7 copy 
number, with 39% of cells in the population containing two copies of chromosome 7, 
while another 42% carried four copies (Figure 6f).
Interestingly, in a previous cytogenetic analysis carried out on the carB cells by G- 
banding, the proportion of diploid cells in the population was estimated as 82% 
(14/17). The remaining 18% of the population (3/17) had a near tetraploid karyotype
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Figure 6 : Analysis of chromosome copy number in papilloma and spindle 
carcinoma cell lines by FISH.
The papilloma cell lines, PI and P6, contained two copies of chromosome 4 
and three copies each of chromosomes 6 and 7. A dual population appeared 
to be present in the carB and carC cell lines, which were both derived from 
spindle carcinomas.
with a mean of 73 chromosomes. Of those cells which had a diploid karyotype, there 
were no consistent gains or losses of particular chromosomes., and for the most part, 
two copies of each chromosome were present (Mairi Clarke, unpublished 
observations). This leads us to suppose that the subpopulation in the carB cell line, 
which have four copies of chromosome 7 and a pseudotetraploid karyotype may have 
arisen as a result of endoreduplication of a diploid cell, followed by chromosome loss. 
These cells must have had a selective advantage, since they now comprise 40% of the 
population. The selection for retention of chromosome 7 can be explained by selection 
for elevated expression of mutant H-ras, since carB cells do not contain any normal H- 
ras. In contrast, the majority of the cells in both populations only harbour two copies 
of chromosomes 4 and 6.
car C had either two or four copies of all three chromosomes examined (Figure 6d-f). 
At present, it is not clear at present whether in the car C cell line, the same 40% of the 
population was diploid for all chromosomes, or whether the population which was 
diploid for chromosome 4 was perhaps tetraploid for chromosome 6. This could be 
addressed using paints labelled with different fluorochromes.
In view of the fact that that two distinct populations exist within carB and carC, it may 
be advisable in the future to subclone these two cell lines.
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Chapter 4 : Generation and characterisation of hybrids between clonallv-
related squamous and spindle cell lines.
Somatic cell fusion is a well characterised approach to answer the question of whether 
a specific phenotypic trait is dominant or recessive.
In the mouse skin model of multistep tumourigenesis, it had been shown by somatic 
cell fusion, that the progression of squamous cell carcinomas to invasive, spindle 
carcinomas was a recessive event (Stoler et al., 1993). Hybrids derived from the fusion 
of spindle carcinoma cells, with cells isolated from earlier stages of mouse skin 
carcinogenesis, resembled the epithelial parent. The hybrids re-expressed various 
markers of differentiation, including E-cadherin and the keratins, which were absent in 
the spindle parent. In addition, tumourigenicity was found to be suppressed to different 
levels by cells at various stages of malignancy.
These cell fusion experiments provided suggestive evidence that a loss of information 
occurred during the progression from squamous to spindle cells. However this 
evidence was based on the finding that although B9 was capable of reverting carB to a 
squamous morphology, hybrids generated between A5 and carB remained spindle. By 
carrying out somatic cell fusion between A5 and B9, which are clonally-related 
squamous and spindle cells, we aimed to address this hypothesis directly.
The cell lines, A5 and B9, were derived from the primary carcinoma, MSC11, induced 
in a CBA / spretus FI hybrid mouse by weekly treatment with DMBA (Burns et 
al.,1991). The primary tumour, and the tumour explant, M SClla, had both squamous 
and spindle components, which were separated by single cell cloning to give B9 
(squamous) and A5 & D3 (both spindle). Mutational analysis of the H-ras and p53 
genes in these cells provided formal proof of a common origin for squamous and 
spindle carcinomas. (Burns et al.,1991).
We obtained B9 cells containing the pHomerb plasmid (Spandidos and Wilkie, 1984), 
which confers resistance to G418, and A5 cells were transfected with the 
pBABEhygro plasmid (Morgenstern and Land, 1990), encoding hygromycin resistance. 
Following cell fusion, hybrids were selected in medium containing G418, and 
hygromycin. Several colonies were ring-cloned for further analysis.
Figure 1 shows the Northern blot analysis of some of the clones, probed with 
neomycin and hygromycin. The blots were re-hybridised with GAPDH to control for
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Figure 1 : Northern blot analysis of A5 x B9 hybrid clones.
20pg of total RNA from putative hybrid clones was probed with the 
bacterial hygromycin resistance gene. A separate blot was probed 
with the bacterial neomycin resistance gene, or a G A PD H  probe to 
control for RNA loading and degradation. B9 homer cells express 
neomycin, and 'A5 hygro 1' and 'A5 hygro 2' express hygromycin.  
True hybrids, such as clones 10, 14, 16, and 25, express both genes. 
The other clones only express one or other of the genes, and were 
disregarded from future analysis .
RNA loading. Only clones which were positive for both probes were considered to be 
true hybrids.
Detailed microsatellite analysis carried out between the two cell lines revealed that at 
D8Mitl3, B9 had lost the CBA allele, while A5 retained both the CBA and spretus 
alleles (Jennifer Liddell, PhD thesis 1995). This finding was used to provide additional 
evidence that we had isolated true hybrid cells. Any squamous hybrid colonies which 
carried a CBA allele must have acquired the allele through fusion with an A5 cell. The 
PCR products were run on a polyacrylamide gel, which was then silver-stained. A 
photograph of this gel is shown in Figure 2.
Characterisation o f  A S  x  B9 hybrids.
The majority of hybrids were squamous in morphology, however, we also obtained a 
few spindle clones, presumably revertant clones, which had lost the suppressive 
information from B9. Representative clones showing both morphologies are depicted 
in Figure 3.
To confirm the extent of reversion of the spindle A5 cell line by its squamous 
counterpart, B9, hybrids were analysed by immunofluorescence and Western blotting 
for the expression of E-cadherin, keratins and vimentin. Simultaneous analysis of 
protein expression at the biochemical level, and the spatial localisation of the proteins 
within a cell population is of particular importance in hybrid cells.
E-cadherin
E-cadherin plays a crucial role in establishing and maintaining cell-cell interactions 
(Takeichi, 1991; Kemler and Ozawa, 1989; Gumbiner, 1992). To examine its 
expression in the hybrid cells, a monoclonal antibody to E-cadherin, ECCD-2, was 
used (Yoshida-Noro et al.,1984; Nose et al.,1987).
E-cadherin expression is found exclusively in epithelial cells, and its expression is also 
usually maintained in squamous carcinomas and cell lines derived from these tumours, 
such as B9 (Figure 4a, lane 2). E-cadherin protein is absent in most spindle 
carcinomas, and is not expressed in A5 cells (Figure 4a, lane 1). Hence, it is reliable 
marker for establishing whether morphological reversion in the hybrids has been 
accompanied by re-appearance of some of the biological characteristics of epithelial 
cells.
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Figure 2 : PCR microsatellite analysis of A5 x B9 hybrid clones at marker D 8M itl3.
A5 and B9 cell lines were derived from a carcinoma generated by multiple 
DMBA treatment of a spretus / CBA FI mouse. The original tumour, 
M S C 1 1, had both spretus and CBA alleles, which are detected in A5 cells. 
B9 cells have lost the smaller allele at this marker. Any squamous hybrids 
which contain this lower band, must therefore be true hybrids. Only clone 
15 lacks this band.
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Figure 4 : Analysis of protein expression in A5 x B9 hybrid clones by 
Western blotting.
A series of clones was investigated with respect to expression 
of E-cadherin, the keratins and vimentin. The squamous hybrids 
(clones 11 and 18), expressed E-cadheriand the keratins at levels 
equivalent to those seen in squamous B9 cells. Similar results were 
obtained for clones 10, 14 and 16, not shown here. Clone 6, which 
appeared predominantly squamous in morphology,  co-expressed 
both the keratins and vimentin (E-cadherin and vimentin were only 
detectable at longer exposures).Spindle hybrids did not express any 
E-cadherin, but did express vimentin. Clones 25 and 26 showed this 
same pattern of expression. Despite the fact that A5 cells are spindle 
they still expresssmall amounts of keratin, which can also be detected 
in some spindle clones, such as clone 4.. The two bands picked up 
by the pan keratin antibody represent low and high molecular weight 
keratins.
Vimentin
Keratin
Squamous hybrids, such as clones 11 and 18, expressed E-cadherin (Figure 4a, lanes 7 
and 8),, and clones 10, 14 and 16, which are not included in the figure, showed similar 
results. In contrast, none of the spindle clones expressed any E-cadherin protein. Clone 
6, a squamous hybrid, expressed very low levels of E-cadherin, which could only be 
detected at longer exposures.
Analysis of protein localisation by immunofluorescence revealed that E-cadherin 
protein in the squamous hybrids was correctly localised to areas of cell-cell contact 
(Figure 5a and 5c). Early passage clones were used for this analysis, which is 
particularly evident in Figure 5b, which shows the presence of heterokaryons within 
this population. Heterokaryons are formed by the fusion of two cell membranes, and 
this event precedes nuclear fusion to produce a true hybrid cell.
Keratins
The keratins are a family of intermediate filament proteins, whose twenty or so 
members are expressed in a tissue-specific and differentiation-specific manner, as well 
as at various times during development (Kopan and Fuchs, 1989). However, it has also 
been demonstrated by several groups that cells transformed by ras oncogenes (Nischt 
et al.,1988; Diaz-Guerra et al.,1992; Cheng et al.,1990) or by DNA tumour viruses 
(Hronis et al.,1984), can express a different pattern of keratins. In these experiments, a 
broad spectrum keratin antiserum was used to investigate the general keratin 
expression in both the parental cells and in the hybrids.
The pan keratin antibody used in this study recognises high and low molecular weight 
cytokeratins, which were both present in the B9 cells, as well as in the squamous 
clones 11 and 18 (Figure 4b, lanes 2, 7 and 8). Several of the other clones showed 
keratin expression, however they appeared to express only the low molecular weight 
species, which are the same keratins usually found in A5 at longer exposures. The type 
of keratins expressed in spindle cells therefore appears to be restricted to the low 
molecular weight forms.
Examination of the keratins in these cells by immunofluorescence revealed that 
squamous hybrid cells maintained a functional keratin filament network. In some cases, 
the degree of staining within a population of cells was heterogeneous (Figure 5d).
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Figure 5 : Detection of E-cadherin and keratin proteins in A5 x B9 hybrids by 
immunofluorescence.
Protein analysis was performed on early passage clones. The three large cells, 
staining positively for E-cadherin in (a), are heterokaryons, which are formed 
by the fusion of two cell membranes prior to nuclear fusion. The phase 
photograph (b), reveals that they contain 2 distinct nuclei, which are in the 
process of fusing to become a true hybrid cell, (c) shows a different clone, 
also staining positively for E-cadherin, and in (d) the cells are stained for 
keratin. The degree of keratin staining between different cells within the same 
clone appears to be heterogeneous. Clones 10, 14 and 16 showed similar 
results. E-cadherin and keratin were expressed and correctly localised in these 
cells. (Magnification x 40).
Vimentin
Finally, we examined the expression of vimentin, an intermediate filament protein 
characteristic of fibroblasts, but which is found to be expressed in A5 cells (Figure 4c, 
lane 1), and other epithelial-derived spindle cells.
Vimentin was not expressed in B9 (Figure 4c, lane 2) or any of the squamous hybrids, 
such as clones 11 and 18 (Figure 4c, lanes 7 and 8), or clones 10, 14 and 16, which are 
not shown in the figure. The spindle clones all expressed vimentin at different levels, 
and a small amount of protein was also present in clone 6, which was initially a 
squamous colony. A few spindle cells were consistently present in the population, even 
after differential trypsinisation, and it is these cells which probably account for the 
presence of vimentin. After a prolonged time in culture, this clone fully converted to a 
spindle morphology. It is not clear whether this occurred because of outgrowth of 
existing spindle cells in the population, or whether the whole population converted to 
the spindle phenotype. Since the levels of E-cadherin and the keratins were very low in 
this clone (lane 5 in Figures 4a and 4b), this might favour the latter hypothesis.
Suppression of twfiourigenicity.
It is generally accepted that more malignant tumours are less differentiated, and that 
re-establishment of the normal pattern of differentiation is associated with tumour 
suppression (Pierce and Wallace, 1971; Sachs, 1978). It is not clear however, if these 
two processes are under separate genetic control. To begin to address this, we injected 
three of the squamous hybrids and two of the spindle hybrids into nude mice. The 
latency of tumour formation following injection of the clones - recorded as the time 
taken for the tumour to reach 1cm diameter - was around 5 weeks for the squamous 
clones, compared with 3 weeks for the spindle clones. The latency of tumour 
formation for A5 is usually 2-3 weeks, and B9 tumours reach the same size after 4-5 
weeks. Thus phenotypic reversion and tumour suppression appear to be tightly 
correlated.
As for the histology of the tumours, representative tumours are shown in Figure 6. The 
morphology of the cells in the tumours closely resembled their morphology on tissue 
culture plastic. The spindle clones produced undifferentiated spindle carcinomas 
(Figure 6d), while clones 10, 14 and 16 gave rise to lobular tumours which were well- 
differentiated (Figure 6b). Despite this, they had developed their own vascular 
network, delivering its supply of red blood vessels, and other factors (Figure 7). This 
implies that angiogenesis is controlled independently from tumourigenesis.
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Figure 1 Histolog\ of tumour generated b\ subcutaneous injection 
of a squamous A5 \  B9 hybrid, clone 16.
Despite the fact that the tumour is a well-differentiated 
squamous carcinoma, it contains an extensive vascular 
network. The red blood cells are particularly evident at 
the higher magnification. This illustrates that tumour 
suppression and angiogenesis are under separate genetic 
control.
Expression of stromelysin and other matrix-degrading enzymes
(in collaboration with Dr. Howard Crawford, Vanderbilt University, USA).
The matrix metalloproteinases are believed to contribute to tumour invasion and 
metastasis, by virtue of their ability to degrade the basement membrane and 
extracellular matrix, which form a barrier between the tumour cells and the lymphatic 
and blood vessels. Elevated levels of stromelysin have been found in spindle cell 
carcinomas induced by chemical carcinogens, and in cell lines derived from them 
(Wright et al.,1994). In particular, B9 had no detectable transcript, whereas A5 cells 
had acquired the capacity to express this gene. One hypothesis put forward to explain 
these findings was that a suppressor of stromelysin expression was present in B9, 
which had been lost in A5. The hybrids provided us with an ideal system to examine 
whether stromelysin expression was suppressed in squamous hybrid cells.
Northern blot analysis demonstrated that the spindle clone, 25, expressed high amounts 
of stromelysin. The squamous clones did not express stromelysin, but appeared to have 
a larger transcript of unknown identity which hybridised to the stromelysin probe. 
Clone 6 expressed low amounts of the transcript, which was consistent with the the 
propensity of this clone to become spindle.
In situ hybridisations performed on tumour sections of A5 x B9 tumours indicated that 
stromelysin and collagenase were expressed in the tumour cells of clone 10, and 
stromelysin was detected in the stroma of clone 26 tumours. Tumours produced by 
injection of clones 14, 16 and 34 (all squamous) were negative for both proteins. The 
in situ data for stromelysin therefore correlates well with the Northern analysis. 
However, the fact that squamous cells in clone 10, expressed stromelysin in vivo at 
least, leads to the conclusion that matrix metalloproteinases are not strictly associated 
with the spindle phenotype.
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Chapter 5 : Biological and genetic changes in squamous and spindle
carcinoma cells.
Fusion of carB and the non-tumourigenic C5N resulted largely in the 
suppression of malignancy, but tumours, which arose after a long latency 
period, were mainly high grade squamous carcinomas or spindle carcinomas 
(Stoler et al.,1993). This reversion to a spindle phenotype was also observed in 
vitro, whereby the cells adopted a fibroblastic morphology, and no longer 
expressed either E-cadherin or the keratins. This suggested that these spindle 
revertants in vitro, or tumours in vivo, must have arisen after segregation of 
chromosomes contributed by the squamous, non-tumourigenic C5N parent.
This provided us with a unique system for analysing chromosomal losses either 
in hybrids which had reverted to the spindle phenotype in vitro, or in the 
tumours. Losses of whole chromosomes, or regions of a chromosome in the 
spindle revertants would be indicative of a locus involved in determining 
epithelial characteristics, whereas alterations in the tumours may indicate bona 
fide tumour suppressor loci, some of which may be involved in the spindle 
phenotype.
Generation of hybrids.
C5N cells were fused to a derivative of carB, which carries the bacterial 
neomycin gene, and an inactivated HPRT (hypoxanthine-guanine 
phosphoribosyltransferase) gene. This permitted double selection of hybrid 
cells, which were able to grow in medium supplemented with G418 and HAT, 
and eliminated both parental cell lines. The resulting hybrids were 
predominantly squamous in morphology as expected (Figure 1).
Characterisation of hybrids.
Analysis of protein expression in the hybrids by Western blotting (Figure 2), 
and protein localisation by immunofluorescence (Figure 3) revealed that the 
characteristic epithelial proteins were present in the squamous hybrids, but were 
absent in the two spindle clones.
The strong fluorescence at cell-cell contact regions observed in the squamous 
hybrid cells (Figure 3b) is typical of the staining found for E-cadherin in 
epithelial cells (Figure 3a). Only the two spindle clones did not express any E- 
cadherin protein (Figure 2a, lanes 1 and 2). Trace amounts of this protein could
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Figure 2 : Expression of E-cadherin, keratin, and vimentin 
proteins in C5N, carB, and selected hybrid clones.
The expression pattern is consistent with that predicted 
by the morphology of the cells, i.e. squamous hybrids 
such as clones 6, 9 and 14, express both E-cadherin and 
keratins, as seen in C5N, whereas the spindle clones, 4 
and 19, only express vimentin, like carB. Sizes in 
kilodaltons are shown on the right.
Figure 3 : Detection of E-cadherin and keratin in
carB x C5N hybrid clones by immunofluorescence.
Hybrid clones were analysed for the expression of  epithelial 
markers, E-cadherin and keratin. Squamous carB x C5N 
hybrids (b,x40), show positive staining for E-cadherin, 
which is correctly localised to the areas of cell-cell contact, 
as is found in normal epithelial cells (a,x20). The characteristic 
staining pattern found for keratin in epithelial cells (c,x40), is 
also found in squamous carB x C5N hybrid cells (d,x40).
be detected in these clones at much longer exposures, unlike carB which 
remains completely negative.
The typical pattern of keratin expression is a filamentous network that traverses 
the cells. As expected, all squamous hybrid clones tested expressed keratin 
(Figure 2b, lanes 3, 4 and 6) which was able to form an intact filament network 
(Figure 3d).
Only the two spindle clones examined by Western blotting expressed vimentin 
protein (Figure 2c, lanes 1 and 2). In these cells, the protein was organised into 
filaments as expected (Figure 4b and c). A small amount of vimentin was 
visible by Western blotting in some squamous hybrid clones at much longer 
exposures, for example clone 8, which shows a punctate staining pattern (Figure 
4d).
This type of punctate staining pattern is reminiscent of the situation found for 
keratin in hybrids between A5 and carB (Stoler et al., 1993). The two parental 
cell lines and the resulting hybrids were all spindle. A5 retained a filamentous 
keratin network, while carB showed no keratin expression. The carB x A5 
hybrids showed an intermediate pattern of keratin expression. It appeared that 
keratin was expressed in these cells, but for some reason was unable to form 
stable networks. The same may be true here. A small amount of vimentin may 
be expressed in this squamous clone, which is present as small aggregates, 
unable to form proper filament structures. An alternative explanation is that the 
vimentin expressed by the carB parent is being degraded, following fusion, by 
some factor in the C5N cell. This theory is supported by Western blotting data, 
which reveals a lower molecular weight band of very low abundance in several 
of the squamous clones, which may be a degradation product.
The general conclusion is that in the carB x C5N hybrids, there was a good 
correlation between the morphology of the hybrid cells, and the profile of 
proteins which they expressed.
Allelotype analysis of spindle revertants and tumours.
To identify chromosomes involved in the development of the spindle 
phenotype, a panel of three squamous clones, three spindle revertants and two 
spindle tumours were examined for allelic losses at multiple microsatellite loci 
on all chromosomes. PCR microsatellite analysis was facilitated by the fact that
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Figure 4 : Detection of of vimentin in carB x C5N hybrid clones 
by immunofluorescence.
The typical staining pattern of vimentin is illustrated in the 
spindle carcinoma cells, carB (a). The protein forms a network 
of filaments which traverses the cells. The two spindle clones 
(b and c) expressed vimentin, which was found to be properly 
localised. Clone 8, a squamous clone, showed punctate staining 
for vimentin (d). (Magnification : x40).
the two parental cell lines were derived from different mouse genetic 
backgrounds. carB was derived from a spindle carcinoma generated by 
DMBA/TPA treatment of an NIH mouse, and C5N is a non-tumourigenic, 
immortalised keratinocyte line, isolated from a Balb/c mouse. At least two 
informative markers were examined on each chromosome.
Figure 5 shows representative autoradiographs for several microsatellite 
markers on different chromosomes. The C5N and carB alleles were 
polymorphic at these loci and were easily resolvable on acrylamide gels. All six 
hybrids showed bands derived from both parents. At the locus D2Mit7, the C5N 
band was absent in the two tumours (cl 4T and cl 6T), although it was present in 
the cells prior to injection (cl 4 and cl 6). At D3M itll, only '4T' had lost the 
C5N allele, while '6T' retained both alleles. In contrast, D18Mitl7 showed no 
losses in either tumour.
PCR was carried out on DNA isolated from the spleen of an NIH / Balb/c FI 
hybrid mouse at each microsatellite locus to determine if there was preferential 
amplification of one allele over the other in the reaction. It was noticeable that 
in several cases, the ratio of the products did not reflect the fact that the alleles 
in FI DNA were present in equal amounts. In all three of the examples shown in 
Figure 5, the band corresponding to the C5N allele appeared to be more 
abundant. If this is taken into consideration for the interpretation of the results, 
then it appears that at marker D3M itll, there has been amplification of the carB 
allele in the ‘6T’ tumour. In addition, despite the fact that all the samples 
retained both alleles at D18Mitl7, there was an imbalance in favour of the carB 
allele in the hybrid cells and in both tumours, when they were compared with 
the FI DNA. Since these imbalances did not differ between the squamous and 
spindle revertants, they do not appear to have consequence for the 
morphological and biological chracteristics of the two cell types. Exceptions 
were the Spl revertant, which showed an approximate 1:1 ratio of the two 
alleles at D2Mit7 and D3M itll, similar to the FI DNA, and Sp3, which had 
amplified the carB allele, or greatly reduced the C5N allele at D18Mitl7.
Thus although allelic imbalances were common amongst the squamous and 
spindle hybrid cells, no complete losses were observed, which is in contrast to 
the situation in the tumours. In total, the tumours had lost the C5N allele at one 
or more markers on thirteen different chromosomes. Four chromosomes had no 
observable losses using the available markers, namely, chromosomes 1, 11, 12
67
i
D3Mitl
ZLT)
u
CQ
i—cao
hybrid cells tumours
711 H(N \o >—' ( N r o ^ T ' O— — — o- a. a. 2. z , ~o o o go go c/o o o t u
D2Mit7
• >
9 m“
W W W  -
D18Mitl7
hybrid cells tumours
Figure 5 : PCR microsatellite analysis o f  carB x C5N hybrids and tumours.
Examples are shown for microsatellite markers on three different 
chromosomes.  None of the squamous (clones 2, 4, and 6) or 
spindle ( Sp l ,  Sp2, and Sp3) hybrids show complete loss of an allele 
at any of the markers. cl4T has lost the C5N allele at marker D3Mit l  1, 
and both tumours show loss at the marker, D2Mit7. Marker D18M it l7  
shows the presence of both alleles (C5N and carB) in all hybrid cells 
and in both tumours.
and 15. The significance of each of these losses in the formation of spindle 
carcinomas is unclear. Nevertheless, the fact that several chromosomes appeared 
to have no gross alterations indicates that the observed changes were significant.
Deletion mapping of tumour suppressor loci on mouse chromosome 7.
Loss of the normal H-ras allele is found specifically at the transition to a spindle 
carcinoma (Bremner and Balmain, 1990). The underlying impetus for the loss of 
the normal allele and / or amplification of the mutant alleles implied that there 
may be some form of tumour suppressor role for the normal H-ras gene.
An increasing number of cases have been reported, of tumours and cell lines in 
which mutations in ras genes were accompanied by the loss of the 
corresponding wild-type allele (Kraus et al.,1984; Guerrero et al.,1985). A 
number of explanations can be envisaged for these results. The presence of the 
normal allele may inhibit the full expression of malignancy by competing with 
the mutant allele for an active site within the cell. Only loss, or under­
representation of the normal allele would then allow full expression of the 
transformed phenotype. Alternatively, the loss of normal ras could be a 
consequence of linkage with a putative tumour suppressor gene locus on 
chromosome 7.
Evidence to support the involvement of another locus on mouse chromosome 7 
has been obtained from the analysis of a primary carcinoma, SN158. The 
tumour showed LOH for markers distal to H-ras, while maintaining 
heterozygosity at the ras locus, and for markers proximal to H-ras. The 
observed allele ratios likely arose by a mitotic recombination event involving a 
region distal to H-ras (Bremner and Balmain, 1990). It is thought that this region 
may harbour a tumour suppressor gene.
In order to investigate the possible involvement of the normal H-ras allele, or an 
as yet unknown tumour suppressor on mouse chromosome 7, we generated 
eighty tumours by subcutaneous injection of four of the squamous hybrid clones 
into nude mice. Some of the mice received cells which had been irradiated at 
2Gy, 4Gy, or 6Gy prior to injection, which is known to generate small 
interstitial deletions. (Thacker, 1985, and reviewed in Hutchinson, 1993).
All four clones were suppressed in their ability to form tumours, with the 
latency of formation of a 1cm diameter tumour increasing from 1-2 weeks for
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carB to between 3 and 5 weeks for the first tumours of that size to be harvested 
from mice receiving hybrid cells (Figure 6). However, some of the tumours 
generated by injection of clone 9, took as long as 11-12 weeks to reach 1cm in 
diameter.
It was proposed that because irradiated cells may have already accumulated 
many random interstitial deletions, some of which may involve tumour 
suppressor loci, we might expect to see these tumours arising and progressing 
more quickly than tumours from non-irradiated cells. In addition, we hoped that 
radiation-induced deletions might be smaller in size, and allow more accurate 
mapping of any tumour suppressor loci. In fact, there appeared to be no 
significant difference in the latency of tumour formation of irradiated versus 
non-irradiated cells of the same clone (data not shown). A possible explanation 
may be, that although the same number of cells were injected in all cases, the 
proportion of viable cells in the irradiated population may have been greatly 
reduced.
The tumours were defined as moderate to poorly differentiated Grade III 
squamous carcinomas (Figure 7c) or undifferentiated Grade IV spindle 
carcinomas (Figure 7d). Marked vasculature was noted in several tumours, and 
a number of haemangiomas developed at the site of injection (Figure 7e), 
indicating that although tumourigenicity was suppressed, angiogenesis was not.
An experiment was carried out to minimise problems associated with nude 
mouse contamination, by selecting polymorphisms using PCR. Microsatellite 
marker, D7Mitl81, gave a clearly discernible band corresponding to spleen 
DNA from the nude mouse strain, which was absent from some of the tumours 
(data not shown). Using this approach, eighteen tumours were chosen from the 
original eighty for detailed microsatellite analysis, on the basis that they were 
apparently free from nude mouse contamination. The tumours used in this 
analysis are listed in Table 1.
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Tumour Cell.line
injected
Treatment
prior.to
injection
Latency .of
tumour
formation
Histological
grade
13 clone 6 unirradiated > 5 weeks Grade III
14 clone 6 unirradiated 5 weeks spindle
17 clone 8 unirradiated 5 weeks spindle
18 clone 8 unirradiated > 5 weeks Grade III
23 clone 8 unirradiated > 4 weeks no histology
31 clone 4 6Gy 8 weeks spindle
32 clone 4 6Gy 8 weeks spindle / 
mod. to undiff.
33 clone 6 2Gy > 6 weeks spindle
34 clone 6 2Gy 7 weeks Grade III / 
undiff.
49 clone 6 6Gy > 6 weeks Grade III
50 clone 6 6Gy 6 weeks spindle
51 clone 8 2Gy 5 weeks spindle
52 clone 8 2Gy > 5 weeks no histology
53 clone 8 2Gy 6 weeks spindle
54 clone 8 2Gy 6 weeks spindle
56 clone 8 4Gy > 4 weeks no histology
57 clone 8 4Gy > 4 weeks spindle
66 clone 9 2Gy 10 weeks spindle
Table 1 : Panel of tumours used in deletion mapping of chromosome 7.
Tumours were generated by subcutaneous injection of four different 
squamous carB x C5N clones into nude mice. 1 x 10  ^ cells were injected per 
site, and each mouse received injections at two sites. Six mice in each group 
received cells which had been irradiated prior to injection for 2Gy, 4Gy, or 
6Gy (two mice each dose), and four mice in each group obtained unirradiated 
cells. Mice were monitored regularly, and tumours were measured each week 
in two dimensions. Mice were sacrificed when at least one of their tumours 
reached 1cm in diameter, which was defined as the latency period of tumour 
formation. Tumours 13, 18, 23, 33, 49, 52, 56, and 57 were less than 1cm in 
diameter when harvested, because the mice had a second tumour which was 
lcm in diameter and therefore had to be sacrificed at this time. In these cases, 
the latency is given as > X weeks. Histological examination was performed 
on haematoxylin / eosin stained sections.
In an attempt to clarify the possible involvement of the normal Yi-ras allele in 
the suppression of tumourigenicity, Southern blot analysis was performed on the 
tumours (Figure 8). Digestion of the DNA with Xba 1 distinguishes the mutant 
and normal bands. The normal musculus H-ras gene resides on a 12kb Xba 1 
fragment. However, due to iheXbal polymorphism generated by the codon 61 
mutation of H-ras, Xbal cleaves the mutant allele into a 4kb and an 8kb 
fragment.
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The B9 cell line was derived from a tumour generated in a mus spretus / CBA 
FI hybrid mouse after multiple DMBA treatment. The normal spretus allele is 
13kb in size, and spretus mice carry an H-ras pseudogene at about 12kb. The 
mutant bands were about 8kb and 4kb in size, indicating that this cell line had 
acquired a codon 61 mutation in the musculus allele.
Duplication of the mutant H-ras allele in some hybrid tumours 
C5N cells contain only normal H-ras, while carB cells have only mutant alleles 
(Figure 8). The FI DNA isolated from an NIH / Balb/c FI hybrid mouse 
showed a single band corresponding to the normal allele, demonstrating that 
there was no polymorphism between these two mouse strains at this locus.
It is known from analysis of A5 revertants which have spontaneously lost their 
double minute chromosomes, that there is a strong correlation between the 
levels of mutant H-ras and tumourigenicity (Robbie Crombie, PhD thesis, 
1993). The ratio of normal : mutant alleles of H-ras was found to vary 
considerably between the tumours.
Tumours 14, 33 and 66 showed predominantly the mutant alleles. These three 
tumours were classified as undifferentiated spindle carcinomas, and tumours 14 
and 33 arose after a relatively short time. The cells from which they were 
derived already showed an imbalance of ras alleles in favour of the mutant 
allele. From the Southern blot analysis, clone 6 has an approximate ratio of 2:1 
mutantinormal H-ros, while in tumours 14 and 33, this increased to an estimated 
three or four copies of the mutant allele to one copy of the normal allele.
In contrast, tumour 66 took ten weeks to reach the same size, which can be 
explained by the fact that it was generated by injection of clone 9. This clone 
showed a large bias for the normal allele of H-ras. This may explain why clone 
9 was particularly suppressed in its ability to form tumours, which arose after a 
much longer latency than the other three clones.
A number of the tumours, such as 18 and 53 showed an imbalance in favour of 
the normal H-ras allele. The ratio in both cases could be estimated at around 2:1 
(normal: mutant). These tumours were not suppressed to any greater extent than 
other tumours which had more mutant copies, nor were they any less 
tumourigenic with respect to their histology. In fact, both tumours appeared 
quite angiogenic, and there was some evidence of lymphocyte infiltration.
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As a general conclusion from the Southern blot analysis of H-ras, there 
appeared to be significant variation in the ratio of the mutant and normal alleles 
in the tumours. These ratios did not strictly correlate with the characteristics of 
the tumours with respect to the latency for formation and histological grading. 
However, complete loss of the normal allele of H-ras was not evident in any of 
the samples, despite the fact that several of these were spindle carcinomas, and 
therefore might be expected to show losses.
Having established that there was no complete loss of the normal allele of H-ras 
in the hybrid tumours, we wished to determine if another locus on this 
chromosome was responsible for suppression in the carB x C5N hybrid 
tumours, using PCR microsatellite analysis. A total of thirteen microsatellite 
markers were used to construct a deletion map of chromosome 7. Only those 
tumours showing losses are included in Figure 9. Just over half of the tumours 
analysed showed deletions of regions of the C5N chromosome. The majority of 
these arose after injection of irradiated cells. The remaining eight tumours 
showed no losses of the C5N allele at any of the markers. Only complete loss of 
the C5N (Balb/c) allele was recorded. Allelic imbalance was frequently 
observed, and in these cases, it was usually the carB (NIH) allele which was 
amplified in the tumours, compared with the hybrid clones prior to injection.
The data allows us to propose two possibilities. We can define two distinct 
tumour suppressor loci lying close together; Region A, which involves the 
region between D7Mitl76 and D7Mit91, and Region B, which lies between 
D7Ndsl and D7Mitl03. Alternatively, there may be a single large loci which 
encompasses both regions. Only finer mapping will distinguish between these 
two possibilities. There were certain tumours which deleted only one of the two 
regions, for example tumour 51, which has a small deletion involving only 
Region A, and tumours 13, 31, 32, 33, 54, and 56, all of which have deleted 
Region B but retain Region A. Only 3 / 1 0  tumours which showed deletions on 
chromosome 7 had a large deletion covering both regions. Interestingly, all 
three of these arose from injection of clone 6.
This data reveals an apparent anomaly. Although several of the tumours do not 
appear to contain the region of the C5N chromosome where the H-ras gene is 
located, none of these tumours showed loss of the normal H-ras allele by 
Southern blotting. Unfortunately, our interpretation of the results has been 
complicated by the fact that polymorphisms had segregated within the nude
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F i g u r e  9 : D e l e t i o n  m a p  o f  m o u s e  c h r o m o s o m e  7
A  t o t a l  o f  t h i r t e e n  m i c r o s a t e l l i t e  m a r k e r s  w e r e  u s e d  t o  c o n s t r u c t  a 
d e l e t i o n  m a p  o f  m o u s e  c h r o m o s o m e  7 in x e n o g r a f t s  g e n e r a t e d  b y  
i n j e c t i o n  o f  c a r B  x C 5 N  h y b r i d s .  T h e  m i n i m a l  r e g i o n ( s )  o f  d e l e t i o n  
( A  /  B )  w e r e  i d e n t i f i e d  f r o m  t h o s e  t u m o u r s  s h o w i n g  l o s s e s  o f  t h e  
C 5 N  a l l e l e .  T h e  m i c r o s a t e l l i t e  m a r k e r s  a r e  i n d i c a t e d  o n  t h e  r i g h t  o f  
t h e  f i g u r e ,  a n d  t h e  t u m o u r  s a m p l e s  i n d i c a t e d  a l o n g  t h e  t o p .
mouse population. In the design of this experiment, we had made the 
assumption that nude mice were inbred. Thus by comparing the DNA from a 
nude mouse spleen at each of the microsatellite markers, we should be able to 
select those tumours which showed minimal host cell contamination. Although 
the selected panel of tumours showed no contamination from the nude mouse at 
the original microsatellite marker, subsequent markers have revealed that most 
of the samples have some component of normal DNA. Examination of the 
histology of all of these tumours revealed that they are angiogenic, and in many 
cases host lymphocytes have infiltrated the tumour. This finding provides an 
explanation for the disparate results obtained by allelotyping and Southern 
blotting. Those tumours which showed loss of the distal region of the 
chromosome would be expected to show loss of the normal H-ras allele derived 
from the C5N parent by Southern blotting. It is likely that the band 
corresponding to the normal allele in these tumours corresponds to nude mouse 
contamination, in particular in tumours 13, 14, 31-34, and 49, which showed 
deletion of the distal region containing H-ras in Figure 9.
In the allelotype analysis, complete loss of the C5N allele was noted at several 
markers in the tumours. Thus, even in the presence of some nude mouse 
contamination, these were still genuine losses. The limitations to the 
interpretation arose only in those cases where the C5N allele was the same size 
as the nude mouse allele. At those markers, the C5N band may have been very 
faint in the tumours, but was not completely lost. These would have been scored 
as retention, but they may in fact be loss. The consequences for the allelotype 
analysis are that it is more likely that one large region is deleted in the tumours, 
rather than two distinct regions.
The region A/B which is commonly deleted in the tumours corresponds to the 
area between markers D7Mitl76 and D7Mitl03. This is a large region which 
encompasses several interesting loci. Figure 10 shows the location of the 
deleted region as defined by the tumour analysis in relation to other known loci 
or genes of interest.
The region deleted in some of the tumours includes the Igfl receptor at 33cM, 
Wntll at 46cM and one of the Major Histocompatibility class I loci at 50cM. 
The FES (feline sarcoma oncogene) has been mapped to human 15q26.1, and 
also lies within this region (Brilliant et al.,1996). A region which confers 
resistance to the development of papillomas in NIH mice is located within the
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F i g u r e  10 : S c h e m a t i c  r e p r e s e n t a t i o n  of  m o u s e  c h r o m o s o m e  7.
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s h o w n .
deleted region, centred around the c locus, but a second modifier locus, which 
confers resistance to carcinoma development is located outside the region 
defined in this analysis (Nagase et al.,1995).
The region defined by LOH analysis of the SN158 primary tumour lies distal to 
H-ras. In the allelotype analysis, this distal region only appears to be deleted in 
those tumours which also show loss of Region A/B. This does not allow us to 
make any conclusions as to the possible location of a tumour suppressor gene, 
distinct from, and located distal to H-ras.
However, this data allows us to tentatively suggest the presence of a tumour 
suppressor gene proximal to H-ras, which is a hypothesis tested in the final 
chapter.
Deletion mapping of tumour suppressor loci on mouse chromosome 4.
The cdk inhibitor, p l6 INK4a, was found to be deleted in 8 out of 10 spindle 
carcinoma cell lines, and its loss is associated with the loss of differentiation in 
these cells (Linardopoulos et al.,1995).
To ascertain whether p l6  loss was a necessary step in the evolution of these 
hybrid tumours, we decided to examine the status of p i 6 in the tumours by 
Southern blotting. The results are shown in Figure 11. C5N contains p l6  which 
is expressed. carB has a homozygous deletion of this locus, which includes the 
neighbouring gene, p i5  and the alternatively-spliced form of p i  6, called p i  9***. 
The Southern blotting data suggested that some of the tumours retained the p i6 
gene, although several of them may have lost some copies of this locus. C5N 
typically has three copies of chromosome 4, and all of these chromosomes 
potentially carry copies of normal p i 6. All of these may be present in the hybrid 
clones.
Taking into consideration the possibility that some of these samples may 
contain nude mouse contamination, it appears that several of the tumours have 
deleted p i 6. For instance, a comparison of tumours 13 and 14 with tumours 33, 
34, 49 and 50 indicates that the latter have probably deletedpl6,  since the bands 
corresponding to p l6  are very faint. A comparison of the same samples in the 
H-ras Southern demonstrated that the reduction in signal was not due to DNA 
loading.
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Tumours 14 and 33 were two of the tumours which showed an imbalance 
favouring the mutant H-ras allele, indicating that they may be more aggressive 
tumours. Tumour 33 also showed a loss of p l6  by Southern blot analysis.
The high frequency of deletions at this locus, specifically in spindle cells 
(Linardopoulos et al.,1996), led us to believe that if p i  6 itself was not deleted in 
all of the hybrid tumours, perhaps another gene on mouse chromosome 4 might 
be involved. In addition, provided we used markers which were polymorphic 
between nude mice and Balb/c mice (from which C5N was isolated), then we 
could minimise the problems associated with contamination of the samples by 
nude mouse DNA.
As a preliminary investigation, several markers on mouse chromosome 4 were 
examined in two tumours, cl 4T and cl 6T, generated previously, by injection of 
clones 4 and 6, and used in Section 5.3. Some of the data is shown in Figure 12.
At markers, D4Mit82 - the most proximal marker used in the study - and 
D4Mitl68, both parental alleles were present in the hybrid cells prior to 
injection, and in both tumours. At markers located either side of D4Mitl68, one 
or both of the tumours showed loss of the C5N allele, even though both bands 
were present in the cells which were injected. This preliminary data indicated 
two potential regions of interest on mouse chromosome 4, which are shown in 
Figure 13. From these results, it was clear that two regions were involved, since 
several markers between Regions 1 and 2 were retained in both tumours.
A total of 116 markers spanning the length of mouse chromosome 4 were 
screened for polmorphisms. Approximately one quarter of these were found to 
be polymorphic for NIH and Balb/c mouse strains. These twenty-four 
informative markers were used to construct a detailed deletion map of 
chromosome 4 in the same panel of tumours which had been used in the 
chromosome 7 analysis. Examples of the results obtained from this analysis are 
shown in Figure 14. The donor cell hybrids, clones 4, 6, 8 and 9, appeared to 
have retained all markers, however analysis of the tumours showed that the C5N 
allele was frequently lost. Once again, only complete loss of the Balb/c allele 
(derived from the non-tumourigenic C5N parent) is depicted.
At D4Mitl26, located just outside Region 1, the allele derived from the nude 
mouse band was of a different size to the allele from the C5N cells. Thus, at this
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Figure 12 : PCR microsatellite analysis of carB x C5N hybrid cells and tumours.
The gels show representative examples  of microsatellites on mouse 
chromosome 4. At markers, D4Mit82 and D4M it l68 ,  both the carB 
and the C5N alleles are present in the hybrids and tumours. At 
D4Mit l67 ,  the C5N allele has been lost from the cl 4 tumour only, 
while at D4Mit l60,  both tumours have lost this allele, which was 
present in the hybrid cells prior to injection.
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Figure 14 : PCR microsatellite analysis of mouse chromosome 4 
in carB x C5N tumours.
Examples are shown for four markers on mouse 
chromosome 4 .
marker, as with the majority of markers, there were no difficulties in the 
interpretation of the data. However, the tumours also showed this band, which 
indicated that they may have normal contamination. Clones 4 and 6 did not 
contain this band.
At marker D4Mitl60 in Region 2, the nude mouse allele was the same size as 
the band corresponding to the carB allele. In this case also, there were no 
complications in interpreting the results, since we were only concerned with 
complete losses of the C5N allele.
At D4Mit59, the nude mouse DNA showed two bands, one of these was a 
unique band, but the other band was the same size as the C5N allele. Few of the 
tumours showed the unique band, indicating that the nude mice were 
polymorphic at this loci. In those tumours which did contain the unique band, it 
was very faint, and therefore the amount of contamination was not sufficient to 
explain the intensity of the band corresponding to C5N. Thus these tumours 
retained the C5N band at this allele.
The DNA from the nude mouse spleen gave two bands at D4Mit219. One of 
these was of the same size as the band corresponding to the C5N allele, and the 
other was of a unique size. Most of the tumours did not contain this latter band. 
Tumours 13, 14, 18, 32 and 66 did contain the unique spleen band. It is possible 
that all of these tumours (except tumour 66) had deleted the C5N allele, since 
the intensity of the band at C5N was approximately equivalent to the level of 
nude mouse contamination. In the case of tumour 66, the C5N allele was likely 
to be present since the C5N band was much more intense than can be explained 
by nude mouse DNA contamination, which was low in this sample. This was 
deduced by comparing the intensity of the band corresponding to the unique 
nude mouse band, which was faint, with the band at the same position as the 
C5N allele, which was more intense in this sample.
In the context of the deletion mapping results, these extra considerations might 
imply that tumours 13, 14, 18 and 32 carry a very small deletion at this marker. 
This would agree well with the results obtained from the Southern blotting 
analysis. In addition, at marker D4Mit58 (data not shown), the C5N and nude 
mouse alleles were the same size. In those samples which showed retention at 
this marker, that is, tumours 14, 33, 34, and 66, this could have been incorrectly
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scored. The presence of a band could be due to contamination. Again, such a 
result would agree with the data on the status of p i  6 in these tumours.
Using this unique approach, we were able to define two minimal regions of 
deletion which are potential tumour suppressor loci (Figure 15): Region 1 which 
lies between markers D4Mitl66 and D4Mit58, and Region 2, which minimally 
encompasses the region between D4Mitl26 and D4Mit48, but in most tumours 
extends between D4Mit54 and D4Mit 131.
Tumours 49 and 50, presumed to have deleted p i  6 from the Southern blotting 
analysis, showed loss of this region in the allelotype analysis. However, 
tumours 33 and 34 which also showed loss of the p i6 gene by Southern blot 
analysis, showed retention of the whole of the proximal region of the 
chromosome, as far as marker D4Mit54, in the deletion mapping study. This 
apparent anomaly can be resolved on the basis that there may be a small 
interstitial deletion of p i 6 in these tumours. This is supported by the 
observation that the nude mouse band was the same size as the C5N allele at 
D4Mit58. However, it was included because it was the closest available 
informative marker to p i 6. Thus tumours which showed loss of the C5N allele 
have genuinely lost this marker, but those samples which retained a band at the 
position corresponding to the C5N or nude mouse alleles, such as tumours 14, 
33, 34 and 66, could in fact have lost the marker, and thus have deletedpl6.
Region 1, corresponding to the area including pl6,  is likely to be important in 
the evolution of these tumours, since it was deleted in the vast majority of the 
tumours which were analysed. Furthermore, the most likely target for deletion 
in Region 1 is the p l6  gene. Unfortunately, the Southern data alone does not 
clarify this matter. The tumours which showed no apparent losses by 
allelotyping analysis but which showed loss of p l6  will be especially useful for 
finer mapping of Region 1. The role of this locus in the genesis of spindle 
carcinomas shall be addressed in the next chapter.
The putative tumour suppressor gene in Region 2 is also likely to be of great 
importance in the evolution of these tumours, since it was found to be deleted in 
the original two tumour samples (cl 4T and cl 6T), as well as in the panel of 
eighteen tumours. Candidates for the distal region of mouse chromosome are 
the mom-1 locus and Pax7. The locations of the putative tumour suppressor loci 
identified on mouse chromosome 4 in this study are shown in Figure 16.
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Chapter 6 : Microcell-mediated monochromosome transfer.
In an attempt to reduce the complexity associated with whole cell fusions, and to further 
define the functions and relevance of each of the loci identified in the preceding chapters, 
we employed the microcell transfer procedure which allows the introduction and 
selective retention of individual chromosomes into the recipient cell of choice.
The library we have been very fortunate to obtain, in collaboration with Professor Rob 
Newbold's lab, consists of a panel of 23 stable human : mouse hybrids (Cuthbert et 
al.,1995). Normal adult human skin fibroblasts were infected with a replication-defective 
retrovirus carrying a hygromycin phosphotransferase-thymidine kinase (HyTK) fusion 
gene, and individual, tagged chromosomes were obtained by microcell transfer into 
mouse A9 cells. The major advantage of the HyTK marker is that it provides the 
opportunity to select for the absence as well as for the presence of the introduced 
chromosome. Cells expressing the fusion gene can be positively selected, by adding 
hygromycin to the medium. Ganciclovir on the other hand, is efficiently converted into a 
cytotoxic nucleotide analogue in cells expressing the herpes simplex virus thymidine 
kinase gene. In this way, the association of a particular phenotype with an individual 
human chromosome, can be confirmed by loss of the phenotype by reverse selection.
We chose the two spindle cell lines, A5 and carB, as the recipients in microcell 
experiments, as we have already accumulated a great deal of information about their 
genetic alterations and biological properties. We have previously demonstrated in 
Chapters 4 and 5, that epithelial characteristics can be completely restored in these cells 
by introduction of genetic material from less malignant cell types. In addition, we have 
been able to define regions on mouse chromosomes 4 and 7, which harbour tumour 
suppressor genes potentially important in the spindle phenotype. Using this procedure, 
we wanted to address whether we could revert the spindle phenotype or cause tumour 
suppression by introducing these loci from the relevant human chromosomes.
The fact that fusion of A5 with carB produced spindle hybrids indicated that the defect in 
the two independently-derived spindle cells lay on the same pathway (Stoler et al., 1993). 
This led us to believe that introduction of the same chromosome might be capable of 
reversing the phenotype in both cell lines.
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Human chromosome 11
Evidence for a tumour suppressor role.
Human chromosome 11 is known to harbour multiple tumour suppressor loci, as 
indicated by a combination of chromosome transfers and molecular genetic evidence. 
The first compelling functional evidence for tumour suppressor genes via chromosome 
transfer demonstrated that human chromosome 11 was capable of suppressing the 
tumourigenic phenotype of the cervical carcinoma cell line, HeLa (Saxon et al., 1986). 
Since those first experiments, introduction of chromosome 11 has suppressed the 
tumourigenic behaviour of another cervical carcinoma line, SiHa (Koi et al., 1989 ; 
Oshimura et al., 1990), a Wilms' tumour (Weissman et al., 1987), a rhabdomyosarcoma 
(Oshimura et al., 1990), a fibrosarcoma (Kugoh et al., 1990), a peripheral 
neuroepithelioma (Chen et al., 1995), a breast cancer cell line (Negrini et al., 1994), as 
well as suppressing metastasis of a prostate cancer cell line (Ichikawa et al., 1992).
The reasons for introducing human chromosome 11 into our spindle cells were many. 
The region of LOH on chromosome 7 identified in chemically-induced mouse squamous 
cell carcinomas (Bremner and Balmain,1990; Bianchi et al.,1991) and region B found in 
carB x C5N hybrid tumours in Chapter 5, are syntenic with human chromosome segment 
Ilp l5 -q l3 , as shown in Figure 1. Normal Yl-ras, previously proposed to act as a tumour 
suppressor in this system, due to the fact that its loss or reduction is favoured particularly 
at the squamous-spindle conversion, is located at llp l5 .5 . Finally, introduction of 
human chromosome 11 into a murine squamous carcinoma cell line led to a reduction in 
cell growth in vitro, and a corresponding doubling of the latency for tumour formation 
(Zenklusen et al.,1995).
Human chromosome 11 may cause growth arrest o f spindle carcinoma cells.
Microcell hybrids were selected for 2-3 weeks in medium containing 350 units/ml 
hygromycin (Calbiochem), conditions under which the parental A5 and carB cells die. 
Addition of HAT to this selective medium allowed elimination of whole A9 cells, which 
are HPRT-, and can occasionally leak through the filters.
Although the efficiency of microcell transfer was high, all the clones remained spindle. 
By using a set of primers to the HyTK fusion gene, we were able to show, not 
surprisingly, that the colonies selected in the presence of hygromycin, contained the 
fusion gene (Figure 2).
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Figure 2 : Detection of the hygromycin-thymidine kinase fusion gene 
in A5 and carB microcell hybrids by PCR.
A5 and carB cells are negative. A9hytkl  1 is included as a positive 
control, and lane 5 is a no DNA negative control. All A5 and carB 
microcell hybrid clones are positive for this gene.
To assess the integrity of  the introduced chromosome, and to identify colonies with 
intact copies of chromosome 11, we analysed thirteen carB clones, and the same number 
of A5 clones by PCR. using seven microsatellite markers along the length of 
chromosome 11. Surprisingly, we found that most of the A5 colonies retained only one 
of the markers, D11S1349,  located on the p arm. However,  in most of these, the signal 
was very faint, indicating that perhaps only a small proportion of the cells in the colony 
retained this region. None of the carB clones retained any of the markers on 
chromosome 11, although as we have demonstrated, they contained the selectable 
marker.
There are several reasonable explanations for this finding. The chromosome may have 
been badly fragmented during the transfer procedure, and cells receiving a small fragment 
containing the fusion gene, were able to stably retain it by integration into one of  their 
own chromosomes. Such integration has been demonstrated by FISH in a separate 
experiment, in which only a small part of the introduced chromosome was retained 
(Nicol Keith, personal communication). Alternatively, this chromosome may harbour 
several genes which are incompatible with proliferation of  our  recipient cells. Thus the
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colonies we have selected may have arisen by expansion of cells which have lost most of 
chromosome 11. In other circumstances, it is usually possible to use these revertants to 
narrow down the region important for the growth-suppressive effect. However, when the 
deletion involves the majority of the chromosome, this is not feasible. The fact that the 
whole of the chromosome is absent, on the basis of the microsatellite data, implies that 
several genes along the length of the chromosome may have tumour suppressor activity.
Human chromosome 15
The proximal region (A), on mouse chromosome 7, identified as being commonly deleted 
in carB x C5N hybrid tumours, is syntenic with human chromosome 15qll-ql3, and 
15q23-qter, which corresponds to the region syntenic with region B (see Figure 3). In 
these hybrid tumours, there is clearly selection to lose the normal information present at 
this locus on the C5N chromosome. For this reason, we wanted to examine the effect of 
re-introducing a normal copy of human chromosome 15 into carB and A5.
Once again, we found no phenotypic reversion of the microcell hybrid clones in either A5 
or carB. Nevertheless, we picked seventeen A5 clones and sixteen carB clones for 
further analysis. We were able to amplify the hygromycin - thymidine kinase gene in all 
clones. We used fourteen microsatellite primer sets which spanned the whole 
chromosome, and found very different results for A5 compared with carB. Figure 4 
shows representative examples of some of the microsatellite markers used in the 
allelotype analysis, and the data is summarised in Figure 5. Only three carB microcell 
hybrids are included in the figure. The remaining 57 carB clones retained only one 
marker, D15S107. The fact that this marker was retained in all clones examined, 
provides compelling evidence that this is the probable location of the integrated fusion 
gene on chromosome 15.
The most obvious feature of the microsatellite analysis carried out on these clones is the 
presence of large deletions, which encompass appreciable portions of the chromosome. 
We find that the D15S107 marker is consistently retained, and, in most cases, this is 
accompanied by retention of one or two additional markers, often near the centromeric 
region.
Analysis of the six informative A5 clones, revealed a common deletion centred around 
the FES marker, located at 15q26.1. The region proximal to this marker, extending to 
D15S111 is deleted in all but one of the clones. The importance of this deletion, with 
regards to epithelial phenotype was difficult to assess in the absence of any epithelial 
clones. The possible involvement of this region in suppressing the growth of the cells
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remains a possibility, as its retention appeared to be incompatible with the formation of 
clones. And in fact, this region is the area which is syntenic with region B identified in 
Chapter 4 which also includes FES at 39cM on mouse chromosome 7. In four out of the 
six informative A5 hybrids, this is the only area of chromosome 15 which was absent.
To visually demonstrate the presence of the introduced chromosome, a human 
chromosome 15 paint was hybridised to metaphase spreads prepared from clones 4 and 
5. Clone 4 retained most of the human chromosome, while clone 5 retained only a 
proportion of the markers, which were dispersed along the length of the chromosome. 
The donor cells, A9hytkl5, were included as positive controls, and contain a single, 
intact copy of human chromosome 15. Figure 6 shows representative metaphase spreads 
of A9hytkl5 and clone 4 hybridised with a DIG (digoxigenin) -labelled chromosome 15 
paint. Only one copy of the labelled chromosome was observed in both cell lines. We did 
not observe any signal in clone 5 (data not shown), indicating that the amount of 
chromosome 15 material present in these cells was not sufficient to produce a signal. 
This also demonstrated that the human paint does not cross-hybridise with any material 
in the mouse genome.
Human chromosome 9
The majority of spindle cells have lost p i 6 by homozygous deletion, however, there 
exists a small class of spindle cell lines which retain p i 6, and, in fact, overexpress the 
gene (Linardopoulos et al., 1995). Thus, although p i 6 alterations are undoubtedly 
important at this stage, they do not account for the whole story. A5 cells, which 
overexpress p l6 , can be reverted to an epithelial morphology following fusion to 
squamous B9 cells, which also express p i 6. This indicated that the spindle phenotype 
was recessive in somatic cell hybrids, even in the presence of an excess of p l6 , and 
implied that a tumour suppressor gene, other than p i 6, had been lost between B9 and 
A5. In this case, at least, p i 6 is not the spindle gene.
In the deletion mapping study of the carB x C5N hybrid tumours, one of the regions 
included the p i 6 locus. However, not all tumours appeared to have deleted thep l6  gene. 
Figure 7 shows the region of synteny shared between human chromosome 9 and mouse 
chromosome 4.
This apparent paradox prompted us to propose two further possibilities to explain the 
involvement o ip l6  in the squamous-spindle conversion :
(i) the actual target for deletion may be a gene located close topl6 , or
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(ii) loss of p l6  may facilitate the progression to the spindle phenotype in some spindle 
cells, but a second genetic event may result in full phenotypic conversion. This second 
gene may be located on the same or another chromosome.
Here, we report the introduction of human chromosome 9 into A5 and carB cells. The 
advantages of the MMCT technique in this case are that the genes are transcribed from 
their own promoter, and we can introduce several genes into the same cell. This is in 
contrast to other methods which employ the use of powerful promoters, and which only 
allow the introduction of a single gene. It also allows us to address the possibility that the 
real target for deletion may be a gene positioned close to p i 6. Finally, if loss of p i 6 
facilitates neoplastic progression in combination with the loss of a second gene, we may 
be able to identify the second gene controlling the spindle phenotype, if it resides on 
human chromosome 9.
The donor cell, in these experiments, was Klhytk9, a hamster cell line carrying an intact 
copy of chromosome 9, tagged with the HyTK fusion gene. When this chromosome was 
introduced into A5 and carB cells, we observed several clones which had adopted a 
much flatter appearance. Several of these were isolated for expansion and 
characterisation. In most cases, the carB clones reverted back to their spindle 
morphology, following trypsinisation. However, 3 clones still retain a more squamous 
phenotype, after several months in culture. The A5 clones, in contrast, appeared to be 
more stable with respect to their epithelial morphology. Figures 8 and 9 show the 
morphology of some of the microcell hybrid clones obtained by introduction of human 
chromosome 9.
The squamous microcell hybrids behaved in vitro like epithelial cells ; they formed close 
contacts with adjacent cells, and when plated out at low density, they grew as small 
discrete colonies. Spindle cells grown under the same conditions extend long 
pseudopodia into the empty spaces on the tissue culture dish, and carB cells, in 
particular, lift off as a sheet when they approach confluence. In contrast, these cells piled 
up on top of one another, and remained attached to the dish when they reached 
confluency (Figure 10). Some clones of A5 and carB formed vacuoles following the 
introduction of human chromosome 9 (see Figure 11).
All clones isolated in the selection medium were found to harbour the fusion gene (see 
Figure 12), and most clones retained the majority of chromosome 9, which is in contrast 
to the findings for other chromosomes. The allelotype data of the microcell hybrids is 
summarised in Figure 13.
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Figure 9 : Morphology of A5 K l-9  microcell hybrid clones.
All four A5 clones shown above are epithelial in 
morphology. The cells have a regular, cobblestone 
appearance, and grow in tightly-packed colonies. 
The cells remain characteristically epithelial even 
at the outer edges of the colony, as shown for 
clones C l and D4. (Magnification : x 10).
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Figure 11 : Cultures of A5 or carB, harbouring an introduced human 
chromosome 9, contain cells with many vacuoles.
(Magnification : x 20)
^  A 5  c l o n e s  c a r B  c l o n e s
-8 m ^1 II-------------------------------------- 1
"ST)J 2  <  o ^ < U U U Q < < < < f f l C Q C Q Q Q Q Q Q
D9S143
D9S157
D9S165
D9S158
HyTK <  18 7 b p
Figure 12 : PCR microsatellite analysis of A5 and carB Klhytk9 microcell hybrids.
The donor cells, K lhytk9, are positive at all markers tested, indicating 
that the human chromosome they harbour is probably intact. A5 and 
carB parental cells are negative at all markers, and are included as 
negative controls. Although all the microcell hybrids contain the HyTK 
fusion gene, and most contain the markers D9S143, D9S157, and 
D9S158, some of the clones have lost the region containing marker, D9S165.
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to the findings for other chromosomes. The allelotype data of the microcell hybrids is 
summarised in Figure 13.
In vitro growth characteristics.
Despite the fact that the microcell hybrids assumed a more epithelial morphology than 
the corresponding parental cell lines, and grew as tightly-packed colonies of cells, 
analysis of protein expression by Western analysis in the clones, revealed that they did 
not express E-cadherin or the keratins, but maintained vimentin expression (data not 
shown).
It was deemed necessary to analyse the growth of these cells in culture, and compare 
their growth rate with that of the parental cells. To this end, we set up growth curves of 
all the cells. Figure 14 shows the growth rate of A5 or carB parental cells, and their 
respective chromosome 9 microcell hybrids.
The most slowly-growing clone, D6 , was one of the two carB clones which had retained 
an intact chromosome 9. The second clone, A6 , appeared to proliferate more quickly. 
Clones such as Al and B l, which grew at the same rate as the parental cells, had lost the 
proximal region at D9S156. However, so had clones A2 and D l, which had slightly 
slower growth rates. None of the carB clones appeared to express p l6  protein (data not 
shown), despite the fact that this region appeared to be present in the clones.
The A5 clones all grew more slowly than the parental A5 cells, but at a similar rate to 
the control cells, DOTAP12, which were A5 cells, containing a hygromycin resistance 
plasmid. In general, no correlation was found between the retention of particular areas 
of the introduced chromosome and rate of growth or between retention of thep l6  locus 
and proliferation in vitro.
Tumour suppression.
Having observed a partial reversion of the phenotype in some of the clones which 
harboured human chromosome 9, we wished to assess whether this change in 
morphology was accompanied by alterations in the ability of these cells to produce 
tumours following introduction into nude mice. 1 x 106 cells were injected 
subcutaneously into the flanks of the mice at two separate sites per mouse, and three 
mice were injected with each clone. The mice were monitored regularly, and sacrificed 
when at least one of their tumours reached 1cm in one dimension. The incidence and 
average latency for tumour formation for the different clones is shown in Figure 15. The 
four A5 clones were clearly suppressed in their ability to form tumours, as shown by the
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reduction in incidence of tumours (Figure 15b), coupled with a reduced growth rate of 
those tumours which did arise (Figure 15a). For the carB microcell hybrids, the only 
clone which appeared to be suppressed was the only clearly squamous clone, D1 (Figure 
15).
In all cases, without exception, undifferentiated spindle carcinomas were produced. This 
is consistent with loss of the locus on human chromosome 9 responsible for tumour 
suppression and reversion of the spindle phenotype. It will be particularly informative to 
examine these tumours using numerous microsatellite markers to map the locus which is 
responsible for the change in phenotype of the suppressed clones.
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Discussion
DISCUSSION
The initial aim of this work was to define the genetic basis of spindle carcinoma cells. In 
particular, we have utilised two novel approaches for the identification of putative 
tumour suppressor loci important at this stage in tumour progression. The first of these 
employed somatic cell hybrids. This method enabled us to investigate chromosome 
segregation in spindle revertants as well as in tumours generated by injection into nude 
mice.
There were several potential problems with the use of these particular hybrids for 
generating tumours, which have become apparent during the course of the study. The 
main disadvantage of this approach was the level of nude mouse contamination in the 
samples. This complicated the interpretation of the results in some cases. This was 
particularly evident in the data from the Southern blot analysis, which did not strictly 
correlate with the results of the deletion mapping study.
Problems with contamination from normal tissue are inherent in any allelotype analysis 
of tumours. Nevertheless, careful surgical procedures can be employed in most cases to 
minimise the extent of the contamination. In some circumstances, microdissection might 
be appropriate. However, in tumours which are highly vascularised, and have a high 
degree of host lymphocyte infiltration, such as the tumours used in this study, 
contamination cannot be avoided.
In addition, we have discovered that nude mice are actually outbred, and polymorphisms 
segregate within the nude mouse population. In future analyses of this kind, it would be 
prudent to obtain normal tissue from all of the mice used in the study, to allow the 
comparison of paired normal and tumour samples, and to enable an assessment of the 
extent of contamination.
Nevertheless, significant conclusions have been reached regarding the possible locations 
of tumour suppressor genes important in the genesis of carB x C5N hybrid tumours.
The second approach involved the introduction of single human chromosomes into 
mouse spindle carcinoma cell lines by chromosome transfer. In many respects, this was 
the more successful of the two approaches. In addition to being able to select for 
phenotypic changes, the use of interspecies microcell hybrids facilitates much finer 
mapping of the loci of interest, since every microsatellite marker is informative. The 
only disadvantage of this technique was that certain chromosomes were not tolerated by
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the cell lines. This may have been due to powerful growth inhibitors or senescence 
genes on these chromosomes, which may not necessarily be related to genetic events in 
the recipient cell. Nevertheless, this approach has been validated by the findings on 
chromosome 9 in both spindle cell lines, and the data from the introduction of 
chromosome 15 into A5 cells. This is the method of choice for future work on this 
system.
7.1. The mechanism o f ras amplification in spindle cells
The data from the FISH experiments enabled us to clarify a problem related to the 
expression levels of normal and mutant Yi-ras in the B9 and A5 cells. Prior to this 
investigation, molecular analysis had shown that the ratio of maternal to paternal copies 
of chromosome 7 was 2:1 in both cell lines. However, the level of expression of mutant 
H-ras was substantially elevated in A5 compared with B9, and A5 expressed lower 
amounts of the normal allele than B9. The duplication of one allele of chromosome 7 
was not sufficient to explain the level of overexpression of the mutant gene in A5. 
However, Fluorescence in situ Hybridisation using a ras gene probe confirmed that the 
double minute chromosomes contained mutant copies of H-ras.
Since A5 and D3 have only three copies, compared with B9 cells which have five or six 
copies of this chromosome, and since the ratio of maternal to paternal copies of 
chromosome 7 was 2:1, we conclude that B9 probably has three or four copies of the 
chromosome carrying the mutant H-ras allele, and two copies with normal H-ras. In A5 
and D3, the ratio remains 2:1, thus they have only one copy of the normal allele, but the 
mutant H-ras is greatly amplified on extrachromosomal double minutes. This particular 
example emphasises the advantage of using a combined molecular and cytogenetic 
approach to address this problem.
In addition to the increase in copy number identified in B9, these cells also seem to 
possess a chromosome, a portion of which hybridises to the chromosome 7 paint. The 
identity of the chromosome to which it is fused is not known, nor is the significance of 
the translocation in determining the phenotype of the cells. These squamous B9 cells 
must have diverged from the A5 and D3 clones prior to this translocation event, as it is 
absent from both of the spindle clones.
7.2. Mutant //-ras  drives malignant progression.
The level of mutant H-ras, or more precisely the ras gene dosage, appears to be one of 
the driving forces behind malignant progression in this system. While an initiated cell 
expresses equivalent amounts of normal and mutant Yi-ras, in papillomas and squamous
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carcinomas, the balance shifts in favour of the mutant allele, predominantly by whole 
chromosome changes. Finally, in some spindle cell lines, a further increase in 
expression is achieved by localised amplification of the mutant H-ras gene on double 
minute chromosomes, such as in A5 and D3, while in other spindle cell lines, for 
example carB and carC, they have completely lost the wild-type allele.
carB and carC have only two or four copies of chromosome 7, and have no double 
minute chromosomes, but they only express mutant H-ras (Robert Crombie,PhD 
thesis, 1993). Therefore, all copies of chromosome 7 harbour a mutant allele of H-ras. In 
these cells, the complete loss of the normal allele of H-ras may obviate the requirement 
to overexpress the mutant allele by gene amplification. Nevertheless, re-introduction of 
the wild-type H-ras does not reverse the spindle phenotype (Robbie Crombie, PhD 
thesis, 1993).
The involvement of ras genes in human cancer is not limited to their activation by point 
mutations. Significant amplification of ras genes (regarded as greater than 10-fold) has 
been observed in a variety of human tumours, although the overall incidence of ras gene 
amplification in human neoplasia is only about 1% (Fujita et al.,1985;- Pulciani et 
al.,1985). However the biological significance of these results is not clear since 
increases in ras transcripts of up to 8 -fold can be detected during normal cellular 
processes such as liver regeneration. Nevertheless, as in mouse skin tumours, loss of the 
normal ras allele has been observed in tumour cell lines as well as in tumour biopsies 
(reviewed in Bos, 1989).
7.3. Thresholds o f  ras activity mediate progression : proliferation versus 
differentiation.
We have already stated that the ras gene dosage appears to be one of the main driving 
forces for tumour progression and may also facilitate the transition to the spindle 
phenotype. The level of expression of the mutant allele increases in a stepwise manner 
during tumour progression, and these thresholds of activity may dictate the behaviour of 
the cell types at different stages.
Studies in which ras oncogenes were introduced by transfection into cultured cells have 
established that a link exists between the level of ras oncogene expression and the 
acquisition of the metastatic phenotype. However, this correlation does not always exist, 
and it appears to depend on the cell type.
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A similar situation exists in the fungus, Aspergillus nidulans, in which the ras 
homologue, A -ras, regulates developmental decisions through changes in the level of 
active GTP-bound protein (Som and Kolaparthi,1994). By manipulating the levels of 
active and inactive A -ras in this organism, development proceeds in an orderly manner, 
by virtue of a series of thresholds of ras activity. Each of these allow development to 
proceed to a certain point, thereby producing the proper cell type, while at the same 
time, preventing further development beyond this point.
Although the complete loss of differentiation is associated with cells from the advanced 
spindle carcinomas, this is a progressive loss of the capacity to differentiate, manifested 
throughout all stages of mouse skin carcinogenesis. Ordinarily, cells must cease 
proliferation in order to enter the terminal differentiation pathway, and the fact that a 
single molecule occupies a central role in regulating both proliferation and 
differentiation tightly couples the two processes. The role of ras as the central player 
controlling the growth and differentiation of a cell is therefore a vital one which is 
controlled at several levels. The strongest of these is the switch between the GTP-bound 
(active) and GDP-bound (inactive) states. Alterations in the proportions of each of these 
two forms can markedly alter the cellular phenotype. This has been demonstrated in 
vitro whereby increasing the amount of signalling through the EGF receptor pathway in 
PC 12 cells altered the balance between proliferation and differentiation 
(Marshall, 1995).
The ras family of proteins mediate a wide variety of functions in diverse organisms. In 
Drosophila melanogaster, ras is involved in adult eye development (reviewed by Ridley 
and Hall, 1992), and in the development of the vulva in Caenorhabditis elegans (Han 
and Stenberg,1990). In Xenopus, the possible involvement of ras in induction of the 
mesenchymal phenotype has been shown, whereby FGF, signalling via the ras pathway, 
can induce different types of mesoderm in a dose-dependent manner (Whitman and 
Melton,1992).
This body of evidence leads us to a possible model for mouse skin tumour progression, 
in which alterations in the ras signal output might lead to phenotypic changes by 
upsetting the equilibrium in favour of proliferation. At higher threshold levels found in 
late stage spindle carcinomas, as well as further increasing proliferation, ras might also 
play a role in promoting the epithelial-mesenchymal conversion and acquisition of the 
metastatic phenotype in these cells, as well as preventing differentiation. This simple 
model is depicted in Figure 1.
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7.4. H-ras and cyclin D l : partners in crime.
Overexpression of cyclin D1 has been suggested to play a role in the pathogenesis of a 
variety of human tumours. The G1 cyclins bind the cy cl in-dependent kinases and are 
necessary for their activation in late Gl. These active complexes are then able to bind 
and phosphorylate pRb, and allow entry of the cells into S phase. Deregulation of cyclin 
D1 therefore leads to a shorter Gl period, and consequently to an increase in cellular 
proliferation.
In mouse skin cell lines, we have found a direct correlation between the levels of mutant 
H -ras, and the expression of cyclin D l. For instance, in the spindle cell lines, A5 and 
D3, both proteins are overexpressed to similar levels. Since they lie close to one another 
on distal mouse chromosome 7, it was possible that they may have been co-amplified on 
the double minute structures. However, this turned out not to be the case, implying that 
ras controls the levels of cyclin Dl. This has been shown more directly in the immortal 
keratinocyte cell line, C5N, as well as in other labs. Introduction of ras into C5N cells 
or other mouse epithelial cells (Filmus et al.,1994) as well as into NIH3T3 fibroblasts 
(Liu et al.,1995), or primary rat fibroblasts (Lovec et al.,1994) caused an elevation in 
cyclin Dl levels in all cases. In the case of the NIH3T3 cells, the authors went as far as 
to claim that the increase in expression of cyclin Dl was necessary for ras 
transformation in these cells. This statement seems surprising in view of the fact that 
NIH3T3 cells have deleted the p l6 INK4A cdk inhibitor, which itself will partly release the 
cell cycle from negative regulation. Nevertheless, these independent studies provided 
the first evidence of the link between events at the cell membrane and cell cycle control, 
and they provide some clues to the mechanism of cellular transformation.
7.5. p53 and gene amplification.
It is known that normal human cells are non-permissive for gene amplification and wild- 
type p53 is one of the genes required to maintain this state. (Livingstone et al.,1992 ; 
Yin et al.,1992). p53 is found to be mutated or lost predominantly at the benign- 
malignant transition in mouse skin carcinogenesis (Kemp et al., 1993a). For the two 
spindle cell lines, A5 and D3, loss of function mutations in p53 may have given rise to 
an environment permissive for gene amplification. In B9, these same mutations may 
have contributed to genomic instability leading to translocations and insertions. 
Interestingly, the other two spindle cell lines, carB and carC, which do not contain 
double minute chromosomes or amplified mutant H-ras, retain wild-type p53 function 
(Bums et al.,1991).
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As well as wild-typep53, carB, one of the most malignant spindle carcinoma cell lines, 
has a diploid karyotype. Although at first somewhat surprising, this is in agreement with 
the model initially proposed by Dutrillaux et al. (1990) to explain the genetic evolution 
of tumour cells in breast cancer, which was more recently extended by Devilee and 
Comelisse (1994).
The authors concluded that the establishment of the invasive and metastatic phenotype 
may precede the development of DNA aneuploidy, since they discovered that diploid 
tumour cell populations with equivalent metastatic potential persisted after the 
development of aneuploidy.
In addition, they found that the DNA index in near-diploid tumours was inversely 
proportional to the frequency of structural chromosomal rearrangements. Thus, despite 
the fact that the number of chromosomes in these cells appears to be normal, their 
composition has altered in favour of a tumourigenic phenotype. So although carB cells 
may carry two copies of chromosome 7, as do normal cells, these chromosomes harbour 
mutant copies of H-ras, which contribute to its malignant phenotype.
7.6. Genetic changes found in vivo are maintained in vitro ; trisomy o f chromosomes 
6 and 7 in papilloma cell lines.
Cytogenetic analysis (Aldaz et al.,1989), and subsequently, molecular analysis (Kemp et 
al., 1993b), revealed frequent trisomy of chromosomes 6 and 7 in both papillomas and 
carcinomas. In papillomas, these were the only abnormalities found, indicating that they 
are early events. It was therefore not surprising to find three copies of both these 
chromosomes in the cell lines derived from chemically-induced papillomas in this 
study.
Papillomas are the expanded population of initiated cells, and Aldaz et al. (1989) have 
proposed that following TPA treatment, this genetically unstable population of cells 
undergo random chromosomal changes. Later, clones develop from the cells bearing 
trisomy of chromosome 6 , presumably because this duplication may impart on them a 
selective growth advantage.
Cowell (1980) has also reported frequent trisomisation of chromosome 6 in mouse 
bladder epithelial cell lines transformed in vitro by DMBA, and Fusenig et al. (1985) 
reported consistent over-representation of chromosome 6 in the majority of 
spontaneously transformed mouse keratinocyte cell lines. Mouse chromosome 6 is
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syntenic with human chromosomes 7 and 12, which frequently show trisomies in human 
tumours of the colon and ovary, respectively (Bardi et al.,1991; Pejovic et al.,1990).
The possible genetic basis for duplication of mouse chromosome 6 , or human 
chromosome 7, can be explained by a look at the ras and met pathways. The region of 
homology shared between mouse 6 and human 7 includes the met protooncogene, which 
is the receptor for hepatocyte growth factor (HGF). Depending on the cell type, and 
growth conditions, scatter factor (SF) or HGF can mediate several distinct activities, 
including cell motility, proliferation, invasiveness, and angiogenesis. Furthermore, 
Graziani et al. (1993) have shown that HGF can activate ras.
Other candidate genes on mouse chromosome 6 , which could also enhance the growth 
of early initiated cells, include raf-1, which is one of the downstream targets of ras. 
Kemp et al. (1993b) have therefore proposed that trisomy of chromosome 7, leading to 
duplication of the mutant H-ras allele, requires a concomitant increase in raf-1 
expression, which might otherwise be rate-limiting for transmission of growth signals 
through the ras pathway (Howe et al.,1992; Cuadrado et al.,1993). Thus activation of H- 
ras by mutation is followed by duplication of the mutant allele on chromosome 7. 
Trisomy of chromosome 6 may result in an increase in the amount of raf-1, which could 
maximise the signal output.
7.7. Development o f aneuploidy is associated with mouse skin tumour progression.
"Acquired genetic lability permits stepwise selection of variant sublines and 
underlies tumour progression." (Nowell, 1976).
The biological characteristics of tumour progression have been well studied. Neoplastic 
cells acquire the capacity to invade locally, and metastasise, to increase their 
proliferative capacity, and to show escape from normal growth control. At the same 
time, it is common for tumours to show alterations in their morphology and metabolism. 
These biological events represent the effects of acquired genetic instability in the 
neoplastic cells. Studies on a number of different neoplasms have led support to this by 
showing that there is generally a good correlation between increasing aneuploidy and a 
more malignant phenotype (Nowell et al.,1976). While such correlations do not prove 
causality, they do provide an explanation for the observation that such variants arise at a 
frequency which is too high to be explained by known rates of somatic mutation in 
normal cells.
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Aneuploidy appears to be a relatively early event in the mouse skin carcinogenesis 
system, with a high level of chromosomal instability characteristic of very early 
chemically-induced papillomas (Conti et al.,1986 ; Aldaz et al., 1987). The two 
papilloma cell lines, PI and P6 , also appeared to be aneuploid. The early appearance of 
genetic instability particularly in this system may be related to an event that occurred 
during initiation, or to the action of the tumour promoter.
The ras oncogenes are present in 10% of the most common forms of human neoplasia, 
making them the most frequently identified oncogene family in human cancer 
(Bos, 1989). Furthermore, the fact that they are regularly and reproducibly activated 
following treatment with a wide range of chemical carcinogens not only in mouse skin 
(Quintanilla et al.,1986; Brown et al.,1986; Brown et al.,1990), but also in multiple 
other tissues in mice and rats, indicates that ras oncogenes participate in the initiation of 
tumour development. To date, there is no evidence to suggest that activation of H-ras 
might lead directly to genomic instability, nor that this should result in inaccuracies 
during cell division. However, it may be its propensity to increase cell proliferation 
which may lead to an increased probability of further mutations in genes with those 
functions, simply because there are more target cells.
Despite the fact that tumour promoters are not mutagenic in different test systems 
(Lankas et al.,1977; Thomson et al.,1980) and do not bind covalently to DNA, there is 
cumulative evidence that TPA induces aneuploidy in various systems (Fusenig et 
al.,1985; Parry et al.,1981 ; Dzarlieva and Fusenig,1982 ; Dutton and Bowden,1985). A 
single application of TPA, at smaller doses than those used in mouse skin 
carcinogenesis protocols, induces single-strand breaks, enhances numerical and 
structural chromosomal aberrations, and leads to gene amplification in mouse skin 
keratinocytes (Petrusevska et al.,1988). Compounds which prevent such phorbol ester- 
induced clastogenic effects, such as inhibitors of arachidonic acid metabolism, act as 
anti-promoting agents when tested in the classical initiation-promotion protocol (Fischer 
et al.,1982). These compounds do not interfere with the hyperproliferative response 
induced by TPA (Petrusevska et al.,1988), indicating that TPA-induced chromosomal 
alterations play a critical role in the conversion of mouse skin.
7.8. A single clonal stemline is observed in cell lines derived from several different 
stages o f tumourigenesis.
One must be cautious when interpreting karyotype results obtained from in vitro cell 
culture, due to the fact that continuous cell lines retain the capacity for genetic variation 
which is not apparent in finite cell lines. This is evident in our immortal keratinocyte
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line, C5N, which has multiple copies of each chromosome. The two main reasons for 
this are the elevated rate of spontaneous mutations in vitro (presumably arising from the 
higher rate of proliferation), and the fact that cells with altered karyotypes are not 
eliminated unless their capacity for growth is impaired. Nevertheless, the data indicates 
that most of the other cell lines were composed of a single clonal germ-line, such that 
deviations from the mean number could be explained by loss or gain of chromosomes 
during preparation. In a few cases, for example, in P6, with respect to chromosomes 6 
and 7, a small, but significant population of cells contained four copies of the 
chromosomes, which cannot be attributed to preparation of the metaphase spreads. It is 
entirely plausible that further selection for over-representation of these chromosomes 
has taken place in culture. In the cases of carB and carC, the presence of two sub­
populations within both of these cell lines may have consequences for allelotype 
analyses. With this in mind, it may be of use to sub-clone the two populations.
A number of the cell lines examined in this study appeared to have a pseudotetraploid 
karyotype. One can speculate as to the origin of the extra chromosomes. Perhaps 
generalised trisomy has occurred followed by duplication of certain of the 
chromosomes, or alternatively tetraploidy followed by chromosome loss. In either case, 
the observed aneuploidy is an indicator of the infidelity of cell division, such that 
following DNA replication, chromosomes are not evenly distributed between daughter 
cells. Nevertheless, it appears that in most cases, although this process is essentially 
random, a specific chromosome complement is selected, giving rise to a population of 
cells which have essentially the same karyotype.
This is in keeping with the model of Devilee and Comelisse (1994), which states that if 
a cell is genetically unstable, multiple chromosomes are usually affected, only a 
proportion of which are important for tumour development. Depending on which 
chromosomes are involved, a clear selective growth advantage may be imparted on the 
cell. There is accumulating evidence that despite the presence of extensive tumour 
heterogeneity, the genetic evolution of the tumour cells eventually reaches a state of 
equilibrium.
7.9. The genetic evolution of tumours.
Although devised from an extensive study of various aspects of human breast 
carcinomas, the main principles of Devilee and Comelisse's rather complicated theory 
are generally applicable to other systems (Devilee and Comelisse, 1994). Their model is 
depicted in Figure 2, alongside the changes identified in mouse skin carcinogenesis.
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In the context of mouse skin carcinogenesis, we could propose that genetic instability 
would be initiated by mutations in crucial genes, including H-ras. In turn, these events 
might increase the probability of further mutations by increasing the number of cells in 
which they could occur. The model proposes that in this phase, structural chromosomal 
rearrangements would predominate, associated with chromosome loss, and/or loss of 
heterozygosity, as well as being instrumental in causing DNA amplification. In mouse 
skin tumours, trisomy of chromosomes 6 and 7 in benign papillomas, followed, in 
malignant tumours, by mutation and LOH at p53, itself involved in preventing gene 
amplification, all take place during this phase, as the model predicts. Their scheme 
further proposes that the resulting tumourigenic clone, at this stage, would be 
hypodiploid, and would then enter into stage two, which consists of endoreduplication. 
This would allow further modulation of chromosome copy number, and dependent on 
which chromosomes are involved, this might result in a clear selective growth 
advantage, giving rise to a single aneuploid tumour cell stemline. The model assumes 
that the growth advantage at the latter stages might be imparted due to alterations in 
gene dosage rather than by an increased number of molecular genetic alterations.
The cytogenetic data accumulated here agrees well with the predicted alterations in 
karyotype from the model. In the papilloma cell lines, only whole chromosomal changes 
were detected by the FISH analysis, while the B9, A5 and D3 cell lines carried both 
numerical and structural chromosomal aberrations. This model is also compatible with 
the data from Slaga's lab showing evidence of aneuploidy in papillomas in vivo 
following TPA treatment (Conti et al.,1986; Aldaz et al.,1987).
Devilee and Comelisse (1994) correctly point out that several discrete clones may 
coexist in a tumour giving rise to multiple stemlines. Cytogenetic examination of 
tumours in situ might address this property of tumour heterogeneity, however, in 
analysing the karyotypes of explant cultures, as we did, a single clonal population is 
preferentially selected when the tumour is placed in tissue culture. This is a separate 
issue from the finding that over a long period in culture, most of these cell lines have a 
single clonal stemline. They appear to be genetically stable, in that they have reached a 
state of equilibrium. The fact that tumours are heterogeneous illustrates that there are 
many routes to tumourigenesis, and this is highlighted in our study by the contrasting 
findings between our two sets of spindle cell lines, A5 / D3 and carB / carC, not only 
with respect to the cytogenetic analysis, but also at the molecular genetic level.
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7.10. The spindle phenotype behaves as a recessive trait in whole cell fusions.
Somatic cell fusions between the clonally-related squamous and spindle cell lines, B9 
and A5, enabled us to prove that the loss of a tumour suppressor gene(s) occurs 
specifically at the squamous to spindle transition. The hybrids were predominantly 
epithelial, although following serial passage in culture, a small subset of these converted 
to a spindle morphology. The squamous clones re-expressed the various markers 
characteristic of epithelial cells, and lost the expression of the fibroblastic proteins. In 
effect, the differentiation pathway in the hybrid cells was re-programmed down an 
epidermal lineage. In vivo, this was tightly linked to the suppression of tumourigenicity 
: epithelial hybrids produced tumours at around the same time as the parental B9 cells, 
and the resulting tumours were relatively well-differentiated squamous carcinomas. This 
is entirely in agreement with the well established dogma that "suppression of 
tumourigenicity is associated with the imposition on the hybrid cell of the terminal 
differentiation programme of the (more) normal parent" (Harris et al.,1996). In contrast, 
carB x C5N hybrids, although initially suppressed, still produced Grade III and IV 
carcinomas (Stoler et al.,1993).
Stromelysin expression is not detectable in normal skin, but is transiently induced by 
TPA treatment (Wright et al.,1994), presumably mediated by AP-1. A small percentage 
of papillomas and around 3/4 of all squamous cell carcinomas produced by DMBA / 
TPA treatment have elevated levels of ST-1 mRNA, however this is localised to the 
stroma surrounding the lesions. In spindle cell carcinomas, the tumour cells often 
acquire the ability to express stromelysin themselves (Wright et al.,1994).
ST-1 transcript was detectable in tumours arising from injection of the M SC lla cell 
line, both in the tumour and in the adjacent stroma. The cell line, A5, expresses 
detectable levels of stromelysin in culture, while the corresponding B9 cell line does not 
(Wright et al.,1994). JunB is an inhibitor of AP-1 dependent transcription. Analysis of 
junB transcription and protein levels in these cells revealed that they were essentially 
equivalent, implying that more subtle post-translational modifications which affect the 
activity of the protein may be important. In agreement with this hypothesis, the activity 
of junB, as determined by band-shift assays, appeared to be high in B9, but virtually 
absent in A5 (Howard Crawford, personal communication).
Thus these cell lines, derived from a carcinoma induced by multiple DMBA treatment, 
have acquired the ability to express stromelysin, independent of TPA-induced AP-1 
activity, perhaps by a mechanism involving junB. Somewhat paradoxically, our most
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invasive cell line, carB, which was induced by DMBA / TPA treatment does not express 
stromelysin.
7.11. Allelotype analysis - identifying putative tumour suppressor loci.
Whole cell fusion between carB and C5N gave rise to epithelial hybrids which re­
expressed epithelial proteins, and which were suppressed in their ability to form 
tumours. The appearance of spindle revertants in vitro, or undifferentiated spindle 
carcinomas in vivo was thought to be due to the segregation of whole chromosomes or 
loss of heterozygosity at tumour suppressor loci in the hybrids, which are involved in 
the transition from squamous to spindle carcinomas.
Having established that the spindle phenotype behaved as a recessive trait in whole cell 
fusions, we wished to use traditional methods of LOH analysis to try to identify putative 
tumour suppressor loci. In this system, we made the assumption that the gene was lost 
in spindle cells by the mechanism proposed by Knudson (1971). In other words, the 
spindle cell line, carB, which had no detectable deletions at any of the loci carried 
mutant copies of the tumour suppressor gene, while the non-tumourigenic, epithelial 
parent, C5N, harboured wild-type alleles. The loss of regions of the C5N chromosomes 
which have been detected in the tumours, corresponds to the second hit in this model, 
which eliminates the remaining wild-type copy of the gene.
An allelotype analysis of spindle revertant clones and tumours revealed alterations at 
many different chromosomal loci. The large number of changes could reflect a general 
instability of the hybrid cells, however, although such instability is characteristic of 
human-mouse hybrids, intraspecies hybrids are, in contrast, deemed to be more stable. If 
losses had occurred randomly, one might expect to see some losses of the carB allele in 
the tumours, or for that matter, losses of either allele in the hybrid cells, which have 
been maintained in culture. Neither was observed.
One can assume that in tumours, cells with the greatest ability to establish and grow in 
the nude mouse will predominate. In such an environment, it is more likely that a 
successful cell will be one which has retained "tumourigenic" chromosomes, from the 
carB parent, and which has lost chromosomes from C5N, which presumably retain 
functional tumour suppressors. Thus regions on each of these chromosomes may indeed 
play a role in the development of the tumour.
carB cells represent the end-point of tumourigenesis. They are aggressive cells, which 
can establish a tumour, promote extensive vasculature within the tumour, and in some
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cases use this blood supply to colonise other sites of the body. Trying to dissect out the 
numerous events in this cell line at the molecular level would be an arduous task, 
especially as many of these may be incidental. By the use of cell hybrids, we have 
developed a unique system to genetically characterise this cell line, which should 
identify those events essential to its properties, and for the most part, ignore 
consequential changes. carB was itself derived from a spindle carcinoma. The changes 
which had to occur in these cells would have been brought about in response to pressure 
to establish and proliferate in the context of an in vivo environment. These same sorts of 
selective pressures are not present in vitro, and perhaps this is why we saw few changes 
in culture, and alterations were only revealed when the cells were injected into mice and 
formed a tumour.
Deletion mapping of tumours generated by subcutaneous injection of carB x C5N 
hybrid clones into nude mice revealed putative tumour suppressor loci on mouse 
chromosomes 4 and 7 which are potentially involved in the acquisition of the spindle 
phenotype.
Mouse chromosome 7
Deletion mapping of tumours generated by injection of carB x C5N hybrids into nude 
mice identified two loci on chromosome 7. Despite the fact that loss of the normal l i ­
ras allele is sometimes selected for in spindle tumours, and indeed has occurred in the 
carB parental cell line, H-ras lies outwith both of the minimal regions of deletion. 
Nevertheless, several of the tumours appear to have lost the entire distal region of this 
chromosome, including H-ras.
The locus defined in the study was more frequently deleted in tumours which showed 
loss of H-ras. Therefore, it could be argued that the loss of more proximal sequences 
was merely a consequence of an event designed to eliminate the H-ras gene. Deletion of 
Region A/B was also detected in those tumours which, from the allelotype analysis, 
appeared to retain the H-ras gene, indicating that there may be a separate locus involved 
in tumour suppression on mouse chromosome 7. However, it remains a possibility that 
these tumours have also deleted H-ras by a small interstitial deletion, which has not 
been detected using the available informative markers. It is difficult to resolve these two 
possibilities in view of the problems associated with the contamination from the nude 
mouse.
In previous studies in this system, the level of mutant YL-ras appeared to correlate with 
tumourigenicity. A5 cells which expressed higher levels of mutant H-ras gave rise to 
tumours after a shorter latency compared with revertants which had lost some of their
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double minute chromosomes, harbouring mutant copies of H-ras. However, altering the 
ras gene dosage in spindle cells in favour of the normal allele did not cause any change 
in the morphology of the cells (Robbie Crombie, PhD thesis, 1993). In this study, the 
ratio of normal : mutant H-ras varied considerably between the different tumours. As 
with the previous study, there appeared to be no correlation between the amount of H- 
ras, and the morphology of the cells in the tumours, although this was difficult to assess 
accurately in view of the problems with nude mouse contamination. With respect to the 
latency for tumour formation, it was evident that clone 9, which had much more normal 
H-ras compared with mutant, was suppressed to a much greater extent than clone 6, 
which showed an approximate 2:1 ratio in favour of the mutant allele. Thus in general 
there is good agreement between the two studies.
Region A / B is a large region which extends from 29cM to 56.5cM. It shares synteny 
with human chromosome 15q, and human llp l5 , which is the site of numerous tumour 
suppressor genes. The region contains several interesting loci, such as the c locus at 
44cM (Brilliant et al.,1996), which is also the location of a papilloma resistance locus in 
NIH mice (Nagase et al., 1995). A locus which confers resistance to chemically-induced 
carcinomas (in spretus mice), maps outside of this region, at 26cM (Nagase et al., 
1995).
Mouse chromosome 4
The presence of tumour suppressor loci on mouse chromosome 4 has been proposed for 
some time. Early studies by Harris and colleagues demonstrated that suppression of 
malignancy in hybrids between different malignant mouse tumours and normal mouse 
fibroblasts required the retention of the chromosome 4 derived from the normal cell 
(Evans et al.,1982). Analysis of hybrids harbouring a translocation involving 
chromosome 4, permitted localisation of the critical region to the lower part of the upper 
half of the chromosome.
The involvement of mouse chromosome 4 in mouse skin carcinogenesis was first 
suspected during an allelotype analysis of papillomas and carcinomas from FI hybrid 
mice (Kemp et al., 1993b). However, the data implicated the loss of most or all of the 
spretus chromosome 4 in these two carcinomas, and therefore was of little use in 
defining the locus driving the loss. Nevertheless, it seemed likely that loss of 
chromosome 4 was a late event, as both carcinomas were poorly or undifferentiated 
spindle cell carcinomas. Further analysis on chromosome 4, focused on the changes 
between B9 (squamous) and A5 / D3 (spindle) cell lines (J.Liddell, PhD thesis, 1995). 
Although all three cell lines suffered trisomy of chromosome 4, in favour of the
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musculus (CBA) allele, B9 had a recombination affecting the distal portion of the 
chromosome, below marker D4Mitl3. This resulted in a ratio of 2:1 CBA : spretus 
above this marker, and amplification of the spretus allele with respect to the CBA allele 
below this marker in B9. In both studies, there is a loss or reduction in the spretus allele 
in spindle carcinomas or spindle carcinoma cell lines affecting all markers distal to 
D4Mitl3.
The data presented here has enabled us to confirm the involvement of mouse 
chromosome 4 in mouse skin tumourigenesis, and predict the locations of two putative 
tumour suppressor loci. Most of the markers on chromosome 4 used in the deletion 
mapping have not yet been accurately mapped, nevertheless we suspect that Region 1, 
from D4Mitl66 to D4Mit58, probably maps to between 42.6cM and 45.5cM. (The 
interval in which D4Mitl66 is likely to reside is given as between 42.6cM and 45.5cM, 
and D4Mit58 probably resides at 45.5cM.) This region borders the interferon cluster at 
42.6cM, and includes c-jun at 44.6cM, and is also likely to include thep l6  locus.
Despite the fact that the majority of tumours had deletions involving Region 1, only a 
proportion of them showed deletion of the p i6 gene by Southern blotting. It is likely 
that several more of the tumours have deleted the gene, but this has been masked by the 
presence of contaminating normal DNA. From the Southern blot analysis, tumours 33 
and 34 were amongst those tumours which had deleted p l6 , although this was not 
detected by the deletion mapping study, using the closest available informative 
microsatellite markers to pl6 . In fact, these tumours (as well as tumours 14 and 66, 
which also appeared to retain Region 1) are likely to be of most use in any attempt to 
narrow the region further. Interestingly, these four tumours were the same ones which 
showed an imbalance in favour of mutant H-ras.
Region 1
Interestingly, a modifier gene has been mapped to mouse chromosome 4. In spretus 
mice, it confers resistance to chemically-induced papillomas, and this locus overlaps 
with Region 1 identified above (Nagase et al., submitted for publication).
Miyasaki et al. (1995) have examined explant cultures from chemically-induced mouse 
hepatocellular carcinomas, and reported the smallest region of LOH also in this area. 
The tumour suppressor locus in these three studies may therefore be the same, and as 
suggested, is probably p i  6, or a gene located very close to it.
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Region 2.
Region 2 maps to between markers, D4Mitl26 and D4Mit48. D4Mitl70, which is just 
proximal to D4Mitl26, has been accurately mapped to 66.4cM, while D4Mitl26 is 
probably located within the range, 66.2cM to 76.5cM. The minimal region, as defined 
by tumour 66, extends to D4Mitl3 / D4Mit48, located at 71cM, thus the deletion must 
at least extend this far. The smallest region of deletion is approximately 4.6cM in size. 
All eighteen tumours appeared to retain marker D4Mit59 at 78.9cM, although the size 
of the spleen band at this marker was similar in size to the C5N allele.
Region 2, and its syntenic region on human chromosome 1, both carry several potential 
candidate genes. The multiple intestinal neoplasia (A/m) mouse is the murine model for 
familial colon cancer. The mice carry a mutation in the Ape gene, which leads to 
development of multiple intestinal adenomas (Moser et al.,1990). The number of 
tumours is modified dramatically when this mutation is bred onto different genetic 
backgrounds. One of the major loci responsible, mom-1 (for modifier o f min) (Dietrich 
et al.,1993), was mapped to distal mouse chromosome 4, at 66.6cM, and lies within the 
most distal region defined by this study.
Candidate tumour suppressor genes which lie within this region are DAN / N03, which 
has been shown to possess tumour suppressive activities when introduced into \-src- 
transformed rat fibroblasts (Ozaki and Sakiyama,1994), and Id3, a member of the family 
of helix-loop-helix proteins, which are believed to play a central role in the regulation of 
cell growth, differentiation and tumourigenesis (reviewed by Jones, 1990, and Solomon 
et al.,1991). Further analyses are necessary for their characterisation and evaluation as 
tumour suppressors.
Herzog et al. (1994, 1995) performed LOH and deletion analyses on mouse lung 
tumours, and identified two regions of loss on mouse chromosome 4, specifically in 
adenocarcinomas. The first region implicated the p l6  locus, and the second region 
centred around the marker D4Mit54. They concluded that these two regions on mouse 
chromosome 4 were important for the progression stage of mouse lung tumourigenesis. 
There is considerable overlap between these loci and the regions identified in this 
analysis, leading to the possibility that the same genes may be involved in both types of 
tumours.
An allelotype analysis of tumours generated in NIH / spretus FI backcross mice 
indicates a region which is lost in 9/23 carcinomas and 2/8 papillomas, and which 
extends from D4Mitl66 to D4Mitl2, an area which includes Region 1 (F.Fee, personal
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communication). A proportion of these tumours also showed deletion of the more distal 
region. The fact that the same two regions were identified in the backcross tumour 
analysis, as well as in the carB x C5N hybrid tumours indicates, that the putative tumour 
suppressor loci identified in this study may also be involved in chemically-induced 
mouse skin tumours.
The tumour suppressor genes located within these two regions appear to be important in 
a range of tumour types. Zhuang et al. (1996) also identified LOH at these positions on 
mouse chromosome 4 during an allelotype analysis of chemically-induced T-cell 
lymphomas.
The fact that four independent studies, analysing diverse tumour types, all yielded the 
same two loci on chromosome 4 is intriguing. Furthermore, the fact that the two loci are 
frequently deleted together by two separate deletion events, implies that the genes may 
act coordinately in tumour cells.
Considerable homology exists between the distal region of mouse chromosome 4 and 
human chromosome lp36-34. And, in contrast to the scattering of reports on the 
location of cancer-related genes on mouse chromosome 4, there is a plethora of papers 
on human lp as the common site of allelic loss in several types of cancer.
Chromosome 1 changes are frequent in virtually all forms of human cancer, and include 
deletions, translocations, and duplications, such as trisomy or localised gene 
amplification (reviewed in Schwab et al.,1996 and Weith et al.,1996). Almost all of the 
deletions have been found in solid tumours, rather than leukaemias, and almost all of 
these involved the short arm (lp). Distal lp  (lp35-36) which is syntenic with the distal 
region identified here, on mouse chromosome 4, was the most common site of deletion, 
found to be involved in neuroblastoma, melanoma, hepatoma, colon cancer, breast 
cancer, Merkel cell tumour and germ cell tumours. Larger deletions which include this 
area were detected in pheochromocytoma, medullary thyroid cancer, and meningioma. 
Interestingly, deletion of the distal short arm of chromosome lp  is a late event in 
melanoma (Dracopoli et al.,1989), colorectal cancer (Leister et al.,1990), and 
meningiomas (Bello et al.,1994), and correlates with enhanced metastatic potential and 
poor prognosis in neuroblastomas (Brodeur et al.,1984; Gilbert et al.,1984).
Functional demonstration of the presence of tumour suppressor genes on human 
chromosome 1 was achieved by somatic cell genetics. In crosses between human 
fibrosarcoma cells (HT1080) and normal human fibroblasts, Benedict et al (1984) found
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that reappearance of malignancy in hybrids, in which it was initially suppressed, was 
systematically associated with the loss of chromosome 1 from the normal parent. 
Introduction of a normal human chromosome 1 by Kugoh et al (1990) completely 
suppressed tumourigenicity in vivo, and the cells had a reduced growth rate, a flatter 
morphology, and a lower colony-forming efficiency, compared with parental HT1080 
cells in vitro. However, analyses by Stanbridge's group (Anderson et al.,1994), argue 
that wild-type p53, and not genes on chromosome 1 or 11, control the tumourigenic 
phenotype of these cells.
7.12. Corroborating the evidence by functional studies.
In an attempt to further define the functions and relevance of each of these loci, we 
attempted to introduce a normal human chromosome, containing the relevant syntenic 
loci into two of our spindle cell lines. The rationale for this approach was based on two 
important assumptions; firstly, that the position of the loci in mice and humans was 
conserved, and secondly, that the function of the human and mouse genes was 
conserved.
The molecular approach was limited by the fact that even with fairly divergent mouse 
strains, only a relatively small proportion of the microsatellite markers were 
informative. In addition, the deletions found in mouse cell lines and primary tumours 
are usually fairly large, and therefore contain thousands of candidates. Thus, by using 
the microcell transfer procedure, not only do we gain some clues as to the function of a 
gene, but, in addition, by generating interspecies microcell hybrids, every molecular 
marker is informative. This allows more accurate mapping prior to the employment of 
more traditional molecular cloning procedures, for isolation of the gene.
It has been difficult to reconcile the data obtained from the deletion analyses on 
chromosomes 4 and 7, with the results obtained from the functional studies using the 
chromosome transfer procedure. This was due to the fact that carB cells did not appear 
to tolerate intact copies of either human chromosome 11 or 15. The carB clones grew in 
selection medium containing hygromycin, due to the presence of the hygromycin gene 
derived from the introduced chromosome, as demonstrated by PCR. However, retention 
of an intact chromosome 11 or 15 appeared to be incompatible with cell growth and 
proliferation, such that the only clones obtained were those that had eliminated most of 
the introduced chromosome. The same was true for chromosome 11 in A5 cells. We are 
convinced that this is a specific effect, related to the genes introduced on each of the 
chromosomes, as A5 and carB microcell hybrid clones retained an intact copy of a 
different human chromosome through many generations.
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7.13. Human chromosome 11 causes growth inhibition o f spindle cells 
The observation that neither cell line was able to tolerate an intact copy of chromosome 
11, might indicate that there are one or more genes on this chromosome which play 
roles in cell proliferation. Some of these may also be important for tumour suppression.
A5 cells express the normal H-ras gene, albeit at low levels, whereas carB has deleted 
the normal allele, inferring that A5 can exist as a proliferating spindle cell, even in the 
presence of normal H-ras. In carB cells, there appears to have been selection for loss of 
the normal allele, and for that reason, introduction of normal H-ras on chromosome 11 
into these cells may decrease proliferation in vitro. However, on the basis of a separate 
set of experiments, it appears unlikely that introduction of the normal H-ras allele 
would be the only driving force for the loss of the chromosome, since overexpression of 
normal H-ras by transfection into A5 or carB cells did not lead to growth suppression or 
toxicity (Robert Crombie, PhD thesis, 1993). In addition, the fact that the rest of the 
chromosome was also lost, indicates that other genes, present on this chromosome may 
have the capacity to suppress growth.
One of the genes which may be involved might lie in the syntenic region of 
chromosome 11 which corresponds to the deletion identified in the carB x C5N hybrid 
tumours. If the gene suppresses growth in vitro, as we are proposing, then why is there 
an apparent contradiction between the hybrid tumour studies and the microcell transfer 
experiments. Introduction of the gene from C5N cells into carB by whole cell fusion 
appears to be tolerated in vitro but must be deleted in vivo, while we propose that 
introduction of the equivalent locus on human chromosome 15 into carB is not even 
tolerated in vitro. One explanation is that we may be dealing with two closely-linked 
loci with different functions; the gene on mouse 7 may be a tumour suppressor, but the 
gene located on human 11 may cause growth suppression. In this case, the hybrids may 
actually have inactivated the growth suppressor gene in vitro, prior to injection, which 
we have not detected. This would be analogous to the locus identified by the microcell 
transfer experiments. The deletion we detect in the tumours may identify the potential 
location of a tumour suppressor which is distinct from the growth suppressor. The 
presence of a tumour suppressor is difficult to demonstrate in this assay if there are 
potent growth inhibitors nearby.
As further support for a growth suppressor on chromosome 11, Stanbridge's lab also 
failed to obtain any carB clones harbouring an intact human chromosome 11 (Eric 
Stanbridge, unpublished observations).
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Human chromosome 11 harbours both tumour suppressor and metastasis suppressor 
activities in other carcinoma cell lines, such as the fibrosarcoma line, HT1080 (Kugoh et 
al.,1990), and the cervical carcinoma cell line, HeLa (Saxon et al.,1986). Not 
surprisingly, re-introduction of the normal Wilms' tumour genes, located at l lp l3  and 
l lp l5 , also led to a reduction in tumourigenicity in a Wilms' tumour explant (Weissman 
et al.,1987). However, chromosome 11 also has a growth suppressor function when 
introduced intact, or as subchromosomal fragments into rhabdomyosarcoma cells (Koi 
et al.,1993). Furthermore, the ability of this chromosome to cause a doubling in the 
latency of tumour formation of a murine squamous cell carcinoma line was due to the 
fact that growth in vitro was repressed (Zenklusen et al.,1995). Thus the findings 
reported here confirm previous reports that the mechanism of action of tumour 
suppression produced by human chromosome 11 is through a decrease in the growth 
rate of the neoplastic cells.
Since the consequences of introducing human chromosome 11 into markedly different 
tumour types appear to be almost universal, with a few notable exceptions (Oshimura et 
al.,1990), the question arises as to whether the effects are meaningful in the context of 
the individual tumours. In other words, the outcome may be unrelated to earlier genetic 
events specific to that tumour cell, and might merely be a consequence of a strong 
growth inhibitory gene(s) on that chromosome. Nevertheless, if this were the case, one 
would have to propose a mechanism whereby certain cell types could overcome this 
growth inhibition, and thereby remain refractory to the effects of introducing this 
chromosome. Such proposals might include a reference to the fact that perhaps elements 
downstream of this growth inhibitory pathway are dysfunctional or have been 
eliminated from these exceptional cases. On the other hand, they may simply have 
become refractory to these growth inhibitory signals, in much the same way as cells 
which are no longer responsive to the growth inhibtory signals of TGF[3. Finally, such a 
proposal might speculate that potent growth stimulatory genes can overcome the 
inhibition imposed by gene(s) on the introduced chromosome. Only identification of the 
relevant genes and pathways will allow a more complete understanding of the 
consequences of introducing this chromosome.
7.14. Human chromosome 15 causes growth suppression of carB cells.
There was a marked difference in the response of the two cell lines to the introduction of 
a human chromosome 15. A total of sixty clones of carB were analysed by PCR for the 
presence of human microsatellites. None of the clones retained an intact copy of 
chromosome 15. In contrast, out of twenty A5 clones examined, over a quarter of these
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retained substantial portions of the introduced chromosome. This data demonstrated that 
the effects were specific to this chromosome, and were not due to technical difficulties. 
From the whole cell fusions, it appeared that the defect in the two cell lines leading to 
the spindle phenotype lay on the same pathway, since hybrids between carB and A5 
remained characteristically spindle (Stoler et al.,1993). However, from this data, it 
appears that at the level of growth suppression in vitro, the cells may differ.
The significance of the effects caused by introduction of chromosome 15 into either A5 
or carB, remain elusive. The fact that we were unable to obtain any carB colonies which 
had retained even a small portion of the chromosome, implies that there may be strong 
growth suppressors on this chromosome which are not tolerated by carB cells. In 
contrast, several A5 clones retained large portions of chromosome 15.
It is difficult to predict possible candidate loci. However, by examining those A5 
revertant clones which harbour small deletions of the introduced chromosome, we can 
begin to define more accurately the putative tumour suppressor loci. In these cells, there 
was a small common deletion centred around the FES marker at 15q26.1. In all but one 
clone, the deletion extended to a marker located at around 15q25, but did not include the 
region at 15q24. Interestingly, the deletions identified on mouse chromosome 7 in the 
carB x C5N hybrids encompassed the region which is syntenic with 15q23-qter. The 
results from the functional analysis therefore correlate well with those obtained from the 
molecular allelotype analysis.
One interesting candidate at this locus is the Bloom syndrome gene, located at 15q26.1 
(Straughen et al.,1996). Individuals with Bloom syndrome (BS) have a significant 
predisposition to cancer. The product of this gene is thought to be involved in 
maintaining genomic integrity, since BS cells are characterised by a generalised genetic 
instability (Foucalt et al.,1996).
Aberrations in human chromosome 15, including loss of one copy, have been detected 
in three out of five human skin squamous carcinoma cell lines, where it is proposed to 
be a late event. As confirmation of its tumour suppressor role, introduction of a normal 
copy by chromosome transfer into these cell lines resulted in significant tumour 
suppression (Boukamp et al.,1995). This further underscores the similarities between the 
mouse skin model and human squamous cell carcinomas of the skin, which also exhibit 
p53 and H-ras mutations.
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7.15. Human chromosome 9 causes partial reversion of the spindle phenotype. 
Introduction of human chromosome 9 by microcell transfer into either A5 or carB cells 
gave rise to squamous colonies. Despite the fact these cells resembled epithelial cells in 
their morphology, and behaved like epithelial cells, forming close contacts with adjacent 
cells, they did not express proteins whose production is associated with epithelial cells. 
We therefore conclude that human chromosome 9 causes a partial reversion of the 
spindle phenotype.
In other instances, such as in the whole cell fusion experiments, reversion to a squamous 
phenotype was accompanied in most cases with a change to a more epithelial 
morphology, re-expression of epithelial proteins including E-cadherin and the keratins, 
and loss of vimentin protein, as well as a reduction in tumourigenicity in the nude 
mouse assay. From those experiments, it appeared that the various aspects of the 
reversion were co-ordinately controlled. In contrast, the results of the microcell 
experiments imply that the various functions can be separated. Introduction of 
chromosome 9 appeared to be able to revert the morphology of the cells, and cause a 
significant reduction in tumourigenicity in those epithelial cells, but appeared to have no 
effect on the expression of either of the epithelial proteins examined.
One possible explanation draws on experiments in which A5 and carB cells were 
transfected with plasmids encoding E- or P-cadherin, in an attempt to revert them to a 
squamous morphology (Navarro et al.,1991). While the authors were able to detect 
cadherin protein, which was associated with the a -  and |3-catenins, they were unable to 
detect any y-catenin / plakoglobin in these complexes. This is in contrast to the situation 
found in normal epithelial cells, where all three catenins associate with E-cadherin. Thus 
the presence of high levels of E-cadherin protein did not force these cells to undergo a 
reversion to a squamous morphology, nor did it influence the tumourigenic behaviour of 
the cells. Since changes in the catenin complex, or modulation of their interaction with 
the cadherins can be directly involved in the loss of functional intercellular adhesion 
involved in tumour progression, then it follows that complete restoration of the adhesion 
complex is necessary to reverse the tumourigenic process.
Although we could not detect E-cadherin, the cells nevertheless remained in close 
contact with one another, even when seeded at low density. Thus we propose that some 
of the other proteins involved in cell-cell contact must be re-expressed in the hybrids, or 
there may be subtle alterations in the integrins, such as changes in the particular 
isoforms which are expressed in the hybrids compared with those found in spindle cells.
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Strikingly, those clones which reverted to a squamous morphology were dramatically 
suppressed in their ability to form tumours when injected into nude mice, both with the 
time taken for tumours to appear, as well as the incidence of tumours. Thus the 
morphology of the microcell hybrids remained closely correlated with their ability to 
form tumours in nude mice.
This reduction in tumourigenicity was not due to a reduction in the proliferative 
capacity of the squamous cells versus the spindle cells, as measured by growth of the 
cells in vitro. The carB clone, D l, which formed tumours at only four out of six sites, 
after a long latency, had an intermediate growth rate with respect to the other spindle 
clones. All of the other carB clones had a 100% take incidence, and produced tumours 
with a latency similar to the carB parental cell line. All four squamous A5 clones grew 
slower than the parental cells in vitro, but grew at the same rate as the DOTAP12 cell 
line (A5 transfected with a plasmid conferring resistance to hygromycin), which 
produced tumours as quickly as the parental A5 cells. The reduction in growth rate in 
vitro was therefore not regarded as sufficient to explain the marked difference in the 
ability of the clones to produce tumours.
7.16. p l6  as the gatekeeper to the spindle phenotype.
Human chromosome 9, and in particular, 9p21, is commonly associated with loss of 
heterozygosity in a wide range of human solid cancers, including glioma, malignant 
melanoma, and small cell lung cancer, but formal proof of its tumour suppressor role by 
MMCT has only been reported in the case of endometrial carcinoma (Yamada et 
al.,1990), and malignant melanoma (England et al., 1996). For the most part, the losses 
can be attributed to the presence of thep l6 INK4a gene, and in several cases, this has been 
demonstrated directly by re-introducing the gene into carcinoma cell lines (Arap et 
al.,1995; Jin et al.,1995; Enders et al.,1996).
Molecular studies had previously shown that there was a close association between loss 
of p l6  and the loss of differentiation seen in spindle carcinomas (Linardopoulos et 
al.,1995), implying that p l6  may be the spindle gene. With respect to the microcell 
transfer experiments, this did not entirely hold true. p l6  is located at 9p21, which 
corresponds to the region between D9S162 and D9S171. This region was retained in all 
four A5 clones, as might be expected, since A5 already expresses large amounts of p l6  
protein. Only half of the carB clones retained this region, and there was no correlation 
between retention of this region, and the morphology of the clones : the most squamous 
clone, Dl, had deleted this region (as had two of the spindle clones, A l and A2), while 
the other spindle clones, A6, B1 and D6 retained this portion of chromosome 9.
108
However, none of the carB clones appeared to express the human p l6  protein at levels 
detectable by Western blotting analysis. The fact that the parental carB cells have 
deleted their endogenousp l6  may mean that expression of the protein is not tolerated in 
these spindle cells.
In addition, fusion of B9 and A5, both of which express pl6 , results in epithelial 
hybrids, so in this case too, reversion to the squamous phenotype was not due to 
introduction of p i  6. Despite this evidence against p l6  being responsible for the spindle 
conversion, the fact that alterations o ip l6  are consistently found in spindle carcinomas, 
implies that this is a necessary step for conversion to the spindle phenotype. However, 
alterations at this locus are not sufficient for the spindle conversion, as exemplified by 
clone Dl above, which has partially reverted to the squamous phenotype, in the absence 
of p l6  protein. In this sense, p l6  may act as a gatekeeper gene, in much the same way 
as Kinzler and Vogelstein (1996) proposed for APC in colorectal carcinoma. In 
squamous cells, expression of p i  6 appears to be important, since no squamous cells had 
lost expression of the protein (Linardopoulos et al.,1995). Thus, other alterations 
observed at this step, such as the imbalance in ras alleles, as well as events prior to the 
transition, such as loss of wild-type p53 function, appear to be insufficient to cause the 
epithelial-fibroblastoid conversion in the absence of alterations at the p i  6 locus.
This association between the phenotype of the cells and the expression of p l6  is also 
evident in somatic cell hybrids. Examination of carB x C5N hybrid cells by Western 
blot analysis, revealed that the squamous hybrids expressed p l6  protein. Furthermore, 
fusion of carB with the papilloma cell lines, or with the squamous carcinoma, B9, also 
generated squamous hybrids (Stoler et al.,1993), which expressedp l6  (Linardopoulos, 
unpublished observations). In contrast, hybrids generated between A5 and carB were 
spindle (Stoler et al.,1993), and did not express p i6 (Linardopoulos, unpublished 
observations), even though the A5 parental cells overexpress the p l6  protein 
(Linardopoulos et al.,1995).
From the microcell transfer experiments, we conclude that a second gene on 
chromosome 9 is ultimately responsible for the partial reversion of the spindle 
phenotype. And further predict that if this gene were introduced into A5 or carB cells, in 
the presence of sustained production of p i  6 protein, then we might be able to cause full 
phenotypic reversion of the spindle cells.
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7.17. Human chromosome 9 candidates
Mouse chromosome 4 is syntenic with a large part of human chromosome 9q (Abbott et 
al.,1992). LOH has been reported here in basal cell carcinomas arising in patients with 
Gorlin syndrome (Gailani et al.,1992). The gene which predisposes to this, and another 
autosomal dominant disorder which affects epithelial morphology, has been mapped to 
this same region. In Ferguson-Smith Syndrome, affected individuals intermittently 
develop locally invasive squamous carcinomas which then spontaneously regress 
(Goudi et al.,1993). Although multiple cutaneous lesions occur in both conditions, the 
morphology and clinical course of the skin lesions are quite distinct. It has been 
proposed that the two conditions may be caused by different mutations within the same 
gene, the human homologue of the Drosophila/?atfc/*e<i gene (Gailani et al.,1996).
Patched RNA is not detectable in normal skin, however in tumours, mutational 
inactivation of the gene leads to a decrease in patched protein, and consequently, to 
overexpression of the mutant transcript.
The similarities between our skin carcinomas and those found in the two inherited 
syndromes make patched an interesting and important candidate for the gene on 
chromosome 9. Patched RNA could easily be detected in the panel of mouse 
keratinocyte cell lines, although the levels of expression did not vary significantly 
between benign and malignant lesions, or between squamous and spindle carcinoma cell 
lines (Carol McCormick, personal communication). The fact that the transcript could be 
detected in the cell lines implies that at least one allele of patched has been mutated, 
since the transcript is not detectable in normal skin.
7.18. TGF[3 and the spindle phenotype
It has become apparent through studies in this laboratory, that there are at least two 
alternative mechanisms for becoming a spindle cell. The most common situation is that 
the squamous and spindle cells are genetically fixed, and cannot be interconverted, 
either by prolonged passage in culture, or by alterations in the growth conditions, for 
example by addition of growth factors, or growth on an extracellular matrix. 
Furthermore, exposure to radiation or treatment with demethylating agents, also fails to 
convert the cells to either phenotype.
In other tumour cells, which have been found to overexpress p l5  and p l6 , TGF(3 has 
been shown to play a very different role. Injection of a lymph node metastasis cell line 
into different sites of a nude mouse produced markedly different tumours : subcutaneous 
injection generated spindle tumours, while cells injected intraperitoneally, gave rise to
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tumours composed of more epithelial cells. This indicated that the microenvironment 
exerted a dramatic influence on the cellular morphology of this clone. This reversible 
switch could be mimicked in vitro by treatment with the growth factor, TGF(3 (Portella 
et al., submitted for publication). The cells adopted a more motile, fibroblastic 
morphology, and loss of functional E-cadherin complexes was noted in these cells 
within several hours after treatment (Jennifer Liddell, PhD thesis, 1995). This ability of 
TGF(3 to induce an epithelial-mesenchymal transition in vitro was also demonstrated in 
ras-transformed mammary epithelial cells (Miettinen et al.,1994). In these experiments, 
there appeared to be co-operation between TGFp and oncogenic H-ras in modulating 
this invasive phenotype, since under the same conditions, normal mammary epithelial 
cells underwent growth arrest. Furthermore, it was evident that the converted cells 
began to produce their own TGFp in an autocrine fashion, in order to maintain their 
fibroblastoid phenotype.
7.19. p i  6, Rb and differentiation
Spindle carcinoma cells have several features : uncontrolled proliferation, loss of cell 
adhesion, and loss of differentiation. Introduction of human chromosome 9 restored 
some degree of cell adhesion together with a reduction in tumourigenic potential. 
However, the cells did not express epithelial differentiation markers, indicating that 
differentiation was still blocked. The cells may require a functional pRb / p i 5 I p i 6 
pathway for differentiation. This may in part be due to the ability of p i5  and p l6  to 
prevent phosphorylation of the pRb protein and thereby cause growth arrest in G l, but 
in addition, this may be due to a more direct role for pRb in differentiation.
In muscle cells, pRb has been found to complex with the myoD transcription factor 
involved in coordinating the production of a series of muscle-specific transcripts (Gu et 
al.,1993). It plays a similar role in adipocytes, where it binds and activates the C/EBPa 
transcription factor. Rb -/- fibroblasts, even in the presence of large amounts of the 
C/EBPs, are unable to differentiate (Chen et al.,1996), highlighting the essential role 
played by Rb in the differentiation of this cell type. Epithelial cells might have a similar 
differentiation-controlling transcription factor which activates transcription from the 
promoters of E-cadherin, keratins and other genes associated with epidermal 
differentiation. Indeed, an element has been identified in the promoter region of both 
genes which would allow coordinate expression of these, and other genes, important for 
epidermal differentiation (Behrens et al.,1991).
I l l
7.20. The Gl/S checkpoint in the spindle cell cycle
In spindle carcinomas, the cell cycle plays a key role. Numerous defects have been 
identified, which lie on a common pathway involved in the control of progression 
through the Gl/S checkpoint. Figure 3 is a model of the cell cycle as it occurs in spindle 
carcinoma cells.
In both spindle cell lines, elevated levels of ras activity stimulate overexpression of 
cyclin Dl. In carB cells, deletion of the cdk inhibitors, p l5  and p l6 , releases the 
negative influence of this pathway on pRb-mediated progression. Although p53 is wild- 
type in carB cells, this cell cycle brake is only activated in instances where there is DNA 
damage. carB cells are near-diploid cells with no observable structural rearrangements 
or gene amplifications, perhaps as a consequence of this. Alternatively, elements 
upstream of the p53 gene may be altered in these cells.
In A5 cells, p i  6 is overexpressed, but it is almost all bound to cdk6, which is also 
overexpressed in these cells. This allows the cdk4/cyclin Dl complex to bind and 
activate pRb. p53 is also inactivated in these cells, which releases the second brake on 
Gl/S progression.
Cells not expressing a functional pRb pathway cycle faster, and deregulated expression 
of cyclin Dl shortens the G1 phase and increases cell proliferation (Quelle et al.,1993; 
Sherr,1994; Resnitsky et al.,1994). In certain granulocyte cell lines, the G1 cyclins have 
been shown to block differentiation (Kato and Sherr,1993). In this way, the various 
alterations in the cell cycle may explain the behaviour of spindle cells with respect to 
cell proliferation and differentiation.
Thus functional inactivation of the p i  6, or p53, or both pathways, which act as brakes at 
the Gl/S checkpoint, appears to be associated with the spindle transition. Restoration of 
one or both of these pathways are likely to be necessary for full reversion.
7.21. The Way Ahead
The approaches employed in this study, have permitted the assignment of tumour 
suppressor genes involved in mouse skin carcinogenesis, to individual chromosomes. In 
the future, it is hoped that we will be able to employ the use of the microcell hybrid 
clones, generated during the course of these studies, to narrow the region containing the 
gene(s) responsible for the phenotype. In addition, the tumours generated by injection of 
the squamous chromosome 9 microcell hybrid clones are likely to have lost the putative
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tumour suppressor gene. Allelotype analysis of these tumour samples will also enable 
finer mapping studies, prior to the employment of positional cloning approaches.
A locus has been identified on human chromosome 15, which corresponds to the 
putative tumour suppressor locus identified on mouse chromosome 7 in the intraspecies 
hybrids. In addition, a second locus, which is distinct fromp l6 , has been identified on 
human chromosome 9. This locus identifies the site of a bona fide tumour suppressor 
gene, which is also capable of causing a partial reversion of the spindle phenotype.
The association of human chromosome 9 with this particular phenotype can be 
confirmed by reverse selection. In this case, treatment of the squamous chromosome 9 
microcell hybrids with ganciclovir, would be expected to revert the cells back to a 
spindle morphology, and eliminate any tumour suppressive effects, due to loss of the 
introduced chromosome.
The candidate gene approach will also be employed. Several interesting candidate genes 
lie within the regions identified on human chromosomes 9 and 15. These include the 
human homolog of Drosophila patched on chromosome 9q, and the Blooms syndrome 
gene on chromosome 15q26.1. Roles for both of these genes can be envisaged in the 
progression of mouse skin tumours. The status of these genes will be examined in the 
microcell hybrid clones. The syntenic mouse loci were originally identified in 
intraspecific hybrids generated by fusion of a mouse keratinocyte line with a 
chemically-induced spindle carcinoma cell line. However, these same regions were 
identified as putative tumour suppressor loci in an allelotype analysis of chemically- 
induced mouse skin tumours, indicating that they are relevant to the mouse skin 
carcinogenesis model. The status of these, and other, candidate genes shall therefore be 
examined in the panel of mouse skin cell lines.
Finally, it is hoped that the function of the distal mouse chromosome 4 locus can be 
defined, by introduction of human chromosome 1. This locus was found to be deleted in 
all tumours examined in this study, so it is likely to be extremely important in the 
genesis of these tumours. In addition, since loss of this region of mouse chromosome 4, 
or human chromosome lp34-36, is seen in a wide variety of tumour types, it is likely 
that genes located in these regions play a central role in neoplasia. Preliminary 
experiments to try to introduce this human chromosome, appeared to cause senescence 
in both cell types. For this reason, modifications of the chromosome transfer procedure, 
which involve the introduction of subchromosomal fragments may need to be 
investigated.
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